Sentence,class,file
b. http://mutationassessor.org/.c.,Non-OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
http://gpcr2.biocomp.unibo.it/cgi/predictors/I-Mutant3.0/I-Mutant3.0.cgi; RI refers to Reliability Index.d.,OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
http://mmb2.pcb.ub.es:8080/PMut/; RS refers to Reliability Score.e.,OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
http://mutpred.mutdb.org/; Pdel refers to the probability that the variant is a deleterious mutation.f.,Non-OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
http://snps-and-go.biocomp.unibo.it/snps-and-go/; RI refers to Reliability Index.g.,OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
http://www.pantherdb.org/tools/csnpScoreForm.jsp; Pdel refers to the probability that a given variant will cause a deleterious effect on prot ein function.,OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Murphy SL, Xu J, Kochanek KD.",Non-OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
http://www.health.govt.nz/system/ ﬁles/ documents/publications/fetal-infant-deaths-2008-2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
"http://www.stats.govt.nz/Census/2006CensusHomePage/QuickStats/quickstats-about-a-subject/culture-and-identity/ethnic-groups-in-new-zealand.aspx 21 Napolitano C, Priori SG, Schwartz PJ, et al.",OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
"http://www.rcpa.edu.au/Library/Publications/Joint-and-Third-Party-Guidelines/Guidelines/Guidelines-on-Autopsy-Practice 640 Glengarry JM, et al.Arch Dis Child 2014; 99:635–640.",Non-OADS,/arxiv_data1/oa_pdf/64/67/archdischild-2013-305331.PMC4078670.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Knowles E, Mason S, Colwell B.",Non-OADS,/arxiv_data1/oa_pdf/bd/fb/emermed-2012-202129.PMC4078671.pdf
Available online at http://www.who.int/violence_injury_prevention/publications/services/39162_oms_new.pdf 3 The Ambulance Service Network.,Non-OADS,/arxiv_data1/oa_pdf/bd/fb/emermed-2012-202129.PMC4078671.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Polosa R, Caponnetto P, Morjaria JB, et al.",Non-OADS,/arxiv_data1/oa_pdf/c6/96/tobaccocontrol-2013-051459.PMC4078672.pdf
http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201304&RIN=0910-AG38 16 Family Smoking and Prevention Tobacco Control Act.,Non-OADS,/arxiv_data1/oa_pdf/c6/96/tobaccocontrol-2013-051459.PMC4078672.pdf
13 A.D. http://www.michigan.gov/documents/mdch/E_cig_factsheet_for_SF_law_website_FINAL6.11.10_324451_7.pdf 18 Maryland Department of Transportation MTA.,Non-OADS,/arxiv_data1/oa_pdf/c6/96/tobaccocontrol-2013-051459.PMC4078672.pdf
2013. http://mta.maryland.gov/advisories/marc-news-and-updates 19 State of Delaware Tobacco-Free Workplace Policy.,Non-OADS,/arxiv_data1/oa_pdf/c6/96/tobaccocontrol-2013-051459.PMC4078672.pdf
2013. http://www.delawarepersonnel.com/policies/ 20 Oklahoma Department of Corrections.,Non-OADS,/arxiv_data1/oa_pdf/c6/96/tobaccocontrol-2013-051459.PMC4078672.pdf
2013. http://www.ok.,Non-OADS,/arxiv_data1/oa_pdf/c6/96/tobaccocontrol-2013-051459.PMC4078672.pdf
2013. http://doc.sd.gov/about/policies/documents/ Tobacco%20Products%20and%20Electronic%20Cigarettes-Use%20and% 20Possession.pdf 22 Consumer Protection; Products and Sales Distribution of Tobacco Products.,Non-OADS,/arxiv_data1/oa_pdf/c6/96/tobaccocontrol-2013-051459.PMC4078672.pdf
"2011 [cited Oct. 17, 2013].http://www.no-smoke.org/pdf/modelordinance.pdf iii40 Gourdet CK, et al.Tob Control 2014; 23:iii37–iii40.",OADS,/arxiv_data1/oa_pdf/c6/96/tobaccocontrol-2013-051459.PMC4078672.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Farsalinos KE, Romagna G, Tsiapras D, et al.",Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
BusinessWeek: Companies & Industries February 2013. http://www.businessweek.,Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
15 Sebastian M. NJoy E-cig TV spot insists ‘friends don ’t let friends smoke ’.Advert Age 2 January 2014. http://adage.com/article/media/njoy-e-cig-tv-spot-insists-friends- friends-smoke/290886/ (accessed 11 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
"Wikipedia, 2014. http://en.wikipedia.org/wiki/ Electronic_cigarette (accessed 11 Mar 2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
Fed Regist 2014. http://federalregister.gov/a/2014-09491.,OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
Wells Fargo Securities 2013. http://www.smallcap ﬁnancialwire.com/wp-content/uploads/2013/11/E-Cigs- Revolutionizing-the-Tobacco-Industry-Interactive-Model.pdf (accessed 11 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
Euromonitor International 23 November 2012. http://blog.euromonitor.,Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
Smokefree Alternatives Trade Association 27 August 2013. http://www.sfata.org/fda-corrects- misleading-wall-street-journal-report-regarding-the-ban-on-electronic-cigarettes-online-sales/ (accessed 11 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
"An introduction to R. The R Project for Statistical Computing, 6 March 2014. http://cran.r-project.org/doc/manuals/R-intro.",Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
"US Food and Drug Administration, 2011. http://www.fda.gov/newsevents/ publichealthfocus/ucm252360.htm (accessed 11 Mar 2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
CBS NEWS 16 February 2012. http://www.cbsnews.com/news/ electronic-cigarette-explodes-in-mans-mouth-causes-serious-injuries/ (accessed11 Marc 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
"Ofﬁcial Journal of the European Union , L 127, 29 April 2014. http://ec.europa.eu/health/tobacco/docs/dir_201440_en.pdf (accessed 6 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tobaccocontrol-2014-051670.PMC4078673.pdf
Programme managersand their contact information were identi ﬁed and obtained from the T obacco Control Networkwebsite (http://www.ttac.org/TCN/).,OADS,/arxiv_data1/oa_pdf/a4/52/tobaccocontrol-2013-051460.PMC4078674.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Corey C WB, Johnson SE, Apelberg BJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/52/tobaccocontrol-2013-051460.PMC4078674.pdf
"To view please visit the journal online(http://dx.doi.org/10.1136/bjophthalmol-2013-304082) 1Multidisciplinary Department of Medical, Surgical and Dental Sciences, Eye Clinic,Second University of Naples,Naples, Italy 2Department of Surgical and Morphological Sciences,University of Insubria, Varese,Italy Correspondence to Dr Francesca Simonelli, EyeClinic, MultidisciplinaryDepartment of Medical, Surgical and Dental Sciences, Second University of Naples,Via S. Pansini, 5, Naples80131, Italy; francesca.simonelli@unina2.it FT and SR contributed equally.Received 28 July 2013 Revised 19 December 2013Accepted 18 January 2014 Published Online First 14 February 2014 To cite: Testa F, Rossi S, Colucci R, et al.Br J Ophthalmol 2014; 98: 946–950.ABSTRACT Aim To investigate the prevalence of macular abnormalities in a large Caucasian cohort of patientsaffected by retinitis pigmentosa (RP).Methods A retrospective study was performed by reviewing the medical records and optical coherencetomography (OCT) scans in a cohort of 581 RP patientsin order to assess the presence of macular abnormalities—that is, cystoid macular oedema (CMO), epiretinal membrane (ERM), vitreo-macular traction syndrome, and macular hole.",Non-OADS,/arxiv_data1/oa_pdf/7b/78/bjophthalmol-2013-304082.PMC4078675.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Hagiwara A, Yamamoto S, Ogata K, et al.",Non-OADS,/arxiv_data1/oa_pdf/7b/78/bjophthalmol-2013-304082.PMC4078675.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/tobaccocontrol-2012-050852).,Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
"(Detailed information is available at the MHLW website, http://www.mhlw.go.jp/topics/tobacco/main.html).",Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Eriksen M, Mackay J, Ross H. The tobacco atlas .",Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://nccd.cdc.gov/GTSSData/Ancillary/ DownloadAttachment.aspx?ID=862 (accessed 9 Apr 2013).,OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.mhlw.go.jp/ bunya/kenkou/eiyou/h21-houkoku.html (accessed 18 May 2012) (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.mhlw.go.jp/stf/ houdou/2r98520000020qbb.html (accessed 13 Feb 2012) (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.mhlw.go.jp/ bunya/kenkou/eiyou/h20-houkoku.html (accessed 18 May 2012) (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.e-stat.go.jp/SG1/estat/ eStatTopPortal.do (accessed 18 May 2012) (in Japanese).,OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.e-stat.go.jp/SG1/estat/eStatTopPortal.do (accessed 18 May 2012) (in Japanese).,OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.who.int/fctc/reporting/ party_reports/jpn/en/index.html (accessed 29 Nov 2012).,OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.who.int/fctc/reporting/ party_reports/chn/en/index.html (accessed 29 Nov 2012).,OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.who.int/fctc/ reporting/party_reports/en/index.html (accessed 29 Nov 2012).,OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://ganjoho.jp/public/statistics/pub/statistics06.html (accessed 11 Mar 2013) (in Japanese).,OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://knhanes.cdc.go.kr/knhanes/index.,Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.fctc.org/index.php?option=com_content&view=article&id=429: cop-4-guidelines-for-fctc-article-6&catid=222:meeting-resources&Itemid=230(accessed 26 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.thecommunityguide.org/tobacco/ cessation/index.html (accessed 18 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://www.thecommunityguide.org/tobacco/environmental/smokingbans.html (accessed 18 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1691348 (accessed 26 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
"http://www.asiacohort.org (accessed 29 Nov 2012).68 Bialous S Aguinaga, Peeters S. A brief overview of the tobacco industry in the last 20 years.",Non-OADS,/arxiv_data1/oa_pdf/0b/93/tobaccocontrol-2012-050852.PMC4078676.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/thoraxjnl-2013-204492).,Non-OADS,/arxiv_data1/oa_pdf/4a/2f/thoraxjnl-2013-204492.PMC4078677.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 WHO.,Non-OADS,/arxiv_data1/oa_pdf/4a/2f/thoraxjnl-2013-204492.PMC4078677.pdf
"Report on a WHO workshop Bonn, Germany 26 –27 March 2007. http://www.euro.who.int/data/ assets/pdf_ ﬁle/0007/78658/E90672.pdf [accessed June 2010].",Non-OADS,/arxiv_data1/oa_pdf/4a/2f/thoraxjnl-2013-204492.PMC4078677.pdf
"U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-08/139F, 2009. http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=216546#Download [accessed 15 June 2013].",OADS,/arxiv_data1/oa_pdf/4a/2f/thoraxjnl-2013-204492.PMC4078677.pdf
"The WHO European Centre for Environment and Health, Bonn, 2013. http://www.euro.who.int/en/what-we-do/health-topics/environment- and-health/air-quality/publications/2013/review-of-evidence-on-health-aspects-of-air-pollution-revihaap-project- ﬁnal-technical-report [accessed Aug 2013].",Non-OADS,/arxiv_data1/oa_pdf/4a/2f/thoraxjnl-2013-204492.PMC4078677.pdf
http://dx.doi.org/10.1016/S0140-6736(13)60898-3 11 Department of Health.,Non-OADS,/arxiv_data1/oa_pdf/4a/2f/thoraxjnl-2013-204492.PMC4078677.pdf
"London: Department of Health, 2007. https://www.gov.uk/government/publications/quantitative-systematic-review-of-short-term-associations-between-ambient-air-pollution-particulate-matter-ozone-nitrogen-dioxide-sulphur-dioxide-and-carbon-monoxide-and-mortality-and- morbidity (accessed 15 Feb 2013).",Non-OADS,/arxiv_data1/oa_pdf/4a/2f/thoraxjnl-2013-204492.PMC4078677.pdf
"http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317137012567 19 Lim SS, Vos T, Flaxman AD, et al.",OADS,/arxiv_data1/oa_pdf/4a/2f/thoraxjnl-2013-204492.PMC4078677.pdf
To viewthisﬁle please visit the journal online (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b2/72/tobaccocontrol-2014-051648.PMC4078680.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Yamin CK, Bitton A, Bates DW.",Non-OADS,/arxiv_data1/oa_pdf/b2/72/tobaccocontrol-2014-051648.PMC4078680.pdf
29 August 2013. http://www.nytimes.com/2013/08/30/business/media/ e-cigarette-makers-ads-echo-tobaccos-heyday.html 6 Associated Press.,Non-OADS,/arxiv_data1/oa_pdf/b2/72/tobaccocontrol-2014-051648.PMC4078680.pdf
"3 August 2013. http://www.pennlive.com/ midstate/index.ssf/2013/08/electronic_cigarettes_marketin.html 7 Noel JK, Rees VW, Connolly GN.",Non-OADS,/arxiv_data1/oa_pdf/b2/72/tobaccocontrol-2014-051648.PMC4078680.pdf
"Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Of ﬁce on Smoking and Health, 2014. http://www.surgeongeneral.gov/ library/reports/50-years-of-progress/index.html 14 King BA, Alam S, Promoff G, et al.",Non-OADS,/arxiv_data1/oa_pdf/b2/72/tobaccocontrol-2014-051648.PMC4078680.pdf
Ad Age Media News [Internet] 2013. http://adage.com/article/media/big-tobacco-spending-ads- e-cigarettes/241993/ (accessed 10 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/b2/72/tobaccocontrol-2014-051648.PMC4078680.pdf
"Pew Research Center ’s Internet & American Life Project, 2013. http://www.pewinternet.org/2013/01/15/ peer-to-peer-health-care/ (accessed 24 Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/b2/72/tobaccocontrol-2014-051648.PMC4078680.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 King BA, Alam S, Promoff G, et al.",Non-OADS,/arxiv_data1/oa_pdf/6f/44/tobaccocontrol-2014-051551.PMC4078681.pdf
"2013. http://pewinternet.org 6 Deyton LR, Woodcock J.",Non-OADS,/arxiv_data1/oa_pdf/6f/44/tobaccocontrol-2014-051551.PMC4078681.pdf
"FDA, 2011. http://www.fda.gov/NewsEvents/PublicHealthFocus/ ucm252360.htm (accessed 20 Sep 2012).",Non-OADS,/arxiv_data1/oa_pdf/6f/44/tobaccocontrol-2014-051551.PMC4078681.pdf
2013. http://socialmediatoday.com/irfan-ahmad/1854311/ twitter-statistics-IPO-infographic (accessed 15 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/6f/44/tobaccocontrol-2014-051551.PMC4078681.pdf
2013. http://www.mirror.co.uk/lifestyle/health/ tobacco-companies-pushing-e-cigs-youngsters-2854699 (accessed 3 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/6f/44/tobaccocontrol-2014-051551.PMC4078681.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Jager RD, Mieler WF, Miller JW.",Non-OADS,/arxiv_data1/oa_pdf/46/ef/bjophthalmol-2013-304736.PMC4078682.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ tobaccocontrol-2012-050831).,Non-OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
Data are from CDC National Institute for Occupational Safety and Health (NIOS H) website of Work-Related Lung Disease (WoRLD) Surveillance System (see table 9 –20 at http://www2a.cdc.gov/drds/WorldReportData/); which presents the average prevalence of current asthma among never smoking employees aged 18 and over in eating and drinking places from 1997 –2005.,Non-OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Oberg M, Jaakkola MS, Woodward A, et al.",Non-OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
http://www.who.int/tobacco/mpower/2009/en (accessed 15 Sep 2010).,Non-OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
http://www.no-smoke.org/pdf/SummaryUSPopList.pdf(accessed 18 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
http://www.no-smoke.org/pdf/current_smokefree_ordinances_by_year.pdf (accessed 17 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
http://cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.,OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
https://apps.nccd.cdc.gov/sammec/index.asp (accessed18 Oct 2010).,OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
http://www2a.cdc.gov/drds/WorldReportData/ (accessed 18 Oct 2010).,OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
http://www.bls.gov/oes/oes_dl.htm (accessed 10 Dec 2011).,OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
http://www.bls.gov/oco/cg/cgs023.htm (accessed 1 Mar 2011).,OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
http://www.bizjournals.com/ twincities/morning_roundup/2011/01/bill-would-repeal-smoking-ban-in-mn-bars.html (accessed 10 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
http://www.epa.gov/riskassessment/health-risk.htm (accessed 15 Dec 2012).,OADS,/arxiv_data1/oa_pdf/f2/24/tobaccocontrol-2012-050831.PMC4078683.pdf
"▸ACoordinating Centre , which serves as an Initiative-wide resource to fostercommunication and collaborationamong components and outside part-ners, participates in working groupsand Initiative evaluation efforts, andfacilitates the packaging and dissemin-ation of Initiative research ﬁndings.A full description of the SCTC Initiative is available at (http://sctcresearch.org/PublicHome).",Non-OADS,/arxiv_data1/oa_pdf/ba/67/tobaccocontrol-2014-051790.PMC4078685.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ To cite Rogers T. Tob Control 2014; 23:iii1–iii2.,Non-OADS,/arxiv_data1/oa_pdf/ba/67/tobaccocontrol-2014-051790.PMC4078685.pdf
2014. http://www.fda.gov/TobaccoProducts/Labeling/ ucm388395.htm (accessed 24 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/ba/67/tobaccocontrol-2014-051790.PMC4078685.pdf
See: http://creativecommons.org/licenses/ by-nc/3.0/ To cite Choonara I. Arch Dis Child 2014; 99:605 –606.,Non-OADS,/arxiv_data1/oa_pdf/f3/99/archdischild-2013-305257.PMC4078697.pdf
Received 24 October 2013 Revised 18 November 2013Accepted 20 November 2013 Published Online First 19 April 2014 ▸http://dx.doi.org/10.1136/archdischild-2013-305052 Arch Dis Child 2014; 99:605 –606.,Non-OADS,/arxiv_data1/oa_pdf/f3/99/archdischild-2013-305257.PMC4078697.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ bjophthalmol-2013-304064).,OADS,/arxiv_data1/oa_pdf/72/e2/bjophthalmol-2013-304064.PMC4078699.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Woodward DF, Liang Y, Krauss AH.",Non-OADS,/arxiv_data1/oa_pdf/72/e2/bjophthalmol-2013-304064.PMC4078699.pdf
http://www.eugs.org/eng/EGS_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/72/e2/bjophthalmol-2013-304064.PMC4078699.pdf
http://www.apglaucomasociety.org/toc/APGG2_fullversionNMview.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/e2/bjophthalmol-2013-304064.PMC4078699.pdf
"The CHTable 1 Timeline of Programme and assessment activities and contextual factors Activity 2007 2008 2009 2010 2011 Programme activity Summit on Illicit tobacco (IT) in north of England X Dec)Developing logic plan and activities X X Setting up management infrastructure: ▸Dedicated programme manager ▸Governance Board (regional governmental health leads, national enforcement (customs and excise), regional enforcement and border agencyrepresentatives), local enforcement, marketing representatives) 3 Regional steering groups and local partnershipsX X X Consumer research X ( July) X (Mar/Apr) (NW/NE) only due to regional fundingstoppage) Social marketing campaign & associated websites: http://www.get-some-answers.co.uk and http://www.keep-it-out.co.ukX ( June/July) NW/NE only Establishing main website aimed at professionals http://www.illicittobacconorth.orgX Establishing regional level enforcement posts X Agreeing 2 hotlines: Crimestoppers and Customs Hotline XEstablishing a protocol for sharing intelligence on the supply of IT among local and national enforcement bodiesXX X Development and implementation of tailored training packages for health professionals, magistrates and prosecutorsX Assessment activity Ethnographic research XX X Stakeholder interviews I X (Nov/Dec) Stakeholder interviews II X (Nov/Dec) Contextual factors Media ‘freeze ’(ie, government funds could not be used on media campaigns) X General election X (May) Recession XX X Funding stopped for Department of Health Regional Offices (Y&H activity stopped) X (Mar)Restructuring of local health service, local government, HMRC etc X X HMRC, Her Majesty ’s Revenue and Customs; NW, northwest; NE, northeast.",Non-OADS,/arxiv_data1/oa_pdf/b6/9b/tobaccocontrol-2013-050957.PMC4078700.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 HM Revenue & Customs and the UK Border Agency.,Non-OADS,/arxiv_data1/oa_pdf/b6/9b/tobaccocontrol-2013-050957.PMC4078700.pdf
"Center for Public Integrity, 2009. http://www.publicintegrity.org/investigations/tobacco/articles/entry/ 1397/ (accessed 21 Jul 2010).",Non-OADS,/arxiv_data1/oa_pdf/b6/9b/tobaccocontrol-2013-050957.PMC4078700.pdf
"Brussels, 15July 2010. http://ec.europa.eu/anti_fraud/budget/2010/BAT-Main-Agreement.pdf (accessed 21 Jul 2012).",Non-OADS,/arxiv_data1/oa_pdf/b6/9b/tobaccocontrol-2013-050957.PMC4078700.pdf
http://www.freshne.com/content/editor/File/ Illicit%20Tobacco/NoE%20ITP%20Health%20Action%20Plan%20Final%20V1-0%20180509.pdf (accessed 21 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/b6/9b/tobaccocontrol-2013-050957.PMC4078700.pdf
"http://www.nemsmr.co.uk/ (accessed 16 Nov 2012).19 General Lifestyle Survey, Smoking and Drinking among adults, 2009.",Non-OADS,/arxiv_data1/oa_pdf/b6/9b/tobaccocontrol-2013-050957.PMC4078700.pdf
"Of ﬁce for National Statistics, 2011. http://www.ons.gov.uk/ons/search/index.html?",Non-OADS,/arxiv_data1/oa_pdf/b6/9b/tobaccocontrol-2013-050957.PMC4078700.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Biegel LB, Hurtt ME, Frame SR, et al.",Non-OADS,/arxiv_data1/oa_pdf/19/3a/oemed-2014-102109.PMC4078701.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ tobaccocontrol-2013-051240).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"http://tobaccoreporter.com/home.php?id=498&art=2424: A third of the tobacco products sold in Bulgaria are illicit, according to a Novinite story quoting sources within Bulgartabac .",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
3. http://www.novinite.com/view_news.php?id=111533: Opponents to the tax hike claim that it will boost cigarette smuggling and may lead to the bankruptcy of the dominant state cigarette maker Bulgartabak.,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"http://www.stumbleupon.com/su/3Urbja/www.tobacco-news.net/bulgarias-new-cigarette-prices-come-into-force: No data but ‘Tobacco business representatives have criticised the idea of raising the excise duty, saying that it would only stimulate contraband and will not bring the expected revenue to the Budget ’.",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
6. http://www.novinite.com/view_news.php?id=114806: Almost identical to (3) above.,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
’ 8. http://www.novinite.com/view_news.php?id=106476: ‘One third of the tobacco products in Bulgaria are sold on the black market according to state owned tobacco monopoly Bulgartabac .’ ▸Recent research on tobacco industry conduct in Bulgaria 43highlights that the ﬁgures the industry uses in its discourse and lobbying on illicit tobacco in the country exaggerate the extent of the problem when compared with independent sources and yet industryﬁgures feature prominently in press coverage.,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Sources: WHO data: http://data.euro.who.int/hfadb/ downloaded 1/3/13 and 17/04/2013; OECD: ‘Tobacco Consumption among adults ’, in Health at a Glance: Europe 2010, OECD Publishing (Eurostat Statistics Database): http://www.oecdilibrary.org/docserver/download/8110161ec026.pdf?expires=1366276217&id=id&accname=guest&checksum=B1837069B1EEF937830FFDD8405DC2B5; EB: Eurobarometer 2009 data, published 2010.",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Rowell A. Britain is centre of European cigarette smuggling racket; export-for-import how billions of smokes blow back to UK.,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
BMJ 2000;321:947 –50.http://www.ncbi.nlm.nih.gov/pubmed/11030690 6 The International Consortium of Investigative Journalists.,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
2 February 2000. http://www.icij.org/node/460/global-reach-tobacco-companys-involvement-cigarette-smuggling-exposed- company-papers (accessed 2 Jul 2013).What this paper adds ▸This is the ﬁrst rigorous evaluation of Philip Morris International ’s (PMI) Project Star report widely used as a source of data on the illicit cigarette trade in Europe.,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
The Guardian 23 August 2001. http://www.guardian.co.uk/uk/2001/aug/23/smoking.conservatives (accessed 30 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"London: Houses of Parliament, 2003. http://www.publications.parliament.uk/pa/cm200203/cmse lect/cmpubacc/143/14302.htm (a ccessed 2 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Dublin: PPACTE, 2011. http://www.ppacte.eu/index.php?option=com_docman&task=doc_download&gid=187&Itemid (accessed 2 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
2013.http://ec.europa.eu/ anti_fraud/investigations/eu-revenue/cigarette_smuggling_en.htm (accessed 12 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
9 July 2004. http://ec.europa.eu/anti_fraud/documents/ cigarette-smugg-2004/agreement_2004.pdf (accessed 2 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
http://www.tobaccotactics.org/index.php?title=Philip_Morris%27_ Regulatory_Litigation_Action_Plan_Against_the_Display_Ban (accessed 26 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
October 2012. http://www.jti.com/ ﬁles/2413/5220/4070/The_Billion_Pound_Drop_ website_version.pdf (accessed 31 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
November 2012 http://www.cancerresearchuk.org/prod_consump/groups/cr_ common/@nre/@pol/documents/generalcontent/smuggling_fullreport.pdf (accessed12 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
6 August 2012. http://www.imperial-tobacco.,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
3 July 2012. http://www.jti.com/ ﬁles/4013/4149/4323/Packaging_Response.pdf (accessed 2 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Brussels: European Union, 15 July 2010. http://ec.europa.eu/anti_fraud/documents/cigarette_ smug/2010/bat_main_agreement.pdf (accessed 30 Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Brussels: European Union, 27 September 2010. http://ec.europa.eu/anti_ fraud/documents/cigarette_smug/2010_i/agreement_sept_2010.pdf (accessed 30Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Brussels: European Union, 14 December 2007. http://ec.europa.eu/ anti_fraud/documents/cigarette_smug/2007/cooperation_agreement.pdf (accessed 30 Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Dublin: PPACTE Consortium, 31 January 2012. http://www.ppacte.eu/index.php?",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
http://ec.europa.eu/taxation_customs/common/travellers/within_eu/ (accessed 16 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
2000. http://www.ash.org.uk/ ﬁles/documents/ASH_250.pdf (accessed 2 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
March 2011. http://www.ofdt.fr/BDD/publications/docs/eftxcbr3.pdf (accessed 30 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
May 2012. http://ec.europa.eu/health/tobacco/docs/ eurobaro_attitudes_towards_tobacco_2012_en.pdf (accessed 2 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Int J Equity Health 2009;8:26. http://www.equityhealthj.com/content/ 8/1/26 38 Nagelhout GE, Levy DT, Blackman K, et al .",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"http://dx.doi.org/10.1111/j.1360-0443.2011.03642.x 39 Lalam N, Weinberger D, Lermenier A, et al.L’Observation du Marche Illicite de Tabac en France [The observation of illicit tobacco market in France].",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
June 2011. http://www.revenue.ie/en/tax/excise/ tobacco/tobacco-strategy.html [accessed 2 Jul 2013].,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
https://reportingproject.net/troubles_with_big_tobacco/ [accessed 30 Apr].,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
2009. http://www.publicintegrity.org/2009/06/29/6347/ukraine-s-lost-cigarettes- ﬂood-europe (accessed 12 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
6 June 2013. http://www.nao.org.uk/wp-content/ uploads/2013/06/10120-001-Tobacco-smuggling-Full-report.pdf (a ccessed 2 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
16 April 2013. http://www.pmi.com/ eng/media_center/media_kit/Documents/Project_Star_2012_Final_Report.pdf[accessed 20 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
17 April 2013. http://www.pmi.com/eng/media_center/press_releases/ pages/201304170400.aspx [accessed 2 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
2008. http://www.who.int/fctc/guidelines/article_5_3.pdf (accessed Dec 2010).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"The Times, 27 May 2013. http://www.thetimes.co.uk/tto/business/industries/consumer/ article3775843.ece [accessed 2 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
The Wall Street Journal August 21 2012. http://online.wsj.com/article/SB100008723963904442331045775 95221203321922.html (subscription required) (accessed 15 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
http://www.pmi.com/eng/media_center/media_kit/pages/star_report_2012.aspx[accessed 26 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Insights 2012;16. http://www.asil.org/pdfs/insights/ insight121214.pdf 59 Liberman J, Blecher E, Carbajales AR, et al.",OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Accessible, respectively, via the following: http://www.idrc.ca/tobacco/ ev-84071-201-1-DO_TOPIC.html http://www.tobaccoevidence.net/itenproducts.html 66 Siggens G, Murray P. NEMS NE Survey: Illicit Tobacco: North of England Study 2013.",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
2007. http://archive.defra.gov.uk/environment/quality/local/legislation/cnea/documents/cigarette-litter.pdf (accessed 22 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Soﬁa: Center for the Study of Democracy, 2004. http://www.csd.bg/ ﬁleSrc.php?",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Dublin: PPACTE Consortium, 31 January 2012. http://www.ppacte.eu/index.php?option=com_docman&task=doc_download&gid=185&Itemid=29 (accessed 30 Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
Novonite News 26 January 2010. http://www.novinite.com/view_news.php?id=112377 (accessed 30Apr 2013).,OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Brussels: European Commission, March 2009. http://ec.europa.eu/public_opinion/ ﬂash/ﬂ_253_en.pdf (accessed 30 Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
"Novonite Newscom, 2011. http://www.novinite.com/view_news.php?id=132645 (accessed 30 Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/46/5d/tobaccocontrol-2013-051240.PMC4078702.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ jmedgenet-2013-102200).,OADS,/arxiv_data1/oa_pdf/09/11/jmedgenet-2013-102200.PMC4078703.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond.,Non-OADS,/arxiv_data1/oa_pdf/09/11/jmedgenet-2013-102200.PMC4078703.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Schuele SU, Luders HO.",Non-OADS,/arxiv_data1/oa_pdf/cf/ec/jnnp-2013-306465.PMC4078707.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/oemed-2013-101827).,Non-OADS,/arxiv_data1/oa_pdf/ee/70/oemed-2013-101827.PMC4078708.pdf
"The Yale research team provided input on survey questions, inparticular recommending survey items from the CDC-NIOSHQuality of W ork Life Module of the General Social Survey(http://www.cdc.gov/niosh/topics/stress/pdfs/QWLsurvey.pdf).However, the wording of the ﬁnal survey was determined by the HR research ﬁrm and their client.",Non-OADS,/arxiv_data1/oa_pdf/ee/70/oemed-2013-101827.PMC4078708.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Concha-Barrientos M, Nelson DI, Fingerhut M, et al.",Non-OADS,/arxiv_data1/oa_pdf/ee/70/oemed-2013-101827.PMC4078708.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Anwar M, Teichmann KD.",Non-OADS,/arxiv_data1/oa_pdf/1c/f0/bjophthalmol-2013-304585.PMC4078709.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 National Health Statistics Reports, No 29, 26 October 2010, pp 1-24. www.cdc.gov/nchs/data/nhsr/nhsr029.pdf 2 Englesbe MJ, Brooks L, Kubus J, et al.",Non-OADS,/arxiv_data1/oa_pdf/8e/27/bmjqs-2013-002223.PMC4078710.pdf
http://www.cms.,Non-OADS,/arxiv_data1/oa_pdf/8e/27/bmjqs-2013-002223.PMC4078710.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 W orld Bank.,Non-OADS,/arxiv_data1/oa_pdf/d1/27/jfprhc-2013-100593.PMC4078711.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Etter JF, Bullen C. Electronic cigarette: users pro ﬁle, utilization, satisfaction and perceived ef ﬁcacy.",Non-OADS,/arxiv_data1/oa_pdf/b7/ad/tobaccocontrol-2013-051461.PMC4078712.pdf
"Washington, DC: Population Estimates, American Community Survey, Census of Population and Housing, Stateand County Housing Unit Estimates, County Business Patterns, NonemployerStatistics, Economic Census, Survey of Business Owners, Building Permits, 2012. http://quickfacts.census.gov/qfd/states/00000.html (accessed 29 Oct 2013).",OADS,/arxiv_data1/oa_pdf/b7/ad/tobaccocontrol-2013-051461.PMC4078712.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 van der Meer EWC, Boot CRL, van der Gulden JWJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/4d/f3/oemed-2013-102034.PMC4078713.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Forster AJ, Murff HJ, Peterson JF , et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/9e/bmjqs-2013-002188.PMC4078714.pdf
2006 [updated2006; cited]; http://www.ihi.org/IHI/T opics/PatientSafety/MedicationSystems/ImprovementStories/AccuracyatEveryStep.htm (accessed 15 Mar 2013).,OADS,/arxiv_data1/oa_pdf/3b/9e/bmjqs-2013-002188.PMC4078714.pdf
"Dublin: Department of Health and Children, 2008. http://www.dohc.ie/publications/building_culture_patient_safety.html (accessed 29May 2013).",Non-OADS,/arxiv_data1/oa_pdf/3b/9e/bmjqs-2013-002188.PMC4078714.pdf
T echnical patient safetysolutions for medicines reconciliation on admission of adults tohospital: NICE/NPSA; PSG001 2007. http://guidance.nice.org.uk/PSG001 (accessed 29May 2013).,Non-OADS,/arxiv_data1/oa_pdf/3b/9e/bmjqs-2013-002188.PMC4078714.pdf
http://www.npc.nhs.uk/improving_safety/medicines_reconciliation/resources/reconciliation_guide.pdf (accessed 29 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/3b/9e/bmjqs-2013-002188.PMC4078714.pdf
"The Hague, The Netherlands, 2009.https://www.fip.org/www/uploads/database_file.php?id=319&table_id= (accessed 29 May 2013).",Non-OADS,/arxiv_data1/oa_pdf/3b/9e/bmjqs-2013-002188.PMC4078714.pdf
"Dublin, 2012. http://www.thepsi.ie/Libraries/Publications/PSI_Hospital_Baseline_Study_Report_2012.sflb.ashx (accessed 29 May 2013).",Non-OADS,/arxiv_data1/oa_pdf/3b/9e/bmjqs-2013-002188.PMC4078714.pdf
ISBN 978-1-907894-04-6. http://www.tcd.ie/tilda/assets/pdf/polpharmacyreport.pdf (accessed 22 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/3b/9e/bmjqs-2013-002188.PMC4078714.pdf
"Dublin: HSE 2012. http://www.hse.ie/eng/staff/PCRS/PCRS_Publications/ (accessed 29 May 2013).68 Kripalani S, Roumie CL, Dalal AK, et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/9e/bmjqs-2013-002188.PMC4078714.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Van Walbeek C. The Economics of Tobacco Control in South Africa .,Non-OADS,/arxiv_data1/oa_pdf/fd/ed/tobaccocontrol-2013-051178.PMC4078715.pdf
http://www.resbank.co.za/ Research/Statistics/Pages/OnlineDownloadFacility.aspx (accessed 22 May 2013).,OADS,/arxiv_data1/oa_pdf/fd/ed/tobaccocontrol-2013-051178.PMC4078715.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ heartjnl-2013-304598).,Non-OADS,/arxiv_data1/oa_pdf/7c/c7/heartjnl-2013-304598.PMC4078716.pdf
"1ICON Health Economics, Oxford, UK 2Servier Laboratories Ltd, Suresnes, France 3Imperial College London, Royal Brompton Hospital,London, UK 4Centre for Health Economics, University of York, York, UK Correspondence to Professor Martin R Cowie, Imperial College London, Dovehouse Street, LondonSW3 6LY, UK;m.cowie@imperial.ac.uk Received 12 July 2013 Revised 16 December 2013 Accepted 9 February 2014Published Online First14 March 2014 ▸http://dx.doi.org/10.1136/ heartjnl-2014-305684 To cite: Grifﬁths A, Paracha N, Davies A, et al.",Non-OADS,/arxiv_data1/oa_pdf/7c/c7/heartjnl-2013-304598.PMC4078716.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 British Heart Foundation.,Non-OADS,/arxiv_data1/oa_pdf/7c/c7/heartjnl-2013-304598.PMC4078716.pdf
"Period expectation of life .O fﬁce of National Statistics, 2010. http://www.statistics.gov.uk 11 New York Heart Association.",Non-OADS,/arxiv_data1/oa_pdf/7c/c7/heartjnl-2013-304598.PMC4078716.pdf
"EuroQol Group, 2011. http://www.euroqol.org/eq-5d/ reference-search/reference-search.html 13 Twisk J.",OADS,/arxiv_data1/oa_pdf/7c/c7/heartjnl-2013-304598.PMC4078716.pdf
"The Department of Health, 2011. http://www.dh.gov.uk 15 Of ﬁce of National Statistics.",Non-OADS,/arxiv_data1/oa_pdf/7c/c7/heartjnl-2013-304598.PMC4078716.pdf
"Consumer price index .O fﬁce of National Statistics, 2011. http://www.statistics.gov.uk/hub/index.html 16 Cleland J. CARE-HF long term follow up [abstract].",Non-OADS,/arxiv_data1/oa_pdf/7c/c7/heartjnl-2013-304598.PMC4078716.pdf
"National Health Service, 2012. http://www.hesonline.nhs.co.uk 19 National Institute for Cardiovascular Outcomes Research (NICOR).",Non-OADS,/arxiv_data1/oa_pdf/7c/c7/heartjnl-2013-304598.PMC4078716.pdf
"NICE technology appraisal 267, 2012. http://guidance.nice.org.uk/TA267/CostingTemplate/xls/English Figure 2 The cost effectiveness acceptability curve for patients with heart failure (HF), heart rate ≥75 bpm (£).",Non-OADS,/arxiv_data1/oa_pdf/7c/c7/heartjnl-2013-304598.PMC4078716.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/thoraxjnl-2013-204517).,Non-OADS,/arxiv_data1/oa_pdf/b7/95/thoraxjnl-2013-204517.PMC4078717.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ To cite Slater M, Rivett DW, Williams L, et al.Thorax 2014; 69:673 –674.",Non-OADS,/arxiv_data1/oa_pdf/b7/95/thoraxjnl-2013-204517.PMC4078717.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Nolan JP, Neumar RW, Adrie C, et al.",Non-OADS,/arxiv_data1/oa_pdf/41/87/emermed-2013-202457.PMC4078719.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/ To cite Weiler R, Allardyce S, Whyte GP, et al.Br J Sports Med 2014; 48:1010–1013.",Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
"Washington, DC: USDHHS, 2008. http://www.health.gov/paguidelines/default/aspx 8 Baird J, Mortimore A, Lucas P. Growing up in the UK: can we deliver a healthy future for our children?",Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
2013. http://www.unicef-irc.,Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
"King’s Fund, 2012. http://www.kingsfund.org.uk/sites/ ﬁles/ kf/ﬁeld/ﬁeld_publication_ ﬁle/clustering-of-unhealthy- behaviours-over-time-aug-2012.pdf 11 BMA.",Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
"2013. http://bma.org.uk/ working-for-change/improving-and-protecting-health/ child-health/growing-up-in-the-uk 12 Ready, set, go for physical activity.",Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
2013. http://wales.gov.,Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
"Department of Health, 2011. http://www.dh.gov.uk/prod_consum_ dh/groups/dh_digitalassets/documents/digitalasset/ dh_128210.pdf 19 Designed to Move.",Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
"2012. http://designedtomove.org/downloads/Designed_To_ Move_Full_Report.pdf 20 de Ferranti SD, Gauvreau K, Ludwig DS, et al.",Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
"Diabetes UK, 2012. http://www.diabetes.org.uk/Documents/Reports/Diabetes-in-the-UK-2012.pdf 23 Biddle SJH, Asare M. Physical activity and mental health in children and adolescents: areview of reviews.",Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
25 http://www.guardian.co.uk/politics/2012/aug/17/ michael-gove-school-playing- ﬁelds Open Access Scan to access more free content 1012 Br J Sports Med July 2014 Vol 48 No 13Editorial,Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
ﬁeldsintrust.org/Policy_statements.aspx 27 http://www.uksport.gov.uk/news/uk-sport-reveals- record-investment-in-bid-to-become- ﬁrst-nation-to- surpass-home-games-medal-haul 28 https://www.gov.uk/government/news/150-million- olympic-legacy-boost-for-primary-school-sport 29 HM Treasury.,Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
"Public Expenditure Statistical Analyses 2012. https://www.gov.uk/government/uploads/system/uploads/attachment_data/ ﬁle/179563/pesa_ complete_2012.pdf.pdf 30 https://www.gov.uk/government/news/helping-people- live-healthier-lives-the-future-for-public-health 31 http://www.sportengland.org/support__advice/ children_and_young_people/school_games.aspx32 http://www.guardian.co.uk/education/2012/aug/06/ michael-gove-own-goal-school-sports 33 Allender S, Cowburn G, Foster C. Understanding participation in sport and physical activityamong children and adults: a review ofqualitative studies.",Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
34 http://epp.eurostat.ec.europa.eu/statistics_explained/ index.php/Overweight_and_obesity_-_BMI_statistics 35 HM Government.,Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
http://media.education.gov.uk/assets/ ﬁles/pdf/ w/working%20together.pdf36 Beyond 2012 —outstanding physical education for all.,Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
2013. http://www.ofsted.gov.uk/resources/ beyond-2012-outstanding-physical-education-for-all 37 International Position Statement on Physical Education.,Non-OADS,/arxiv_data1/oa_pdf/c7/47/bjsports-2013-093018.PMC4078747.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2013-304965).,Non-OADS,/arxiv_data1/oa_pdf/d5/60/gutjnl-2013-304965.PMC4078748.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Littlejohn C, Hilton S, Macfarlane GJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/60/gutjnl-2013-304965.PMC4078748.pdf
"The environmental interventions were partof the ‘Liveable Neighbourhoods ’programme promoted by Sustrans, a sustainable transport charity in the UK (http://www.sustrans.org.uk).",Non-OADS,/arxiv_data1/oa_pdf/bd/ad/bjsports-2012-091718.PMC4078749.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Hallal PC, Bauman AE, Heath GW, et al.",Non-OADS,/arxiv_data1/oa_pdf/bd/ad/bjsports-2012-091718.PMC4078749.pdf
"Fact sheet: current levels of physical activity in older adults .. BHFNC, Loughborough University, 2012, http://www.bhfactive.org.uk (accessed 24 Oct 2012) 4 British Heart Foundation National Centre (BHFNC) for Physical Activity and Health.",Non-OADS,/arxiv_data1/oa_pdf/bd/ad/bjsports-2012-091718.PMC4078749.pdf
"BHFNC, Loughborough University, 2012, http://www.bhfactive.org.uk (accessed 24 Oct 2012).",Non-OADS,/arxiv_data1/oa_pdf/bd/ad/bjsports-2012-091718.PMC4078749.pdf
"26 Indices of Deprivation are combined measures of local area economic, social and environmental deprivation, de ﬁned in similar but distinct ways by the governments of England (http://www.communities.gov.uk/publications/communities/indiciesdeprivation07), Wales (http://wales.gov.uk/topics/statistics/theme/wimd) and Scotland (http://www.scotland.gov.uk/topics/Statistics/SIMD) (accesses 3Nov 2012).",Non-OADS,/arxiv_data1/oa_pdf/bd/ad/bjsports-2012-091718.PMC4078749.pdf
1990. http://www.euroqol.org (accessed 29 Apr 2011).,Non-OADS,/arxiv_data1/oa_pdf/bd/ad/bjsports-2012-091718.PMC4078749.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2013-305600).,Non-OADS,/arxiv_data1/oa_pdf/a1/d9/gutjnl-2013-305600.PMC4078750.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Dawson J, Doll H, Fitzpatrick R, et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/d9/gutjnl-2013-305600.PMC4078750.pdf
http://www.rcplondon.ac.uk/resources/in ﬂammatory-bowel-disease-audit (accessed 1 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/a1/d9/gutjnl-2013-305600.PMC4078750.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ References AGRESTI, A.",Non-OADS,/arxiv_data1/oa_pdf/7e/1a/vetrec-2013-101993.PMC4078751.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Numans ME, Lau J, de Wit NJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/e0/07/gutjnl-2013-306393.PMC4078752.pdf
"Correspondence to Professor Massimo Colombo,1st Division of Gastroenterology,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Via F. Sforza 35, Milan 20122,Italy;massimo.colombo@unimi.it Received 15 July 2013 Revised 3 October 2013Accepted 15 October 2013Published Online First 7 November 2013 ▸http://dx.doi.org/10.1136/ gutjnl-2013-306480 To cite: Colombo M, Fernández I, Abdurakhmanov D, et al .",Non-OADS,/arxiv_data1/oa_pdf/fa/ab/gutjnl-2013-305667.PMC4078754.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Ghany MG, Strader DB, Thomas DL, et al .",Non-OADS,/arxiv_data1/oa_pdf/fa/ab/gutjnl-2013-305667.PMC4078754.pdf
http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/fa/ab/gutjnl-2013-305667.PMC4078754.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-204788).,OADS,/arxiv_data1/oa_pdf/53/ed/annrheumdis-2013-204788.PMC4078755.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Smolen JS, Landewe R, Breedveld FC, et al.",Non-OADS,/arxiv_data1/oa_pdf/53/ed/annrheumdis-2013-204788.PMC4078755.pdf
http://www.nvr.nl/uploads/ki/tO/kitOmw9WmZQBHEq61H4YMQ/ NVR-Medicijnen-MTX-richtlijn-2009-update-2011.pdf (accessed 27 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/53/ed/annrheumdis-2013-204788.PMC4078755.pdf
http://www.nvr.nl/uploads/ki/tO/ kitOmw9WmZQBHEq61H4YMQ/NVR-Medicijnen-richtlijn-Sulfasalazine-2002.pdf (accessed 27 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/53/ed/annrheumdis-2013-204788.PMC4078755.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-203301).,OADS,/arxiv_data1/oa_pdf/06/33/annrheumdis-2013-203301.PMC4078756.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Galiè N, Hoeper MM, Humbert M, et al.",Non-OADS,/arxiv_data1/oa_pdf/06/33/annrheumdis-2013-203301.PMC4078756.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2012-203146).,Non-OADS,/arxiv_data1/oa_pdf/39/b4/annrheumdis-2012-203146.PMC4078757.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 NHS Business Services Authority.,Non-OADS,/arxiv_data1/oa_pdf/39/b4/annrheumdis-2012-203146.PMC4078757.pdf
"Naoki Saito,  Hideto Chono and Junichi Mineno are employees of Takara Bio Inc. (http://www.takara-bio.com).",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/mtna201420a.PMC4078760.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/mtna201420a.PMC4078760.pdf
"(http://www.somalogic.com/Technology.aspx) has generated thousands of single-stranded DNA aptamers (as known as SOMAmer)  for over 1,100 protein targets that cover a diverse set of  molecular functions, including receptors, kinases, growth factors, and hormones.",OADS,/arxiv_data1/oa_pdf/3c/9c/mtna201421a.PMC4078761.pdf
"The Ellington laboratory generated a comprehensive online aptamer Database (http://aptamer.icmb.utexas.edu/), which collects and organizes all known  information about aptamer selection.",OADS,/arxiv_data1/oa_pdf/3c/9c/mtna201421a.PMC4078761.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/3c/9c/mtna201421a.PMC4078761.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/ad/e6/mtna201422a.PMC4078762.pdf
The conformational structure of dSLIM under isotonic con- ditions was calculated using the mfold web server http://www.bioinfo.rpi.edu/applications/mfold/.,OADS,/arxiv_data1/oa_pdf/0f/24/mtna201428a.PMC4078763.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/0f/24/mtna201428a.PMC4078763.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005484).,Non-OADS,/arxiv_data1/oa_pdf/27/1b/bmjopen-2014-005484.PMC4078769.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3e/37/bmjopen-2014-005554.PMC4078770.pdf
http://www.surgeons.,Non-OADS,/arxiv_data1/oa_pdf/3e/37/bmjopen-2014-005554.PMC4078770.pdf
http://www.statsdirect.com 9.,Non-OADS,/arxiv_data1/oa_pdf/3e/37/bmjopen-2014-005554.PMC4078770.pdf
http://www.asahq.org/For-Members/Clinical-Information/ASA-Physical-Status-Classification-System.aspx 12.,Non-OADS,/arxiv_data1/oa_pdf/3e/37/bmjopen-2014-005554.PMC4078770.pdf
http://www.surgeons.org/media/20220590/2013-11-26_rpt_cnrb_v5_final.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/3e/37/bmjopen-2014-005554.PMC4078770.pdf
https://app.box.com/s/zcwo9yga7vwuukq731um 24.,Non-OADS,/arxiv_data1/oa_pdf/3e/37/bmjopen-2014-005554.PMC4078770.pdf
http://www.health.gov.au/internet/main/publishing.nsf/Content/1A0D1857F9101D2FCA257BF0001F96F1/$File/ocpahfsv6.pdf 30.,Non-OADS,/arxiv_data1/oa_pdf/3e/37/bmjopen-2014-005554.PMC4078770.pdf
http://www.hqsc.govt.nz/assets/POMRC/Publications/POMRC-progress-report-Mar-2014.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/3e/37/bmjopen-2014-005554.PMC4078770.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005044).,Non-OADS,/arxiv_data1/oa_pdf/65/9b/bmjopen-2014-005044.PMC4078771.pdf
The national annual report of adverse drug reaction monitoring in 2011. http://www.sda.gov.cn/WS01/CL0078/72193.html (accessed May 2012).,Non-OADS,/arxiv_data1/oa_pdf/77/5b/bmjopen-2014-004904.PMC4078772.pdf
12(13)-0085. http://www.ahrq.gov/professionals/quality-patient-safety/patientsafetyculture/pharmacy/index.html 10.,Non-OADS,/arxiv_data1/oa_pdf/77/5b/bmjopen-2014-004904.PMC4078772.pdf
12-0085-1-EF: U.S. http://www.ahrq.gov/professionals/quality-patient-safety/patientsafetyculture/pharmacy/index.html 21.,Non-OADS,/arxiv_data1/oa_pdf/77/5b/bmjopen-2014-004904.PMC4078772.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005295).,Non-OADS,/arxiv_data1/oa_pdf/e6/05/bmjopen-2014-005295.PMC4078774.pdf
48. https://regepi.bwh.harvard.edu/health/KIDS/files/03.%202012% 20Youth%20Adolescent%20Food%20Frequency%20Questionnaire.pdf (accessed 9 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/e6/05/bmjopen-2014-005295.PMC4078774.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005164).,Non-OADS,/arxiv_data1/oa_pdf/dc/45/bmjopen-2014-005164.PMC4078775.pdf
"Throughout the data collection period, the trial man- agement group will hold weekly Twitter question andanswer sessions (http://www.twitter.com/STARSurgUK),giving an opportunity for collaborators to clarify any uncertainties regarding the protocol.",Non-OADS,/arxiv_data1/oa_pdf/dc/45/bmjopen-2014-005164.PMC4078775.pdf
The Association of Surgeons in Training (http://www.asit.,Non-OADS,/arxiv_data1/oa_pdf/dc/45/bmjopen-2014-005164.PMC4078775.pdf
"The protocol document will be made available online and will also bedisseminated through social media, including Twitter (https://twitter.com/STARSurgUK) and Facebook (https://www.facebook.com/STARSurgUK).",Non-OADS,/arxiv_data1/oa_pdf/dc/45/bmjopen-2014-005164.PMC4078775.pdf
Funding A regional meeting grant has been received from the Association of Surgeons in Training (http://www.asit.org) towards the costs of the national collaborator training day.,Non-OADS,/arxiv_data1/oa_pdf/dc/45/bmjopen-2014-005164.PMC4078775.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/45/bmjopen-2014-005164.PMC4078775.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 004817).,Non-OADS,/arxiv_data1/oa_pdf/50/16/bmjopen-2014-004817.PMC4078776.pdf
"The second ﬁeld test took place from 22 February to 15 March 2013 in villages around Walikunda, about280 km east of Banjul, among participants in an ongoing randomised controlled, observer blind trial (http://www.who.int/whopes/en/).",Non-OADS,/arxiv_data1/oa_pdf/50/16/bmjopen-2014-004817.PMC4078776.pdf
"Washington, DC: U.S. Department of Health & Human Services, 1979. http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html (accessed 18 Nov 2013).",Non-OADS,/arxiv_data1/oa_pdf/50/16/bmjopen-2014-004817.PMC4078776.pdf
"Geneva, Switzerland, 2002. http://www.cioms.ch/publications/guidelines/guidelines_nov_2002_blurb.htm (accessed 2 Jun 2013).",Non-OADS,/arxiv_data1/oa_pdf/50/16/bmjopen-2014-004817.PMC4078776.pdf
http://www.gambia.gm/Statistics/Statistics.htm (accessed 5 Mar 2014).,OADS,/arxiv_data1/oa_pdf/50/16/bmjopen-2014-004817.PMC4078776.pdf
The Gambia Demographic Profile 2013. http://www.indexmundi.com/ the_gambia/demographics_profile.html (accessed 3 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/50/16/bmjopen-2014-004817.PMC4078776.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005353).,Non-OADS,/arxiv_data1/oa_pdf/4b/3b/bmjopen-2014-005353.PMC4078777.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004744).,Non-OADS,/arxiv_data1/oa_pdf/c9/bd/bmjopen-2013-004744.PMC4078778.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005083).,Non-OADS,/arxiv_data1/oa_pdf/4e/8c/bmjopen-2014-005083.PMC4078780.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 004850).,Non-OADS,/arxiv_data1/oa_pdf/0a/c1/bmjopen-2014-004850.PMC4078781.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/c1/bmjopen-2014-004850.PMC4078781.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005208).,Non-OADS,/arxiv_data1/oa_pdf/71/38/bmjopen-2014-005208.PMC4078782.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 004798).,Non-OADS,/arxiv_data1/oa_pdf/89/a5/bmjopen-2014-004798.PMC4078784.pdf
http://gateway.ovid.com/ (accessed 23 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/89/a5/bmjopen-2014-004798.PMC4078784.pdf
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (access date 26 Apr2014).,Non-OADS,/arxiv_data1/oa_pdf/89/a5/bmjopen-2014-004798.PMC4078784.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005788).,Non-OADS,/arxiv_data1/oa_pdf/86/44/bmjopen-2014-005788.PMC4078785.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2013- 003987).,Non-OADS,/arxiv_data1/oa_pdf/f1/c0/bmjopen-2013-003987.PMC4078786.pdf
http://data.worldbank.org/about/country-classifications 11.,Non-OADS,/arxiv_data1/oa_pdf/f1/c0/bmjopen-2013-003987.PMC4078786.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005745).,Non-OADS,/arxiv_data1/oa_pdf/04/d8/bmjopen-2014-005745.PMC4078787.pdf
The clonal cluster wa s generated using eBURST software version 3 (http://eburst.mlst.net/).Figure 3 UPGMA-generated dendrogram showing the relationships of the strain isolated from the fatal case with other L. hongkongensis strains isolated from humans and fish.12The ST of the isolate from the fatal case is displayed in bold.,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/emi201439a.PMC4078790.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/Fatal Laribacter hongkongensis bacteremia CWS Tse et al 7 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/1b/8f/emi201439a.PMC4078790.pdf
Available at http://www.hpa.org.uk/webc/hpawebfile/ hpaweb_c/1194947403482 (accessed 29 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/d6/4f/emi201443a.PMC4078791.pdf
Available at http://www.cdc.gov/hicpac/pdf/isolation/isolation2007.pdf (accessed 29 April 2014).,OADS,/arxiv_data1/oa_pdf/d6/4f/emi201443a.PMC4078791.pdf
Available at http://dx.doi.org/10.1787/health_glance- 2011-en (accessed 29 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/d6/4f/emi201443a.PMC4078791.pdf
Available at: http://www.cdc.gov/hai/organisms/cdiff/cdiff_faqs_hcp.html (accessed 29 April 2014).,OADS,/arxiv_data1/oa_pdf/d6/4f/emi201443a.PMC4078791.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Assessing control bundles for Clostridium difficile L Yakob et al 8 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/d6/4f/emi201443a.PMC4078791.pdf
"52,53 METHODOLOGY USED IN THE PRESENT REVIEW In the present review, literature searches were completed using the following databases: Medline (PubMed; http://www.ncbi.nlm.nih.gov/pubmed/), Web of Science (http://thomsonreuters.com/web-of- science-core-collection/) and Science Direct (http://www.sciencedirect.",OADS,/arxiv_data1/oa_pdf/6e/c3/emi201445a.PMC4078792.pdf
MLST results were obtained from the S. suis MLST Database (http://ssuis.mlst.net/).,OADS,/arxiv_data1/oa_pdf/6e/c3/emi201445a.PMC4078792.pdf
This publication made use of the Multilocus Sequence Typing Website (http://www.mlst.net) at Imperial College London developed by DavidAanensen and funded by the Welcome Trust.,Non-OADS,/arxiv_data1/oa_pdf/6e/c3/emi201445a.PMC4078792.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Up-to-date distribution of Streptococcus suis G Goyette-Desjardins et al 20 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/6e/c3/emi201445a.PMC4078792.pdf
Available at http://dx.doi.org/10.1016/j.jocn.,OADS,/arxiv_data1/oa_pdf/b8/f9/acn30001-0379.PMC4078876.pdf
"Chan, M. Cancer in developing countries: facing the challenge, WHO, (2010): 21/ 09/2010, IAEA forum: http://www.who.int/dg/speeches/2010/iaea_forum_20100921/en/index.html.",Non-OADS,/arxiv_data1/oa_pdf/cc/a2/srep05410.PMC4078903.pdf
"297, http://www.who.int/mediacentre/factsheets/fs297/en/index.",Non-OADS,/arxiv_data1/oa_pdf/cc/a2/srep05410.PMC4078903.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cc/a2/srep05410.PMC4078903.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5410 | DOI: 10.1038/srep05410 6",Non-OADS,/arxiv_data1/oa_pdf/cc/a2/srep05410.PMC4078903.pdf
"Methods The death declarations (DD) records of each Brazilian  state, from 1996 to 2011, were obtained from the  website of the Unified Health System Information  System (DATASUS) (http://tabnet.datasus.gov.br/cgi/sim/ dados/cid10_indice.htm#dados, which was accessed in  November, 2013.",OADS,/arxiv_data1/oa_pdf/27/6b/abc-102-06-0557.PMC4079019.pdf
"Populations in census years were also obtained in the  DATASUS website (http://www2.datasus.gov.br/DATASUS/ index.php?area=0206&VObj=http://tabnet.datasus.gov.br/cgi/ deftohtm.exe?ibge/cnv/pop, which was accessed in November,  2013, by age groups (younger than 1 year old, from 1 to 4 years  old, from 5 to 9, from 10 to 14, from 15 to 19, and after that,  with 10 year intervals, up to the age of 80).",OADS,/arxiv_data1/oa_pdf/27/6b/abc-102-06-0557.PMC4079019.pdf
[Acesso em 2013 nov 20] Disponível em:  http://www.datasus.gov.br 2.,OADS,/arxiv_data1/oa_pdf/27/6b/abc-102-06-0557.PMC4079019.pdf
2010 [acesso em 2011  out.20] Disponível em: http://www.nice.org.uk/guidance/PH25.,Non-OADS,/arxiv_data1/oa_pdf/5f/b3/abc-102-06-0571.PMC4079021.pdf
Disponível em: http://portalsaude.saude.gov.br/portalsaude/ arquivos/pdf/2012/Set/25/cp16.pdf.References 577,Non-OADS,/arxiv_data1/oa_pdf/5f/b3/abc-102-06-0571.PMC4079021.pdf
Available from:  http://www.mendeley.com/catalog/validation-verification-task-force-monitor/ 22.,OADS,/arxiv_data1/oa_pdf/a7/b1/abc-102-06-0579.PMC4079022.pdf
Disponível em: http://www.cochrane.org/training/cochrane-handbook.,Non-OADS,/arxiv_data1/oa_pdf/cf/4b/abc-102-06-0588.PMC4079023.pdf
Disponível em: http://www.brasil.gov.br/educacao 10.,Non-OADS,/arxiv_data1/oa_pdf/0e/d9/abc-102-06-0593.PMC4079024.pdf
Disponível em: http://www.inep.gov.br 11.,Non-OADS,/arxiv_data1/oa_pdf/0e/d9/abc-102-06-0593.PMC4079024.pdf
Disponível em: http://www.inep.gov.br.,Non-OADS,/arxiv_data1/oa_pdf/0e/d9/abc-102-06-0593.PMC4079024.pdf
Disponível em:   http://www.who.int/mediacentre/factsheets/fs340/en.,Non-OADS,/arxiv_data1/oa_pdf/00/2d/abc-102-06-0602.PMC4079025.pdf
"The citation for the chapter and full report appear as reference 18 in the present paper and can be accessed at http://www.ncbi.nlm.nih.gov/books/NBK133412/ Contributors ZB, TEF , EP and KAM were responsible for the study concept, design, analysis, interpretation and preparationof the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/09/da/bmjqs-2012-001769.PMC4079036.pdf
See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 The Joint Commission .,Non-OADS,/arxiv_data1/oa_pdf/09/da/bmjqs-2012-001769.PMC4079036.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/e0/ea/13554_2013_Article_12.PMC4079096.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/a3/evu115.PMC4079193.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/41/evu101.PMC4079195.pdf
"2002 ) and are accessible through GEO Series accession number GSE54874 (http://www.ncbi.nlm.nih.g ov/geo/query/acc.cgi?acc ¼GSE54 874, last accessed May 23, 2014).",OADS,/arxiv_data1/oa_pdf/4e/41/evu101.PMC4079195.pdf
Mapping was disabled for novel splice discovery and used the JGI transcript annotation of IPO323 as reference ( Goodwin et al .2011 ;http://genome.jgi.,OADS,/arxiv_data1/oa_pdf/4e/41/evu101.PMC4079195.pdf
"Total read counts per transcript were estimated in htseq-count ( http://www-huber.embl.de/users/ anders/HTSeq/doc/count.html , last accessed May 23, 2014) applying the intersection-strict mode.",OADS,/arxiv_data1/oa_pdf/4e/41/evu101.PMC4079195.pdf
"Identification of Gene Families and Phylogenetics To deﬁne gene families in IPO323, sequence data sets of tran-scripts and proteins from the Z. tritici reference genome ver- sion 2.0 from the Joint Genome Institute ( http://genome.jgi.Host-Speciﬁc Transcription Proﬁle GBE Genome Biol.",OADS,/arxiv_data1/oa_pdf/4e/41/evu101.PMC4079195.pdf
Bootstrap supportvalues were mapped on the most likely tree that was visualized and edited in FigTree v1.4 ( http://tree.bio.ed.ac.,OADS,/arxiv_data1/oa_pdf/4e/41/evu101.PMC4079195.pdf
"Of the 10,952 predicted Z. tritici genes ( http://genome.jgi.doe.gov/ Mycgr3/Mycgr3.home.html , last accessed May 23, 2014), 8,053 were expressed at >2 read per million in any of the three growth conditions ( supplementary table S2 , Supplementary Material online), and we considered this set of genes to represent the core active transcriptional programofZ.",Non-OADS,/arxiv_data1/oa_pdf/4e/41/evu101.PMC4079195.pdf
"2013 ), it is temptingTable 1 Genes on Z. tritici Accessory Chromosomes Differentially Expressed between Growth Conditions Gene ID Chromosome Length (bp) KOG ID Sequence Homology Mean RPKM of Replicates Paralogs Ta Bd YMS 97552 14 966 KOG4207 Predicted splicing factor SR protein superfamily3.20 4.01 0.38 None 18496 14 306 NA No homology 11.73 9.60 0.67 None 78038 14 1514 NA C4-decarboxylate transporter 318.21 364.45 16.34 Mg40431 51580 14 3154 KOG0243 Kinesin like protein 0.31 0.66 4.08 Mg65848 51599 14 558 NA No homology 24.29 21.97 3.63 None 106608 15 658 NA No homology 0.75 0.50 3.57 None106610 15 702 NA No homology 2.73 2.71 13.12 None 111745 15 1619 NA HnH endonuclease 3.56 4.33 26.82 None 97676 15 1014 NA No homology 1.14 2.23 11.04 Mg97711, Mg97810, Mg98061 106633 16 1273 NA No homology 1.82 2.08 0.00 None 97764 16 3679 KOG2992 Nucleolar GTPase ATPase p130 (Nop14) 2.57 2.06 7.50 None 97825 17 1380 NA No homology 1.45 1.18 29.50 Mg97877 97829 17 1164 NA Secretion signal 0.38 0.00 2.02 None 51731 17 204 NA No homology 0.00 0.00 117.05 None 97935 19 3901 KOG0663 Nucleolar GTPase ATPase p130 (Nop14)4.45 3.02 0.00 None 97941 19 1290 KOG4297 C-type lectin (chromosome segregation) 0.68 2.14 0.22 Mg111803 111789 19 499 NA No homology 10.75 21.47 2.89 None97959 19 489 NA No homology 12.99 31.23 4.00 None 111795 20 1435 NA No homology 3.63 0.94 0.68 None 98067 20 2035 NA No homology 5.11 0.00 1.13 None98089 21 519 NA No homology 4.59 6.42 0.00 None98123 21 465 NA No homology 3.53 0.47 0.00 None NOTE.—Gene ID, based on JGI genome annotation ( http://genome.jgi.doe.gov/Mycgr3/Mycgr3.home.html , last accessed May 23, 2014); KOG, eukaryotic orthology group (genome.jgi.doe.gov/Tutorial/tutorial/kog.html); NA, not available.",Non-OADS,/arxiv_data1/oa_pdf/4e/41/evu101.PMC4079195.pdf
Supplementary Material Supplementary tables S1–S5 andﬁgures S1–S10 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/4e/41/evu101.PMC4079195.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/2a/evu111.PMC4079196.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/ce/evu105.PMC4079211.pdf
"(NCBI; http://www.ncbi.nlm.nih.gov , last accessed May 31, 2014) ( supplementary table S1 ,Supplementary Material online).",OADS,/arxiv_data1/oa_pdf/2c/ce/evu105.PMC4079211.pdf
"First, we blasted these genes in GenBank(http://www.ncbi.nlm.nih.gov , last accessed May 31, 2014) to ensure the high hits.",Non-OADS,/arxiv_data1/oa_pdf/2c/ce/evu105.PMC4079211.pdf
"Homology Modeling Three-dimensional (3D) protein structures of four zebraﬁshproteins (Piwil1-PAZ domain, Piwil2-PAZ domain, Tdrd1-the third Tudor domain, Tdrkh-Tudor domain) were built using the SWISS-MODEL server ( http://swissmodel.expasy.org ,l a s t accessed May 31, 2014) ( Schwede et al.",OADS,/arxiv_data1/oa_pdf/2c/ce/evu105.PMC4079211.pdf
Available at: http://bioinf.man.ac.uk/robertson/ recombination/programs.shtml .,Non-OADS,/arxiv_data1/oa_pdf/2c/ce/evu105.PMC4079211.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/9f/evu110.PMC4079213.pdf
"The PDB database was downloaded from National Center for Biotechnology Information (NCBI)’s FTP site ( ftp://ftp.ncbi.nih.gov/blast/db/ FASTA/pdbaa.gz , last accessed June 13, 2014).",OADS,/arxiv_data1/oa_pdf/60/9f/evu110.PMC4079213.pdf
2011 )(http://www.cbs.dtu.,Non-OADS,/arxiv_data1/oa_pdf/60/9f/evu110.PMC4079213.pdf
"2004 ) (http://www.cbs.dtu.dk/services/SecretomeP/ , last accessed June 13, 2014), trained with mammalian sequences, due tothe lack of fungal-speciﬁc prediction software.",Non-OADS,/arxiv_data1/oa_pdf/60/9f/evu110.PMC4079213.pdf
"2003 )(http://mendel.imp.ac.at/gpi/fungi_ server.html , last accessed June 13, 2014).",Non-OADS,/arxiv_data1/oa_pdf/60/9f/evu110.PMC4079213.pdf
"2001 )(http://www.cbs.dtu.dk/services/TMHMM/ ,l a s t accessed June 13, 2014).",Non-OADS,/arxiv_data1/oa_pdf/60/9f/evu110.PMC4079213.pdf
2010 )(http://bioinf.fbb.msu.,Non-OADS,/arxiv_data1/oa_pdf/60/9f/evu110.PMC4079213.pdf
"2004 )(http://weblogo.berkeley.edu/ , last accessed June 13, 2014), and AP structures were visualized and edited with Jmol ( www.jmol.org , last accessed June 13, 2014).",OADS,/arxiv_data1/oa_pdf/60/9f/evu110.PMC4079213.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/13/evu114.PMC4079214.pdf
The consensus sequence of each clade was obtained from the EMBL consensus sequence server ( http://coot.embl.,OADS,/arxiv_data1/oa_pdf/4b/13/evu114.PMC4079214.pdf
"2009 )(http://circos.ca , last accessed June 3, 2014) was employed for constructing this diagram.Comparative Genomic Analysis GBE Genome Biol.",OADS,/arxiv_data1/oa_pdf/4b/13/evu114.PMC4079214.pdf
Further exam- ination and comparison of complete genomic componentsand genomic property between the two genomes will helpuncover the genetic and epigenetic basis underlying theunique features of PbrCassandra s in the pear genome.Supplementary Material Supplementary tables S1–S12 andﬁgures S1–S5 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/4b/13/evu114.PMC4079214.pdf
A conventional method to quantify RNA localization is based on manual This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License (CC-BY-NC-ND; http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode ).,Non-OADS,/arxiv_data1/oa_pdf/f5/33/nihms-605161.PMC4079260.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/de/prbm-7-167.PMC4079627.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2014:7 167–174Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  167ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S5235 2The influence of psychoeducation on regulating  biological rhythm in a sample of patients with  bipolar ii disorder: a randomized clinical trial augusto Duarte Faria1 luciano Dias de Mattos  souza2 Taiane de azevedo  cardoso2 Karen amaral Tavares  Pinheiro2 Ricardo Tavares Pinheiro2 Ricardo azevedo da silva2 Karen Jansen2 1Department of Clinical and Health  Psychology, Universidade Federal do  Rio grande – FURg, Rio grande,  Rs,   Brazil; 2health and Behavior  Postgraduate Program, Universidade  católica de Pelotas – UcP el, Pelotas,   Rs, Brazil correspondence: Karen Jansen   Universidade católica de Pelotas,   Rua Félix da cunha, 412, Pelotas,   Rs, Brazil, 96010-000   Tel +55 532 128 8012   Fax +55 532 128 8298   email karenjansen315@hotmail.co mIntroduction:  Changes in biological rhythm are among the various characteristics of bipolar  disorder, and have long been associated with the functional impairment of the disease.",Non-OADS,/arxiv_data1/oa_pdf/7b/de/prbm-7-167.PMC4079627.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/7b/de/prbm-7-167.PMC4079627.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7b/de/prbm-7-167.PMC4079627.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/26/copd-9-685.PMC4079628.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/7c/26/copd-9-685.PMC4079628.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/26/copd-9-685.PMC4079628.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/ba/vhrm-10-389.PMC4079630.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2014:10 389–397Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  389ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/VHRM.S6372 5effects of aliskiren- and ramipril-based treatment  on central aortic blood pressure in elderly with  systolic hypertension: a substudy of ageless Fabio Baschiera1 William chang2 Patrick Brunel1 On behalf of the ageless   study group 1novartis Pharma ag, Basel,   switzerland;  2novartis  Pharmaceuticals corporation,    east Hanover, nJ, Usa correspondence: Patrick Brunel   cardiovascular and Metabolism  Department, novartis campus,   Fabrikstrasse  4-3.14.4 cH-4056   Basel, switzerland   Tel +41 61 324 0245  Fax +41 61 324 2078  email patrick.brunel@novartis.co mBackground:  Systolic hypertension is the most common form of hypertension in elderly  patients.",Non-OADS,/arxiv_data1/oa_pdf/40/ba/vhrm-10-389.PMC4079630.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/40/ba/vhrm-10-389.PMC4079630.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/ba/vhrm-10-389.PMC4079630.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/53/dddt-8-839.PMC4079631.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 839–850Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  839Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S3910 0Clinical effectiveness and safety of montelukast  in asthma.",Non-OADS,/arxiv_data1/oa_pdf/d0/53/dddt-8-839.PMC4079631.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d0/53/dddt-8-839.PMC4079631.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/53/dddt-8-839.PMC4079631.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/5e/tcrm-10-493.PMC4079632.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 493–504Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  493Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6673 1Asunaprevir, a protease inhibitor   for the treatment of hepatitis C infection ivan Gentile1 Antonio Riccardo  Buonomo1 emanuela Zappulo1 Giuseppina Minei1 Filomena Morisco2 Francesco Borrelli1 Nicola Coppola3 Guglielmo Borgia1 1Section of infectious Diseases,   2Section of Gastroenterology,   Department of Clinical Medicine   and Surgery, University of Naples   Federico ii, 3Section of infectious   Diseases, Department of Mental   Health and Public Medicine, Second   University of Naples, Naples, italy Correspondence: ivan Gentile   Department of Clinical Medicine   and Surgery (ed  18), University   of Naples Federico ii, via S Pansini  5,   i-80131 Naples, italy   Tel +39 81 746 3 178  Fax +39 81 746 3 190  email ivan.gentile@unina.i tAbstract:  According to the World Health Organization, approximately  150 million people  worldwide are chronic carriers of hepatitis C virus (HCV).",Non-OADS,/arxiv_data1/oa_pdf/6e/5e/tcrm-10-493.PMC4079632.pdf
"Available  from: http://www.who.int/mediacentre/factsheets/fs164/en/index.htm l.  Accessed January  17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6e/5e/tcrm-10-493.PMC4079632.pdf
"Available from:  http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/ ucm377920.ht m. Accessed January  17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6e/5e/tcrm-10-493.PMC4079632.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/6e/5e/tcrm-10-493.PMC4079632.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/5e/tcrm-10-493.PMC4079632.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/7e/ccid-7-201.PMC4079633.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 201–205Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  201RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S4437 1Cryolipolysis for noninvasive body contouring:  clinical efficacy and patient satisfaction Nils Krueger1 Sophia v Mai2 Stefanie Luebberding1 Neil S Sadick3 1Rosenpark Research, Darmstadt,   Germany;  2Department of  Dermatology, Louisiana State  University, New Orleans, LA,   3Department of Dermatology, weill  Cornell Medical College, New Y ork,   NY, USA Correspondence: Nils Krueger   Rosenpark Research,  wilhelminenstrasse  13,   64283 Darmstadt, Germany   Tel +49 6151 1598 8385  email nils.krueger@rosenparkresearch.d eAbstract:  In recent years, a number of modalities have become available for the noninvasive  reduction of adipose tissue, including cryolipolysis, radiofrequency, low-level laser, and high- intensity focused ultrasound.",Non-OADS,/arxiv_data1/oa_pdf/5d/7e/ccid-7-201.PMC4079633.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/5d/7e/ccid-7-201.PMC4079633.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/7e/ccid-7-201.PMC4079633.pdf
"Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf13/ K133212.pd f. Accessed May  17, 2014.",OADS,/arxiv_data1/oa_pdf/5d/7e/ccid-7-201.PMC4079633.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/32/oajsm-5-159.PMC4079634.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 159–172Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  159OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S6597 7Sex difference in top performers from ironman   to double deca iron ultra-triathlon Beat Knechtle1 Matthias A Zingg2 Thomas rosemann2 christoph A rüst2 1gesundheitszentrum St gallen,    St gallen, Switzerland;  2institute   of general Practice and health  Services research, University of  Zurich, Zurich, Switzerland correspondence: Beat Knechtle   gesundheitszentrum St gallen,  Vadianstrasse  26, St gallen  9001,  Switzerland   Tel +41 71 226 82 82  Fax +41 71 226 82 72  email beat.knechtle@hispeed.c hAbstract:  This study investigated changes in performance and sex difference in top  performers  for ultra-triathlon races held between  1978 and  2013 from Ironman (3.8 km swim,  180 km  cycle, and  42 km run) to double deca iron ultra-triathlon distance (76 km swim,  3,600 km cycle,  and 844 km run).",Non-OADS,/arxiv_data1/oa_pdf/6c/32/oajsm-5-159.PMC4079634.pdf
20. International Ultra -Triathlon Association (IUTA) http://www.iutas - port.com .,Non-OADS,/arxiv_data1/oa_pdf/6c/32/oajsm-5-159.PMC4079634.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/6c/32/oajsm-5-159.PMC4079634.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/32/oajsm-5-159.PMC4079634.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/28/opth-8-1227.PMC4079635.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1227–1232Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1227Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6404 8Factors affecting the use of antioxidant  supplements in patients with late aMD Correspondence: alice Yu   ludwig-Maximilians-University,  Department of Ophthalmology,  Mathildenstrasse 8, 80336 Munich,  germany   Tel +49 89 5160 3811   Fax +49 89 5160 5160   email alice.yu@med.uni-muenchen.d ealice l Yu1 T obias Paul1 Markus schaumberger1 Ulrich Welge-lussen2 1Department of Ophthalmology,   ludwig-Maximilians-University,   Munich, 2Department of  Ophthalmology, Friedrich-alexander- University, erlangen, germanyBackground:  The purpose of this study was to assess the use of oral antioxidant supplements  in patients with late age-related macular degeneration (AMD) and to identify influencing factors  that may affect the use of such supplements.",Non-OADS,/arxiv_data1/oa_pdf/e0/28/opth-8-1227.PMC4079635.pdf
"Nonetheless, a great number of patients, in particular those with late  AMD, are currently taking the AREDS supplements despite the missing evidence of Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Yu et al Running head recto: Supplement use in patients with late AMD DOI: http://dx.doi.org/10.2147/OPTH.S64048",Non-OADS,/arxiv_data1/oa_pdf/e0/28/opth-8-1227.PMC4079635.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e0/28/opth-8-1227.PMC4079635.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1232Yu et al Disclosure The authors have no financial or proprietary interest in any  material or method used in this study.,Non-OADS,/arxiv_data1/oa_pdf/e0/28/opth-8-1227.PMC4079635.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/6d/cia-9-1009.PMC4079636.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1009–1010Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1009Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/ 10.2147/CIA.S6597 1Albert J Finestone temple University, School of Medicine,   Philadelphia, PA, USA Correspondence: Albert J Finestone  606 Webb road, elkins Park, PA 190267,  USA  tel +1 215 782 1383 Fax +1 267 627 2505  email afinestone@comcast.ne tAppropriate blood pressure for the “old-old”   (85 years and older) Dear editor Treating hypertension in patients over the age of 85 years, ie, the “old-old”, presents  a challenge that is different from that encountered when treating any other age group.",Non-OADS,/arxiv_data1/oa_pdf/d9/6d/cia-9-1009.PMC4079636.pdf
"In the  US, the strong beliefs of patients, physicians, and pharmaceutical companies make the  production of guidelines for managing hypertension a progressively more difficult and  controversial process.4 Further, it has been commented that current performance mea - sures for blood pressure control modeled after the Joint National Committee guidelines Journal name: Clinical Interventions in Aging Journal Designation: Letter Y ear: 2014 Volume: 9 Running head verso: Finestone Running head recto: Appropriate blood pressure for the “old-old” DOI: http://dx.doi.org/10.2147/CIA.S65971",Non-OADS,/arxiv_data1/oa_pdf/d9/6d/cia-9-1009.PMC4079636.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d9/6d/cia-9-1009.PMC4079636.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d9/6d/cia-9-1009.PMC4079636.pdf
Available from: http://www.nytimes.com/2010/07/27/opinion/27tue3.,Non-OADS,/arxiv_data1/oa_pdf/d9/6d/cia-9-1009.PMC4079636.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/1c/ijn-9-3119.PMC4079637.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3119–3130International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3119OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6182 3entrapment of curcumin into monoolein-based  liquid crystalline nanoparticle dispersion for  enhancement of stability and anticancer activity rengarajan Baskaran1 Thiagarajan Madheswaran2 Pasupathi sundaramoorthy1 hwan Mook Kim1 Bong Kyu Y oo1 1college of Pharmacy, gachon  University, Incheon, south Korea;   2college of Pharmacy Yeungnam  University, gyeongsan, south Korea correspondence: Bong Kyu Y oo   college of Pharmacy, gachon University,  191 hambakmoero, Incheon 406-799,  south Korea   T el +82 32 899 6415   Fax +82 32 820 4829   email byoo@gachon.ac.k r Abstract:  Despite the promising anticancer potential of curcumin, its therapeutic application  has been limited, owing to its poor solubility, bioavailability, and chemical fragility.",Non-OADS,/arxiv_data1/oa_pdf/ee/1c/ijn-9-3119.PMC4079637.pdf
"Curcumin, a well-known dietary pigment from the turmeric plant (Figure 1), has  been found to inhibit the in vivo and in vitro growth of several malignant cell types,  showing no harm to normal cells.2–5 Specifically, curcumin-induced apoptosis in  human breast tumor cell lines (MCF-7 and MDAMB), and in a human hepatocellular  carcinoma cell line (HepG2), in a dose-dependent and time-dependent manner.6 Cur- cumin has also been shown to possess apoptotic activity against human colon cancer  cells,7 stomach and skin tumors,8 and prostate cancer cells.9Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Baskaran et al Running head recto: Curcumin-loaded liquid crystalline nanoparticle dispersion DOI: http://dx.doi.org/10.2147/IJN.S61823",Non-OADS,/arxiv_data1/oa_pdf/ee/1c/ijn-9-3119.PMC4079637.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ee/1c/ijn-9-3119.PMC4079637.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3130Baskaran et al  28.,Non-OADS,/arxiv_data1/oa_pdf/ee/1c/ijn-9-3119.PMC4079637.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/4a/opth-8-1213.PMC4079638.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1213–1219Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1213Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6670 1Prospective, randomized, contralateral eye  comparison of tetracaine and proparacaine   for pain control in laser in situ keratomileusis   and photorefractive keratectomy Majid Moshirfar1 Mark D Mifflin1 Michael V McCaughey2 adam J gess1 1John a Moran eye Center, University  of Utah, salt lake City, UT, Usa;   2University of new Mexico school   of Medicine, albuquerque, nM, Usa Correspondence: Majid Moshirfar   Moran eye Center, University of Utah,   65 Mario Capecchi Dr, salt lake City,   UT 84132, Usa   T el +1 801 581 2352   email majid.moshirfar@hsc.utah.ed uBackground:  Tetracaine and proparacaine are two of the most commonly used medications  for providing topical anesthesia in laser in situ keratomileusis (LASIK) and photorefractive  keratectomy (PRK).",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/opth-8-1213.PMC4079638.pdf
"These agents have  been widely used in ophthalmic surgery for years, but their efficacy has only been  studied and compared in emergency room settings1 and in the setting of intravitreal  injection.2 Studies comparing the efficacy of these anesthetic agents in LASIK and Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Moshirfar et al Running head recto: Preferred analgesia for patients undergoing LASIK and PRK procedures DOI: http://dx.doi.org/10.2147/OPTH.S66701",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/opth-8-1213.PMC4079638.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/opth-8-1213.PMC4079638.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1219Preferred analgesia for patients undergoing lasiK and PrK procedures resulting in suppression of epithelial regeneration, in addition  to several other unfavorable side effects.14,15 Consideration  of corneal epithelial toxicity as a result of topical anesthetic  administration is of particular concern following procedures  which require epithelial disruption, such as PRK.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/opth-8-1213.PMC4079638.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org101Efficacy of a Patient’s Own Blood as Colonic Localization  Agent Dae Y oun Won, Won-Kyung Kang Department of Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea  College of Medicine, Seoul, KoreaEditorial Ann Coloproctol 2014;30(3):101-102 http://dx.doi.org/10.3393/ac.2014.30.3.101 tive study is necessary if the use of a patient’s own blood as a tat - tooing method is to become widely accepted as the new standard  technique.",Non-OADS,/arxiv_data1/oa_pdf/4f/46/ac-30-101.PMC4079802.pdf
"Department of Sugery, Seoul St. Mary’s Hospital, The Catholic University of  Korea  College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701,  Korea Tel: +82-2-2258-6104, Fax: +82-2-595-2822 E-mail: wonkkang@catholic.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/46/ac-30-101.PMC4079802.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org103Endless Arguments Over Diversion Stomas Seung Chul Heo Department of Surgery, SMG-SNU Boramae Medical Center, Seoul, KoreaEditorial Ann Coloproctol 2014;30(3):103 http://dx.doi.org/10.3393/ac.2014.30.3.103 essary through further research whether PSS which is cosmeti - cally superior but requires laborious dressing during the discharge  of 2–3 weeks is worthwhile to replace the primary closure.",Non-OADS,/arxiv_data1/oa_pdf/d6/2b/ac-30-103.PMC4079803.pdf
"Department of Surgery, SMG-SNU Boramae Medical Center, Seoul National  University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu,   Seoul 156-707, Korea  Tel: +82-2-870-2273, Fax: +82-2-870-3866 E-mail: heosc3@brm.co.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/2b/ac-30-103.PMC4079803.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org104Sacral Chordoma: Challenging for Resection Margin Seung-Hyun Lee, Byung-Kwon Ahn Department of Surgery, Kosin University College of Medicine, Busan, KoreaEditorial Ann Coloproctol 2014;30(3):104-105 http://dx.doi.org/10.3393/ac.2014.30.3.104 Differential diagnosis is important for the surgical and the post - surgical management of a chordoma.",Non-OADS,/arxiv_data1/oa_pdf/55/e8/ac-30-104.PMC4079804.pdf
"Department of Surgery, Kosin University College of Medicine,   262 Gamcheon-ro, Seo-gu, Busan 602-702, Korea Tel: +82-51-990-6462, Fax: +82-51-246-6093,   E-mail: gsabk@hotmail.com © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/e8/ac-30-104.PMC4079804.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org106Treatment Option for Aged, Multiparous Women With a  Chronic Anal Fissure Y ong Hee Hwang Department of Surgery, Sahmyook Medical Center, Seoul, KoreaEditorial Ann Coloproctol 2014;30(3):106 http://dx.doi.org/10.3393/ac.2014.30.3.106 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/da/44/ac-30-106.PMC4079805.pdf
"Department of Sugery, Sahmyook Medical Center, 82 Mangu-ro,  Dongdaemun-gu, Seoul 130-711, Korea  Tel: +82-2-2210-3563, Fax: +82-2-2212-2673 E-mail: hwangyon@hotmail.com © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/44/ac-30-106.PMC4079805.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org107Spinal Block Anesthesia With Morphine in a  Hemorrhoidectomy Byung Chun Kim Department of Surgery, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, KoreaEditorial Ann Coloproctol 2014;30(3):107-108 http://dx.doi.org/10.3393/ac.2014.30.3.107 addition group at 6, 12, and 24 hours after surgery.",Non-OADS,/arxiv_data1/oa_pdf/0d/aa/ac-30-107.PMC4079806.pdf
"Department of Surgery, Kangnam Sacred Heart Hospital, Hallym University  College of Medicine, 1 Singil-ro, Yeongdeungpo-gu, Seoul 150-950, Korea Tel: +82-2-829-5130, Fax: +82-2-849-4469 E-mail: bckimgs@hallym.or.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/aa/ac-30-107.PMC4079806.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 109Pelvic Floor Rehabilitation to Improve Functional Outcome  After a Low Anterior Resection: A Systematic Review Wilhelmina S Visser, Wouter W te Riele, Djamila Boerma, Bert van Ramshorst,   Henderik L van Westreenen1 Department of Surgery, St. Antonius Hospital, Nieuwegein, 1Department of Surgery, Isala Clinics, Zwolle, The NetherlandsReview Ann Coloproctol 2014;30(3):109-114 http://dx.doi.org/10.3393/ac.2014.30.3.109 Purpose:  Impaired functional outcome is common after a low anterior resection (LAR).",Non-OADS,/arxiv_data1/oa_pdf/33/8a/ac-30-109.PMC4079807.pdf
"Department of Surgery, Isala Clinics, Zwolle PO box 10400, 8000 GK Zwolle,  The Netherlands Tel: :+31-38-424-2787, Fax: +31-38-424-7720 E-mail: h.l.van.westreenen@isala.nl © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/8a/ac-30-109.PMC4079807.pdf
"The characteristics of patients, the  anatomy of colon cancer, and the efficacy and the side effects of Preoperative Localization of Early Colorectal Cancer or a  Malignant Polyp by Using the Patient’s Own Blood Seung Hwan Lee, Do Y oon Kim, Seung Y eop Oh, Kwang Jae Lee, Kwang Wook Suh Colon Cancer Center, Ajou University School of Medicine, Suwon, KoreaOriginal Article Ann Coloproctol 2014;30(3):115-117 http://dx.doi.org/10.3393/ac.2014.30.3.115 Purpose:  Preoperative localization is the most important preparation for laparoscopic surgery.",Non-OADS,/arxiv_data1/oa_pdf/39/dd/ac-30-115.PMC4079808.pdf
"Department of Surgery, Ajou University School of Medicine,   206 World cup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: +82-31-219-5200, Fax: +82-31-219-5755 E-mail: suhkw@ajou.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/dd/ac-30-115.PMC4079808.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 118Feasibility and Safety of a Fold-Over Diverting Ileostomy  Reversal After Rectal Cancer Surgery: Case-Matched  Comparison to the Resection Technique Jinock Cheong, Jeonghyun Kang, Im-Kyung Kim, Nam Kyu Kim, Seung-Kook Sohn, Kang Y oung Lee Department of Surgery, Y onsei University College of Medicine, Seoul, KoreaOriginal Article Ann Coloproctol 2014;30(3):118-121 http://dx.doi.org/10.3393/ac.2014.30.3.118 Purpose:  Compared to the stapling technique, the fold-over technique (FO) has the benefit of avoiding the sacrifice of the  bowel segment.",Non-OADS,/arxiv_data1/oa_pdf/13/74/ac-30-118.PMC4079809.pdf
"© 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/74/ac-30-118.PMC4079809.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 122The Unresolved Case of Sacral Chordoma: From  Misdiagnosis to Challenging Surgery and Medical Therapy  Resistance Fabio Garofalo1,2, Dimitrios Christoforidis2,3, Pietro G. di Summa4, Béatrice Gay5, Stéphane Cherix6,  Wassim Raffoul4, Nicolas Demartines2, Maurice Matter2 1Department of Surgery, Intercantonal Hospital Broye, Payerne; 2Department of Visceral Surgery, University Hospital of Lausanne (CHUV),  Lausanne; 3Department of Surgery, Hospital Civico, Lugano; Departments of 4Plastic and Reconstructive Surgery, 5Oncology, and  6Orthopedics, University Hospital of Lausanne (CHUV), Lausanne; SwitzerlandOriginal Article Ann Coloproctol 2014;30(3):122-131 http://dx.doi.org/10.3393/ac.2014.30.3.122 Purpose:  A sacral chordoma is a rare, slow-growing, primary bone tumor, arising from embryonic notochordal remnants.",Non-OADS,/arxiv_data1/oa_pdf/07/80/ac-30-122.PMC4079810.pdf
"Radi - cal surgery is the only hope for cure as no chemotherapy has been Received: July 22, 2013   •   Accepted: October 18, 2013 Correspondence to: Nicolas Demartines, M.D., FACS, FRCS Department of Visceral Surgery, University Hospital of Lausanne (CHUV),  Rue du Bugnon 46, Lausanne 1011, Switzerland Tel: +41-213142400, Fax: None E-mail: demartines@chuv.ch © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/80/ac-30-122.PMC4079810.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 132Sphincter-Preserving Therapy for Treating a Chronic Anal  Fissure: Long-term Outcomes Ridzuan Farouk Department of Surgery, National University Hospital, SingaporeOriginal Article Ann Coloproctol 2014;30(3):132-134 http://dx.doi.org/10.3393/ac.2014.30.3.132 Purpose:  To estimate the risk of recurrent fissure in ano after sphincter preserving treatments.",Non-OADS,/arxiv_data1/oa_pdf/f2/04/ac-30-132.PMC4079811.pdf
"Patients with Crohn’s disease, radia -Received: September 3, 2013   •   Accepted: November 24, 2013 Correspondence to: Ridzuan Farouk, LLB (Hons) MCh FRCS Department of Surgery, National University Hospital, Tower Block #8,   1E Kent Ridge Road, Singapore 119228, Singapore Tel: +65-6772-4235, Fax: +65-6777-8206 E-mail: ridzuan_farouk@nuhs.edu.sg © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/04/ac-30-132.PMC4079811.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 135Morphine Spinal Block Anesthesia in Patients Who Undergo  an Open Hemorrhoidectomy: A Prospective Analysis of  Pain Control and Postoperative Complications Hélio Moreira Jr, José PT Moreira, Raniere R Isaac, Onofre Alves-Neto1, Thiago AC Moreira1,   Tiago HM Vieira1, Andressa MS Brasil Department of Surgery, Colorectal Service, School of Medicine of the Federal University of Goias, Goias; 1Department of  Surgery,  Anesthesiology Service, School of Medicine of the Federal University of Goias, Goias, Brazil Original Article Ann Coloproctol 2014;30(3):135-140 http://dx.doi.org/10.3393/ac.2014.30.3.135 Purpose:  This study evaluated the use of adding morphine to bupivacaine in spinal anesthesia for pain control in patients  who underwent an open hemorrhoidectomy.",Non-OADS,/arxiv_data1/oa_pdf/0e/26/ac-30-135.PMC4079812.pdf
"Department of Surgery, Colorectal Service School of Medicine, Federal  University of Goiás, Avenida B, N.435, Setor Oeste, Goiânia Goiás 74110-030,  Brazil Tel: +556232259300, Fax: +556232259300 E-mail: drhmjr@gmail.com © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/26/ac-30-135.PMC4079812.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 141TisN0M1 Sigmoid Colon Cancer: A Case Report Kyung Ha Lee, Jin Su Kim, Kwang Sik Cheon, In Sang Song, Dae Y oung Kang1, Ji Y eon Kim Departments of Surgery and 1Pathology, Chungnam National University Hospital, Daejoen, KoreaCase Report Ann Coloproctol 2014;30(3):141-146 http://dx.doi.org/10.3393/ac.2014.30.3.141 Distant metastasis of a colon carcinoma in situ  has not yet been reported.",Non-OADS,/arxiv_data1/oa_pdf/4e/83/ac-30-141.PMC4079813.pdf
"Department of Surgery, Chungnam National University Hospital,   282 Munhwa-ro, Jung-gu, Daejeon 301-721, Korea Tel: +82-42-280-7175, Fax: +82-42-257-8024 E-mail: jkim@cnu.ac.kr  © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/83/ac-30-141.PMC4079813.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 147Surgical Strategy for Colonic Intussusception Caused by a  Giant Colonic Lipoma: A Report of Two Cases and a  Review of the Literature Seung-Jin Kwag, Sang-Kyung Choi, Eun-Jung Jung, Chi-Y oung Jung, Sang-Ho Jung, Tae-Jin Park, Y oung-Tae Ju Department of Surgery, Gyeongsang National University Postgraduate School of Medicine, Gyeongsang National University Hospital, Jinju,  KoreaCase Report Ann Coloproctol 2014;30(3):147-150 http://dx.doi.org/10.3393/ac.2014.30.3.147 A colon lipoma is a remarkably rare tumor.",Non-OADS,/arxiv_data1/oa_pdf/32/3e/ac-30-147.PMC4079814.pdf
"Department of Surgery, Gyeongsang National University Hospital,  Gyeongsang National University Postgraduate School of Medicine,   79 Gangnam-ro, Jinju 660-702, Korea Tel: +82-55-750-8096, Fax: +82-55-750-9244 E-mail: drjyt@naver.com © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/3e/ac-30-147.PMC4079814.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 151Commentary on “Data on the Characteristics and the  Survival of Korean Patients With Colorectal Cancer From  the Korea Central Cancer Registry ” Mohammad Mohammadianpanah Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, IranLetter to the Editor Ann Coloproctol 2014;30(3):151-152 http://dx.doi.org/10.3393/ac.2014.30.3.151 To the editor In the July 2013 issue of Annals of Coloproctology, I read with  great interest the article entitled “Data on the Characteristics and  the Survival of Korean Patients with Colorectal Cancer from the  Korea Central Cancer Registry” by Park et al.",Non-OADS,/arxiv_data1/oa_pdf/1a/0b/ac-30-151.PMC4079815.pdf
"Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz  71936, Iran Tel: +98-711-6125170, Fax: +98-711-6474320 E-mail: mohpanah@gmail.com © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Table 1.",Non-OADS,/arxiv_data1/oa_pdf/1a/0b/ac-30-151.PMC4079815.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 153Reply on “Data on the Characteristics and the Survival of  Korean Patients With Colorectal Cancer From the Korea  Central Cancer Registry ” Hyoung-Chul Park, Bong Hwa Lee Korea Colorectal Cancer Study Group (KOCCS), Seoul, KoreaLetter to the Editor Ann Coloproctol 2014;30(3):153 http://dx.doi.org/10.3393/ac.2014.30.3.153 To the editor Thank you for great interest to our article.",Non-OADS,/arxiv_data1/oa_pdf/f3/db/ac-30-153.PMC4079816.pdf
"Department of Surgery, Hallym University Sacred Heart Hospital,   22 Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang 431-796, Korea Tel: +82-31-380-3772, Fax: +82-31-380-0157 E-mail: bslee@hallym.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/db/ac-30-153.PMC4079816.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/d1/ndt-10-1183.PMC4079817.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1183–1190Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1183ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/NDT .S6127 5COMT   Val158Met, but not BDNF  Val66Met, is  associated with white matter abnormalities of  the temporal lobe in patients with first-episode,  treatment-naïve major depressive disorder:   a diffusion tensor imaging study Kenji Hayashi1 Reiji Y oshimura1 Shingo Kakeda2 Taro Kishi3 Osamu Abe4 Wakako Umene-Nakano1 Asuka Katsuki1 Hikaru Hori1 Atsuko Ikenouchi-Sugita1 Keita Watanabe2 Satoru Ide2 Issei Ueda2 Junji Moriya2 Nakao Iwata3 Yukunori Korogi2 Marek Kubicki5 Jun Nakamura1 1Department of Psychiatry,    2Department of Radiology, University  of Occupational and Environmental  Health, Kitakyushu, Japan;  3Department  of Psychiatry, Fujita Health University,  T oyoake, Japan; 4Department of  Radiology, Nihon University School  of Medicine, T okyo, Japan;  5Psychiatry  Neuroimaging Laboratory, Brigham and  Women’s Hospital, Harvard Medical  School, Boston, MA, USA Correspondence: Reiji Yoshimura   Department of Psychiatry, University of  Occupational and Environmental Health,  Kitakyushu,  8078555, Japan   Tel +81 93 691 7253  Fax +81 93 692 4894  Email yoshi621@med.uoeh-u.ac.j pAbstract:  We investigated the association between the Val158Met polymorphism of the  catechol-O-methyltransferase  (COMT ) gene, the Val66Met polymorphism of the brain-derived  neurotrophic factor  (BDNF ) gene, and white matter changes in patients with major depres - sive disorder (MDD) and healthy subjects using diffusion  tensor imaging (DTI).",Non-OADS,/arxiv_data1/oa_pdf/b0/d1/ndt-10-1183.PMC4079817.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b0/d1/ndt-10-1183.PMC4079817.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/d1/ndt-10-1183.PMC4079817.pdf
"3: 123-127, June, 2014http://dx.doi.org/10.4110/in.2014.14.3.123 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 123Received on March 31, 2014.",Non-OADS,/arxiv_data1/oa_pdf/1d/79/in-14-123.PMC4079818.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/79/in-14-123.PMC4079818.pdf
"3: 128-137, June, 2014http://dx.doi.org/10.4110/in.2014.14.3.128 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 128Received on April 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/f9/a7/in-14-128.PMC4079819.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/a7/in-14-128.PMC4079819.pdf
"3: 138-148, June, 2014http://dx.doi.org/10.4110/in.2014.14.3.138 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 138Received on May 22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/24/2b/in-14-138.PMC4079820.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/2b/in-14-138.PMC4079820.pdf
"3: 149-155, June, 2014http://dx.doi.org/10.4110/in.2014.14.3.149 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 149Received on April 3, 2014.",Non-OADS,/arxiv_data1/oa_pdf/07/21/in-14-149.PMC4079821.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/21/in-14-149.PMC4079821.pdf
"3: 156-163, June, 2014http://dx.doi.org/10.4110/in.2014.14.3.156 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 156Received on May 6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8c/b8/in-14-156.PMC4079822.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/b8/in-14-156.PMC4079822.pdf
"3: 164-170, June, 2014http://dx.doi.org/10.4110/in.2014.14.3.164 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 164Received on April 18, 2014.",Non-OADS,/arxiv_data1/oa_pdf/67/b9/in-14-164.PMC4079823.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/b9/in-14-164.PMC4079823.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/0e/ndt-10-1161.PMC4079824.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1161–1174Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1161Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S3071 3Kerri A Schoedel1 Sarah A Morrow2 edward M Sellers3,4 1Altreos Research Partners, inc.,   T oronto, 2western University, London,   3DL Global Partners, inc., T oronto,   4University of T oronto, T oronto,   Ontario, Canada Correspondence: Kerri A Schoedel   Altreos Research Partners, inc.,   50 wanda Rd, T oronto,   Ontario M6P 1C6, Canada   T el +1 416 434 6921   email kschoedel@altreos.co mEvaluating the safety and efficacy of  dextromethorphan/quinidine in the   treatment of pseudobulbar affect Abstract:  Pseudobulbar affect (PBA) is a common manifestation of brain pathology associated  with many neurological diseases, including amyotrophic lateral sclerosis, Alzheimer’s disease,  stroke, multiple sclerosis, Parkinson’s disease, and traumatic brain injury.",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/ndt-10-1161.PMC4079824.pdf
"PLC is defined as involuntary and uncontrollable  expressed emotion (laughing or crying or both) that is exaggerated relative to the  stimulus as well as the experienced emotion.2 In contrast, PBA is a broader term in  which the emotion is still exaggerated and inappropriate and also incongruent with Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Review Y ear: 2014 Volume: 10 Running head verso: Schoedel et al Running head recto: Dextromethorphan/quinidine for pseudobulbar affect DOI: http://dx.doi.org/10.2147/NDT.S30713",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/ndt-10-1161.PMC4079824.pdf
"Available from: http://www.page-meeting.org/ pdf_assets/6239-Celerion_Poster_Page2010_PopPK_QDMDX.pd f.  Accessed December 28, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/ndt-10-1161.PMC4079824.pdf
Available from: http://www.nhtsa.gov/people/ injury/research/job185drugs/dextromethorphan.htm.,OADS,/arxiv_data1/oa_pdf/ee/0e/ndt-10-1161.PMC4079824.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/ndt-10-1161.PMC4079824.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1174Schoedel et al  103.,Non-OADS,/arxiv_data1/oa_pdf/ee/0e/ndt-10-1161.PMC4079824.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/7b/jpr-7-367.PMC4079825.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 367–378Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  367Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/JPR.S4607 1Medication-overuse headache: a review espen Saxhaug  Kristoffersen1–3 Christofer Lundqvist1,2,4 1Research Centre, Akershus University  Hospital, Lørenskog, 2Department  of Neurology, Akershus University  Hospital, Nordbyhagen, 3Department  of General Practice, institute of  Health and Society, University of Oslo,   Oslo, 4institute of Clinical Medicine,   Campus Akershus University Hospital,   University of Oslo, Nordbyhagen,   Norway Correspondence: espen Saxhaug  Kristoffersen   Department of General Practice,   institute of Health and Society,   University of Oslo, PO Box 1130  Blindern, 0318 Oslo, Norway   Tel +47 2285 0550   Fax +47 2285 0650   email e.s.kristoffersen@medisin.uio.n oAbstract:  Medication-overuse headache (MOH) is a worldwide health problem with a preva - lence of 1%–2%.",Non-OADS,/arxiv_data1/oa_pdf/ca/7b/jpr-7-367.PMC4079825.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/ca/7b/jpr-7-367.PMC4079825.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/7b/jpr-7-367.PMC4079825.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/f4/ijn-9-3137.PMC4079826.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3137–3149International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3137OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S5954 1anticancer nanodelivery system with controlled  release property based on protocatechuate–zinc  layered hydroxide nanohybrid Farahnaz Barahuie1 Mohd Zobir hussein1 shafinaz abd gani2,3 sharida Fakurazi3,4 Zulkarnain Zainal1 1Materials synthesis and  characterization laboratory,   Institute of advanced Technology  (ITM a), Universiti Putra Malaysia,  2Department of Biochemistry, Faculty  of Biotechnology and Biomolecular  sciences, Universiti Putra Malaysia,   3laboratory of Vaccines and  Immunotherapeutics, Institute of  Bioscience, Universiti Putra Malaysia,   4Department of human anatomy,   Faculty of Medicine and health  sciences, Universiti Putra Malaysia,   serdang, selangor, Malaysia correspondence: Mohd Zobir hussein   Materials synthesis and characterization  laboratory, Institute of advanced  T echnology, Block B, Faculty of  engineering, Universiti Putra Malaysia,  43400 UPM, serdang, selangor, Malaysia   T el +603 8946 8092   Fax +603 8946 7006   email mzobir@upm.edu.m yBackground:  We characterize a novel nanocomposite that acts as an efficient anticancer  agent.",Non-OADS,/arxiv_data1/oa_pdf/31/f4/ijn-9-3137.PMC4079826.pdf
Many successful intercalations have been reported  with regards to the use of LDHs as anticancer drug carrier systems.3–7 LDHs structure  has the general formula of: 23 12 2M M (OH) (A ) H Oxm x x xmn+++ − − ⋅ Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Barahuie et al Running head recto: Controlled release anticancer nanodelivery system DOI: http://dx.doi.org/10.2147/IJN.S59541,Non-OADS,/arxiv_data1/oa_pdf/31/f4/ijn-9-3137.PMC4079826.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/31/f4/ijn-9-3137.PMC4079826.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3149controlled release anticancer nanodelivery system  23.,Non-OADS,/arxiv_data1/oa_pdf/31/f4/ijn-9-3137.PMC4079826.pdf
"45 Lab Anim Res 2014: 30(2), 45-53 http://dx.doi.org/10.5625/lar.2014.30.2.45 Proteomic analysis of domestic pig pancreas during development  using two-dimensional electrophore sis and matrix-assisted laser  desorption/ionization-time of flight mass spectrometry Ji Ye Ahn1, Il Yong Kim1, Sae Jin Oh1, Hye Sook Hwang1, Sun Shin Yi2, Yo Na Kim1,  Jae Hoon Shin1, Yeo Sung Yoon1, Je Kyung Seong1* 1Laboratory of Developmental Biology and Genetics, College of Veterinary Medicine, BK21Plus Program for Creative  Veterinary Science Research, BIO-MAX institute, Seoul National University, Seoul, Korea 2Department of Biomedical Laboratory Science, College of Biomedical Science, Soonchunhyang University, Asan, Korea Pig pancreas may be a therapeutic resource for human diabetic patients.",Non-OADS,/arxiv_data1/oa_pdf/45/08/lar-30-45.PMC4079831.pdf
Classification by function The 24 identified proteins were classified by their functions based on a search at http://harvester.embl.de(Table 2).,OADS,/arxiv_data1/oa_pdf/45/08/lar-30-45.PMC4079831.pdf
"54 Lab Anim Res 2014: 30(2), 54-63 http://dx.doi.org/10.5625/lar.2014.30.2.54 Toxicity of fermented soybean product (cheonggukjang)  manufactured by mixed culture of Bacillus subtilis  MC31 and  Lactobacillus sakei 383 on liver and kidney of ICR mice Young-Ju Lee1, Ji-Eun Kim1, Moon-Hwa Kwak1, Jun Go1, Hong-Joo Son1, Dong-Sup Kim1,  Byeong-Cheol Kang2, Hee-Seob Lee3, Dae-Youn Hwang1* 1College of Natural Resources & Life Science, Pusan National University, Miryang, Korea 2Department of Experimental Animal Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea 3College of Human Ecology, Pusan National University, Busan, Korea To investigate the toxic effects of cheonggukjang (CKJ) manufactured using mixed cultures of Bacillus subtilis  MC31 and Lactobacillus sakei 383 on the liver and kidney of ICR mice, an alteration on the related markers including body weight, organ weight, urine composition, liver pathology and kidneypathology were analyzed after oral administration at dosage of 25, 50 and 100 mg/kg body weight/day of CKJ for 14 days.",OADS,/arxiv_data1/oa_pdf/00/8c/lar-30-54.PMC4079832.pdf
"64 Lab Anim Res 2014: 30(2), 64-72 http://dx.doi.org/10.5625/lar.2014.30.2.64 Establishment of linear accelerator-based image guided  radiotherapy for orthotopic 4T1 mouse mammary tumor model Seung-Heon Lee1#, Ji-Young Kim2#, Kyu-Chan Lee1*, Jeong-Seok Nam2, Jinho Choi1,  Seok-Ho Lee1, Ki-Hoon Sung1, So-Hyun Ahn1 1Department of Radiation Oncology, Gachon University Gil Medical Center, Incheon, Korea 2Laboratory of Tumor Suppressor, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Korea This study was conducted to assess the feasibility of image guided radiotherapy (IGRT) for orthotopic 4T1 mouse mammary tumor using linear accelerator (LINAC).",OADS,/arxiv_data1/oa_pdf/2d/ec/lar-30-64.PMC4079833.pdf
"73 Lab Anim Res 2014: 30(2), 73-78 http://dx.doi.org/10.5625/lar.2014.30.2.73 Effects of anti-obesity drugs, phentermine and mahuang, on the behavioral patterns in Sprague-Dawley rat model Ryeo-Eun Go1, Kyung-A Hwang1, Seung-Hee Kim1, Min-Young Lee1, Cho-Won Kim1,  So-Ye Jeon1, Yun-Bae Kim2, Kyung-Chul Choi1* 1Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea 2Laboratory of Toxicology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea According to WHO global estimates from 2008, more than 1.4 billion adults were overweight and among them, over 200 million men and 300 million women were obese.",Non-OADS,/arxiv_data1/oa_pdf/98/83/lar-30-73.PMC4079834.pdf
WHO is also warning that overweight and obesity are the fifth leading risk for global death (http://www.who.int/mediacentre/factsheets/fs311/en).,Non-OADS,/arxiv_data1/oa_pdf/98/83/lar-30-73.PMC4079834.pdf
"However, as the adverse side effects related with gastrointestinal, cardiovascular and autonomic nervous system were reported [25], the U.S. FDA prohibited the use of mahuang and ephedrine as food additives in 2004(http://www.fda.gov/oc/initiatives/ephedra/february2004/ finalsummary.html).",Non-OADS,/arxiv_data1/oa_pdf/98/83/lar-30-73.PMC4079834.pdf
"79 Lab Anim Res 2014: 30(2), 79-83 http://dx.doi.org/10.5625/lar.2014.30.2.79 The potential mechanism of the detr imental effect of defibrillation  prior to cardiopulmonary resuscitation in prolonged cardiac arrest model Joon-Ho Bae1, Chan-Woo Park1, Jun-Hwi Cho1,*, Yoon-Sung Kim1, Hui-Young Lee2, Moo-Ho Won3 1Department of Emergency Medicine and Institute of Clinical Science, Kangwon National University Hospital, School of Medicine, Kangwon National University, Chuncheon, Korea 2Department of Internal Medicine, Kangwon National University Hospital, School of Medicine, Kangwon National University, Chuncheon, Korea 3Departmemt of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, Korea Defibrillation is no longer universally recommended as initial intervention for the reversal of ventricular fibrillation (VF) after a prolonged and untreated cardiac arrest.",Non-OADS,/arxiv_data1/oa_pdf/b4/32/lar-30-79.PMC4079835.pdf
"84 Lab Anim Res 2014: 30(2), 84-89 http://dx.doi.org/10.5625/lar.2014.30.2.84 An ethanolic extract of Angelica gigas  improves atherosclerosis by  inhibiting vascular smooth muscle cell proliferation Ja Young Jang1#, Jihyun Kim1#, Jingmei Cai1, Youngeun Kim1, Kyungha Shin1, Tae-Su Kim2,  Sung-Pyo Lee2, Sung Kyeong Park3, Ehn-Kyoung Choi1*, Yun-Bae Kim1* 1College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea 2Misuba RTech Co., Ltd., Asan, Korea 3Daejeon Health Sciences College, Daejeon, Korea The effects of an ethanolic extract of Angelica gigas  (EAG) on the vascular smooth muscle cell (VSMC) proliferation and high-cholesterol diet-induced hypercholesterolemia and atherosclerosis were investigated.",OADS,/arxiv_data1/oa_pdf/ca/45/lar-30-84.PMC4079836.pdf
"90 Lab Anim Res 2014: 30(2), 90-93 http://dx.doi.org/10.5625/lar.2014.30.2.90 No expression of porcine endogenous retrovirus after pig to monkey xenotransplantation Seongsoo Hwang1#, Yi-Deun Jung2#, Kahee Cho3, Sun-A Ock1, Keon-Bong Oh1,  Heui-Soo Kim2, Ik-Jin Yun4, Curie Ahn5, Jin-Ki Park1, Seoki Im1* 1National Institute of Animal Science, Suwon, Korea 2Pusan National University, Busan, Korea 3Orient Genia Inc., Seongnam, Korea 4Konkuk University School of Medicine, Seoul, Korea 5Seoul National University College of Medicine, Seoul, Korea This study was performed to investigate the expression of two porcine endogenous retrovirus (PERV) elements, PERV gag and full-length conserved PERV, in blood cells collected periodically from organ- recipient monkeys that underwent pig to non-human primate xenotransplantation.",Non-OADS,/arxiv_data1/oa_pdf/9c/85/lar-30-90.PMC4079837.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Movement/non-movement behaviors and adiposity in children J-P Chaput et al 5 &2014 Macmillan Publishers Limited Nutrition & Diabetes (2014), 1 – 5",Non-OADS,/arxiv_data1/oa_pdf/9d/88/nutd201414a.PMC4079924.pdf
http://www.who.int/topics/obesity/en/.,Non-OADS,/arxiv_data1/oa_pdf/76/0f/nutd201415a.PMC4079925.pdf
Clinical break- points-bacteria http://www.eucast.org/ﬁleadmin/src/media/PDFs/EUCAST_ﬁles/ Breakpoint_tables/Breakpoint_table_v_2.0_120221.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/0f/nutd201415a.PMC4079925.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Nutrition & Diabetes website (http://www.nature.com/nutd)b-Lactams in obese patients M Hites et al 7 &2014 Macmillan Publishers Limited Nutrition & Diabetes (2014) 1 – 7",Non-OADS,/arxiv_data1/oa_pdf/76/0f/nutd201415a.PMC4079925.pdf
"To view a copy of this license, visit http://creativecommon-s.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Nutrition & Diabetes website (http://www.nature.com/nutd)Gene score and adiposity inﬂuence triglycerides N Zubair et al 7 &2014 Macmillan Publishers Limited Nutrition & Diabetes (2014) 1 – 7",Non-OADS,/arxiv_data1/oa_pdf/fd/5d/nutd201416a.PMC4079926.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Coffee- and diet-induced diabetes in mice I Rustenbeck et al 9 &2014 Macmillan Publishers Limited Nutrition & Diabetes (2014) 1 – 9",Non-OADS,/arxiv_data1/oa_pdf/65/e1/nutd201419a.PMC4079928.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Refeeding and metabolic syndromes OA Obeid et al 8 Nutrition & Diabetes (2014) 1 – 8 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/11/b3/nutd201421a.PMC4079929.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Nutrition & Diabetes website (http://www.nature.com/nutd)Adiposity and short chain fatty acids J Fernandes et al 7 &2014 Macmillan Publishers Limited Nutrition & Diabetes (2014) 1 – 7",Non-OADS,/arxiv_data1/oa_pdf/e4/00/nutd201423a.PMC4079931.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Cellular basis of dysferlin-mediated muscle cell repair A Defour et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/00/6c/cddis2014272a.PMC4079937.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Institute of Medicine.,Non-OADS,/arxiv_data1/oa_pdf/2d/2a/bmjqs-2013-002172.PMC4079961.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/ 4.0/.6Corresponding author E-mail matthew_meyerson@dfci.harvard.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.163659.113.",Non-OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
Methods Data Sequencing data Sequencing data were downloaded from the TCGA CGHub re- pository (https://cghub.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
"Primary and processed data for TCGA can be downloaded by registered users at https://tcga-data.nci.nih.gov/tcga/tcgaDownload.jsp, https://cghub.ucsc.edu/.The downloaded BAM file for each tumor and normal sample (aligned to genome build hg18 for LAML, COAD, READ, and two OV samples, and hg19 for all others using BWA) were used as inputto TranspoSeq.",OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
Retrotransposon data Consensus retrotransposon sequences were downloaded from GIRI Repbase (http://www.girinst.org/repbase/).,OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
HPV status for 28 HNSC samples were derived from the paperfreeze analysis set provided by the TCGA HNSC AWG (http://www.broadinstitute.org/collaboration/gcc/samples/hnsc).,OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
"Retrotransposon high and low clusters were correlated to so- matic mutation, arm-level, and focal copy-number changes, miRNA levels, and methylation data when available, using The Broad Institute’s TCGA GDAC (https://confluence.broadinstitute.org/display/GDAC/Home).",OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
Data access Source code for TranspoSeq and TranspoSeq-Exome is available at http://www.broadinstitute.org/cancer/cga/transposeq.,OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
Retro-transposon insertion positions have been submitted to NCBIdbVar (http://www.ncbi.nlm.nih.gov/dbvar/) under accession nstd94.Somatic retrotransposition in cancer Genome Research 1061 www.genome.org,Non-OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
"http://www.aacr.org/home/scientists/meetings–workshops/special-conferences/previous-special-conferences/2011—2012-special-conferences/translation-of-the-cancer-genome/program.aspx (AccessedJune 7, 2013).",Non-OADS,/arxiv_data1/oa_pdf/77/e4/1053.PMC4079962.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/8d/a6/1075.PMC4079964.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0 In- ternational), as described at http://creativecommons.org/licenses/by-nc/4.0/.4These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/8d/a6/1075.PMC4079964.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.163915.113.",OADS,/arxiv_data1/oa_pdf/8d/a6/1075.PMC4079964.pdf
"Comparison between zebrafish and medaka ChIP-seq data In order to compare acetylation peaks obtained from ChIP-seqanalyses in both species, chained and netted alignments (axtformat) between danRer7 and oryLat2 assemblies were down-loaded from the UCSC Genome Browser downloads web page (http://hgdownload.cse.ucsc.edu/downloads.html).",OADS,/arxiv_data1/oa_pdf/8d/a6/1075.PMC4079964.pdf
"2013) Data access The ChIP-seq and RNA-seq data included in this work have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under the following acces-sion numbers: GSE46351 (medaka stage 24 ChIP-seq tracks), GSE46484 (medaka stage 24 RNA-seq tracks), and GSE47033 (mouse E10.5 RNA-seq tracks).",OADS,/arxiv_data1/oa_pdf/8d/a6/1075.PMC4079964.pdf
"Its former homolog, the X chromosome, ac- quires mechanisms to compensate for gene loss associated with /C2112014 Brown and Bachtrog This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/1e/6d/1125.PMC4079968.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0 In- ternational), as described at http://creativecommons.org/licenses/by-nc/4.0/.1Corresponding author E-mail dbachtrog@berkeley.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/1e/6d/1125.PMC4079968.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.172155.114.",OADS,/arxiv_data1/oa_pdf/1e/6d/1125.PMC4079968.pdf
Data access The ChIP-seq data generated in this study have been submitted tothe NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra/) under accession number SRP040696.,OADS,/arxiv_data1/oa_pdf/1e/6d/1125.PMC4079968.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 In- ternational), as described at http://creativecommons.org/licenses/by-nc/4.0/.1Corresponding author E-mail ja219@cam.ac.uk Article published online before print.",Non-OADS,/arxiv_data1/oa_pdf/da/42/1138.PMC4079969.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.161992.113.",Non-OADS,/arxiv_data1/oa_pdf/da/42/1138.PMC4079969.pdf
"DNA sequencing librarieswere constructed using the Illumina TruSeq sequencing kit and were sequenced on the Illumina platform.Data sets, processing, and visualization C. elegans ChIP-seq data H3K4me3 (modENCODE_5166) and H3K4me1 (modENCODE_5158) and Drosophila ChIP-seq data H3K4me3 (modENCODE_789) and H3K4me1 (modENCODE_777) were obtained from modENCODE (http://www.modencode.org/).",OADS,/arxiv_data1/oa_pdf/da/42/1138.PMC4079969.pdf
"H3K4me3 (wgEncodeBroadHistoneHepg 2H3k4me3StdSig.bigWig) and H3K4me1 (wgEncodeBroadHistoneHepg2H3k04me1StdSig.bigWig) ChIP-seq data in HepG2 cells wereobtained from the ENCODE Project (The ENCODE Project Con- sortium 2012; AP Boyle, CL Araya, C Brdlik, P Cayting, C Cheng, Y Cheng, K Gardner, L Hillier, J Janette, L Jiang, et al., in prep) (http://genome.ucsc.edu/ENCODE/downloads.html).",OADS,/arxiv_data1/oa_pdf/da/42/1138.PMC4079969.pdf
TF ChIP-seq data sets used in the HOT region study are listed in Supplemental File S3 and can be downloaded from http://anshul.kundaje.net/projects/modencode (for C. elegans and Drosophila )a n d http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/ wgEncodeAwgTfbsUniform/ (for human).,OADS,/arxiv_data1/oa_pdf/da/42/1138.PMC4079969.pdf
Humanubiquitously expressed genes were defined as those detectably expressed in all examined cell lines ( n=34) in human RNA-seq data sets from the ENCODE Project (The ENCODE Project Consortium2011) data from http://genome.crg.es/encode_RNA_dashboard/hg19/.,OADS,/arxiv_data1/oa_pdf/da/42/1138.PMC4079969.pdf
Data access The ChIP-seq data for C. elegans CFP-1 and H3K4me3 tracks used in this study have been submitted to the NCBI Gene ExpressionOmnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under acces-sion number GSE49870.,OADS,/arxiv_data1/oa_pdf/da/42/1138.PMC4079969.pdf
"This article, published in Genome Research ,i s available under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/ 4.0/.1Present address: Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria 2Corresponding author E-mail stark@starklab.org Article published online before print.",Non-OADS,/arxiv_data1/oa_pdf/dd/87/1147.PMC4079970.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.169243.113.",Non-OADS,/arxiv_data1/oa_pdf/dd/87/1147.PMC4079970.pdf
Data access All deep sequencing data from this study have been submitted tothe NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under series accession number GSE49809 and are also available at http://www.starklab.org.,OADS,/arxiv_data1/oa_pdf/dd/87/1147.PMC4079970.pdf
Deep sequencing was performed at the CSF Next- Generation Sequencing Unit (http://csf.ac.at).,OADS,/arxiv_data1/oa_pdf/dd/87/1147.PMC4079970.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 In- ternational), as described at http://creativecommons.org/licenses/by-nc/4.0/.6These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/35/7d/1157.PMC4079971.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.168260.113.",OADS,/arxiv_data1/oa_pdf/35/7d/1157.PMC4079971.pdf
"To determine whether the spike adjustment method might be more gen- erally applicable, we applied it to chroma- tin samples immunoprecipitated with anti-POLR2B antibodies, and we calcu- lated preliminary scores around TSSs using the SPP software (https://sites.google.com/ a/brown.edu/bioinformatics-in-biomed/ spp-r-from-chip-seq) (Kharchenko et al.",OADS,/arxiv_data1/oa_pdf/35/7d/1157.PMC4079971.pdf
"We thank Keith Harshman, Director of the Lausanne Technologies Facility, where all the ultra-high-throughput sequencing was performed, andIoannis Xenarios, Director of the Vital-IT (http://www.vital-it.ch) Center for High Performance Computing of the Swiss Institute of Bioinformatics.",Non-OADS,/arxiv_data1/oa_pdf/35/7d/1157.PMC4079971.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 In- ternational), as described at http://creativecommons.org/licenses/by-nc/4.0/.15Corresponding author E-mail charles.chiu@ucsf.edu Article published online before print.",Non-OADS,/arxiv_data1/oa_pdf/c1/bd/1180.PMC4079973.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.171934.113.",OADS,/arxiv_data1/oa_pdf/c1/bd/1180.PMC4079973.pdf
"Available at http://snap.cs.berkeley.edu, SNAP runs 10–100 3faster than existing tools while maintaining comparable or higher accuracy (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c1/bd/1180.PMC4079973.pdf
Data access The genome sequence of the human parechovirus 1 (HPeV-1) strain described in this study has been deposited in GenBank (http://www.ncbi.nlm.nih.gov/genbank/) as HPeV-1 isolate MX1(KJ152442).,OADS,/arxiv_data1/oa_pdf/c1/bd/1180.PMC4079973.pdf
NGS data used for SURPI analysis with potentially identifiable human sequences removed have been submitted to the NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) under accession number SRP035368.,OADS,/arxiv_data1/oa_pdf/c1/bd/1180.PMC4079973.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 In- ternational), as described at http://creativecommons.org/licenses/by-nc/4.0/.18These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/d4/e8/1209.PMC4079975.pdf
"Article, supplemental material, and publica-tion date are at http://www.genome.org/cgi/doi/10.1101/gr.159384.113.",OADS,/arxiv_data1/oa_pdf/d4/e8/1209.PMC4079975.pdf
2012) reads were aligned to the D. pseudoobscura genome using StatMap (http://www.statmap- bio.org/) and represented as a 1-bp CAGE site.,OADS,/arxiv_data1/oa_pdf/d4/e8/1209.PMC4079975.pdf
Post-translational modifications Splicing analysis was performed with the Splicing Analysis Toolkit(Spanki) v.0.4.0 (http://www.cbcb.umd.edu/software/spanki; and https://github.com/dsturg/Spanki).,OADS,/arxiv_data1/oa_pdf/d4/e8/1209.PMC4079975.pdf
Data access The RNA-seq data from this study have been submitted to theNCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE44612.,OADS,/arxiv_data1/oa_pdf/d4/e8/1209.PMC4079975.pdf
"Reads for all CAGE experiments have been submitted to the NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) under thefollowing accession numbers: SRR488282, SRR488283, SRR488284,SRR488285, SRR488308, SRR488309, and SRR488325 ( D. mela- nogaster ); and SRR488317, SRR488318, SRR488319, and SRR488320 (D. pseudoobscura ).",Non-OADS,/arxiv_data1/oa_pdf/d4/e8/1209.PMC4079975.pdf
"Genome assemblies have been sub-mitted to NCBI GenBank (http://www.ncbi.nlm.nih.gov/genbank/)under identifiers: D. biarmipes (Dbia_2.0), D. bipectinata (Dbip_2.0), D. elegans (Dele_2.0), D. eugracillis (Deug_2.0), D. ficusphila (Dfic_2.0), D. kikkawai (Dkik_2.0), D. rhopaloa (Drho_2.0), and D. takahashii (Dtak_2.0).",OADS,/arxiv_data1/oa_pdf/d4/e8/1209.PMC4079975.pdf
"This study utilized the high-performance computational capabilities of theBiowulf Linux cluster at the National Institutes of Health, Bethesda, Maryland (http://biowulf.nih.gov).",OADS,/arxiv_data1/oa_pdf/d4/e8/1209.PMC4079975.pdf
"Many of these are available via the Drosophila Geno- mics Resource Center, which collects other information such as culture conditions, morphological properties, and gene expression properties (https://dgrc.cgb.indiana.edu/).",OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 In- ternational), as described at http://creativecommons.org/licenses/by-nc/4.0/.7Corresponding author E-mail laie@mskcc.org Article published online before print.",Non-OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.161554.113.",OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
The sample IDs are tracked in the metadata of the respective data files at the modENCODE Data Coordination Center (http://www.modencode.org).,OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
"We compared the expression of predicted con- served targets by TargetScanS (http://www.targetscan.org/fly_12/) of highly (miR-184/bantam/K box miRNAs), lowly (bottom 20%), and moderately (middle 40%–60%) expressed miRNAs in cell lines.",OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
The raw data were de- posited in and are publicly available at the modENCODE DataCoordination Center (http://data.modencode.org/).,OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
2012) to identify novelmiRNA loci using our cell line libraries (Table 1) and additionalsRNA data sets from SRA (http://www.ncbi.nlm.nih.gov/sra) orGEO (http://www.ncbi.nlm.nih.gov/geo/) (Supplemental Table S1).,OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
We aligned these to the D. melanogaster reference genome (dm3; http://hgdownload.soe.ucsc.edu/goldenPath/dm3/) usingmiRDeep2’s mapper.pl script with default parameters.,OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
Detailed HTML (http://compgen.bscb.cornell.edu/ mirna/cellline/) and PDF (Supplemental Fig.,Non-OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
"Data access All small RNA sequencing data are available from the modENCODE data coordination center, the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/), and/or the NCBI Se-quence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra),under the accession numbers listed in Table 1.",OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
http://www.bioconductor.org/packages/2.12/bioc/html/ topGO.html.,Non-OADS,/arxiv_data1/oa_pdf/87/1d/1236.PMC4079977.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5560 | DOI: 10.1038/srep05560 3",Non-OADS,/arxiv_data1/oa_pdf/06/72/srep05560.PMC4080196.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/34/7d/srep05555.PMC4080197.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5555 | DOI: 10.1038/srep05555 9",Non-OADS,/arxiv_data1/oa_pdf/34/7d/srep05555.PMC4080197.pdf
are publicly available (15; http://www.endophyte.uky.edu/) and all contain sequences sim- ilar to the E. festucae mcf-like gene.,OADS,/arxiv_data1/oa_pdf/b8/32/srep05562.PMC4080199.pdf
Schematic Representation of mcfGene Structure .Schematic representation of the mcfgene structures was done using Gene Structure Display Server (57; http://gsds.cbi.,OADS,/arxiv_data1/oa_pdf/b8/32/srep05562.PMC4080199.pdf
poae Ps1-Mcf protein was performed using Gene Evolution and Conservation Analysis (GECA) (58; http://peroxibase.toulouse.,OADS,/arxiv_data1/oa_pdf/b8/32/srep05562.PMC4080199.pdf
"Phylogenetic Analysis .To identify genes in addition to MCM7 and TSR1 for use in the phylogenetic analyses, the FUNYBASE genome database (http://genome.jouy.inra.fr/funybase/) 59was searched for single copy orthologs identified as phylogenetically high-performing genes by Aguileta et al.29.",OADS,/arxiv_data1/oa_pdf/b8/32/srep05562.PMC4080199.pdf
DNA sequences for thesegenes were obtained from the Genome Project at the University of Kentucky website (http://www.endophyte.uky.edu/) or from NCBI.,OADS,/arxiv_data1/oa_pdf/b8/32/srep05562.PMC4080199.pdf
poae Ps1-mcfgene has been deposited in the GenBank database (http://www.ncbi.nlm.nih.gov/) under accessionnumber KJ502561.,OADS,/arxiv_data1/oa_pdf/b8/32/srep05562.PMC4080199.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b8/32/srep05562.PMC4080199.pdf
Census bureau: https://www.census.gov/ (date of access:01/04/2014).39.,OADS,/arxiv_data1/oa_pdf/5f/c2/srep05561.PMC4080200.pdf
Urban mobility report: http://mobility.tamu.edu/ums/ (date of access: 01/04/ 2014).,OADS,/arxiv_data1/oa_pdf/5f/c2/srep05561.PMC4080200.pdf
Federal Highway administration: https://www.fhwa.dot.gov/ (date of access: 01/ 04/2014).,Non-OADS,/arxiv_data1/oa_pdf/5f/c2/srep05561.PMC4080200.pdf
41. http://measuringurban.oecd.org (Date of access: 01/04/2014).,Non-OADS,/arxiv_data1/oa_pdf/5f/c2/srep05561.PMC4080200.pdf
http://dx.doi.org/10.1016/j.mgene.2014.04.012 2214-5400/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/ab/main.PMC4080205.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/ab/main.PMC4080205.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/ab/main.PMC4080205.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)HM1.24-directed immunotoxin M Staudinger et al 11 &2014 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/2a/c9/bcj201438a.PMC4080209.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)CD33 and CD123 in AML A Ehninger et al 10 Blood Cancer Journal &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/c4/a5/bcj201439a.PMC4080210.pdf
org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Helicobacter pylori -positive diffuse large B-cell lymphoma of stomach S-H Kuo et al 7 &2014 Macmillan Publishers Limited Blood Cancer Journal,Non-OADS,/arxiv_data1/oa_pdf/89/85/bcj201440a.PMC4080211.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Letter to the Editor 3 &2014 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/3d/5c/bcj201441a.PMC4080212.pdf
"To identify potential exonic and intronic motifs and predict the effects of mutations on pre-mRNA splicing, a preliminary bioinformatics study was performed using ‘Human Splicing Finder’ algorithm http://www.umd.be/HSF/.",Non-OADS,/arxiv_data1/oa_pdf/a8/ca/bcj201443a.PMC4080214.pdf
org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Letter to the Editor 4 Blood Cancer Journal &2014 Macmillan Publishers Limited,Non-OADS,/arxiv_data1/oa_pdf/a8/ca/bcj201443a.PMC4080214.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Letter to the Editor 3 &2014 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/45/32/bcj201444a.PMC4080215.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ad/fc/srep05557.PMC4080221.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5557 | DOI: 10.1038/srep05557 5",Non-OADS,/arxiv_data1/oa_pdf/ad/fc/srep05557.PMC4080221.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/de/ab/srep05556.PMC4080222.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e2/d9/srep05550.PMC4080223.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5550 | DOI: 10.1038/srep05550 7",Non-OADS,/arxiv_data1/oa_pdf/e2/d9/srep05550.PMC4080223.pdf
"To this end, we have collected the full information dynamics and topological network structure of a large dataset representing pub- lic blog posts published at LiveJournal.com (LJ), a well-known online community of bloggers (all datasets used in this work are available at http://lev.ccny.cuny.edu/ ,hmakse/soft_data.html).",OADS,/arxiv_data1/oa_pdf/d3/61/srep05547.PMC4080224.pdf
This inset is created with the Lanet-vi tool (http://lanetvi.soic.indiana.edu/lanetvi.php).,OADS,/arxiv_data1/oa_pdf/d3/61/srep05547.PMC4080224.pdf
"Here we use the datasetof approximately 16 million tweets sampled between January 23rdand February 8th, 2011 and publically shared by Twitter (http://trec.nist.gov/data/tweets/) 53.",OADS,/arxiv_data1/oa_pdf/d3/61/srep05547.PMC4080224.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5547 | DOI: 10.1038/srep05547 12",Non-OADS,/arxiv_data1/oa_pdf/d3/61/srep05547.PMC4080224.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Antipurinergic therapy of ASD JC Naviaux et al 11 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –11",Non-OADS,/arxiv_data1/oa_pdf/2a/44/tp201433a.PMC4080315.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Burnout and empathy-related brain activity S Tei et al 7 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/02/4d/tp201434a.PMC4080316.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Identi ﬁcation of NFT-associated genes A Miyashita et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d0/67/tp201435a.PMC4080317.pdf
"55 Quantitative real-time PCR Real-time quantitative PCR was performed by Varionostic GmbH (Ulm,Germany; http://www.varionostic.de) on the LightCycler 480 I (Roche) using the SensiFast Sybr green mix from Bioline (Luckenwald, Germany).",OADS,/arxiv_data1/oa_pdf/18/f2/tp201437a.PMC4080318.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Molecular correlates of early adversity and 5-HTTLPR M Wankerl et al 9 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/18/f2/tp201437a.PMC4080318.pdf
"We determined the functional signi ﬁcance of variants using scale-invariant feature transform (SIFT) and PolyPhen2 (the LJB version 2) for missense mutations 33and used the SIFT Indel tool (http://sift.bii.a-star.edu.sg/www/ SIFT_indels2.html) for frameshift indels.34Finally, we excluded genomic regions that are likely to contribute false-positive signals in variant calling of exome sequencing.35De novo and inherited variant selection We used the phase-by-transmission, a Genome Analysis Toolkit module, to identify DNVs and IVs from given familial information.",OADS,/arxiv_data1/oa_pdf/fc/d9/tp201438a.PMC4080319.pdf
"The PPI network visualization and functional analysis was performed as previously reported1using Cytoscape.40We examined nonredundant DNA variants found in our sequence analysis using a binomial distribution with a standardized Z-score to test whether sets of genes are overrepresented in the AXAS-PPI network of four different mental health disorders; ASD, X-linked intellectual disorder, attention de ﬁcit and hyperactivity disorder and schizophrenia.1 Functional ontology analysis We used ClueGo version 1.8 (a Cytoscape plug-in),41to perform functional enrichment analysis based on annotations of three functional ontologydatabases: gene ontology (GO) (http://geneontology.org/), Kyoto encyclo- pedia of genes and genomes (KEGG) pathways (http://www.genome.jp/ kegg/) and Reactome (http://www.reactome.org/).",OADS,/arxiv_data1/oa_pdf/fc/d9/tp201438a.PMC4080319.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)A molecular systems approach of autism JY An et al 9 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/fc/d9/tp201438a.PMC4080319.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NMDAR blockade in subiculum and glutamate release TL Stan et al 7 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/25/e0/tp201439a.PMC4080320.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)PhenoWorld: a new tool to screen rodent behavior M Castelhano-Carlos et al 11 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –11",Non-OADS,/arxiv_data1/oa_pdf/a2/c7/tp201440a.PMC4080321.pdf
We also compared differentially expressed genes from miR-137 overexpression to computationally predicted miR-137 targets (TargetScan v6.2; http://www.targetscan.org)43 with signi ﬁcance determined using permutation.,OADS,/arxiv_data1/oa_pdf/43/66/tp201442a.PMC4080323.pdf
"The project was funded by theFoundation For Hope (Raleigh, NC, http://www.walkforhope.com).",Non-OADS,/arxiv_data1/oa_pdf/43/66/tp201442a.PMC4080323.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)miR-137 targets AL Collins et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/43/66/tp201442a.PMC4080323.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Motivation, Parkinson's disease and D3 receptor S Carnicella et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/98/cd/tp201443a.PMC4080324.pdf
Detection was performedusing ECL kit and bands were quanti ﬁed using ImageJ (http://rsbweb.nih.,OADS,/arxiv_data1/oa_pdf/54/08/tp201445a.PMC4080326.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Prenatal glucocorticoid exposure modulates motivation C Soares-Cunha et al 10 Translational Psychiatry (2014), 1 –10 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/54/08/tp201445a.PMC4080326.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Neural correlates of clomipramine mood response CT Cerqueira et al 7 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/b6/25/tp201447a.PMC4080327.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)The role of FKBP5 genotype in exposure-based psychotherapy S Wilker et al 7 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/80/19/tp201449a.PMC4080328.pdf
"Given the fact that B80% of all dialysis sessions in 2006 were performed in the developed world, 11whereashttp://www.kidney-international.org clinical investigation &2014 International Society of Nephrology Correspondence: Sergey Zakharov, Department of Occupational Medicine, Toxicological Information Center, General University Hospital and First Faculty of Medicine of Charles University in Prague, Na Bojisti 1, 12000,Prague 2, Prague, Czech Republic.",Non-OADS,/arxiv_data1/oa_pdf/da/73/ki201460a.PMC4080337.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Kidney International (2014) 86, 199– 207 207S Zakharov et al.",Non-OADS,/arxiv_data1/oa_pdf/da/73/ki201460a.PMC4080337.pdf
"17,18 Many strategies have been proposed to bypass the defec- tive V2R signaling and restore physiological AQP2 expression and/or trafficking.15,19–28In the last years, our group developed the first viable animal model of X-NDI.15We also showed that an prostaglandin E receptor subtype EP4receptor agonist had a beneficial effect in X-NDI mice 15andhttp://www.kidney-international.org basic research &2014 International Society of Nephrology Correspondence: Giuseppe Procino, Department of Biosciences, Biotechno- logies and Biopharmaceutics, University of Bari, Via Orabona 4, Bari 70126,Italy.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/ki201410a.PMC4080339.pdf
"The primers (forward: 5 0-ACCTGCTGAAGCTCAAGGC-30, reverse: 50-GTCATCTGCGGGGAAGAGTA-30) were designed on the basis of the mus musculus SCTR nucleotide sequences available in the GenBank database (web site: http://www.ncbi.nlm.nih.gov/ nuccore).",OADS,/arxiv_data1/oa_pdf/05/5f/ki201410a.PMC4080339.pdf
"Tissue fractionation and immunoblotting Whole-kidney or kidney CTX, OM, and IM were isolated from Wt C57BL/6 or V2Rfl/yEsr1-Cre mice and homogenized using an Heidolf tissue homogenizer (http://www.heidolph-instruments.com) at 1250 r.p.m.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/ki201410a.PMC4080339.pdf
"Kidneys were rapidly excised and thintransversally sliced kidneys (250 mm) were cut using a McILWAIN Tissue Chopper (Ted Pella, http://www.tedpella.com).",Non-OADS,/arxiv_data1/oa_pdf/05/5f/ki201410a.PMC4080339.pdf
Supplementary material is linked to the online version of the paper at http://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/ki201410a.PMC4080339.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 138 Kidney International (2014) 86,1 2 7 – 1 3 8basic research G Procino et al.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/ki201410a.PMC4080339.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/49/evu124.PMC4080426.pdf
"Materials and Methods Collection of Single Base-Re solution DNA Methylation, TFBS, and miRNA Target Data The human gene annotations, gene orthology assignments, and human–mouse/human–rhes us macaque evolutionary rates ( dN,dS,a n d dN/dS) were downloaded from the Ensembl database at http://www.ensembl.org/ (last accessed November 2013) (version 73).",OADS,/arxiv_data1/oa_pdf/7c/49/evu124.PMC4080426.pdf
"The human, rhesus macaque, and mouse genes examined in this study (together with the related information) are available at http://idv.sinica.edu.tw/trees/DM_TF_miRNA/DM_TF_miRNA.html (last accessed June 25, 2014).",OADS,/arxiv_data1/oa_pdf/7c/49/evu124.PMC4080426.pdf
Supplementary Material Supplementary ﬁgures S1–S4 andtables S1–S6 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/7c/49/evu124.PMC4080426.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6c/04/srep05551.PMC4080431.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5551 | DOI: 10.1038/srep05551 10",Non-OADS,/arxiv_data1/oa_pdf/6c/04/srep05551.PMC4080431.pdf
Available from: http://www.eucast.org [Last  accessed on Feb 2012].,Non-OADS,/arxiv_data1/oa_pdf/5e/d0/PR-6-195.PMC4080498.pdf
Available from:  http://www.uicnmed.org/nabp/database/HTM/ PDF/p108.pdf.,OADS,/arxiv_data1/oa_pdf/c1/42/PR-6-218.PMC4080502.pdf
Available  from:  http://www.ars-grin.gov/cgi-bin/duke/ethnobot.pl.,Non-OADS,/arxiv_data1/oa_pdf/c1/42/PR-6-218.PMC4080502.pdf
Available from: http://browse.oecdbookshop.org/oecd/pdfs/ free/9742501e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/f9/PR-6-246.PMC4080506.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ee/3c/srep05416.PMC4080516.pdf
Available from: https://ash.confex.com/ash/2009/webprogram/Paper23968.html.,Non-OADS,/arxiv_data1/oa_pdf/39/44/IJMPO-35-10.PMC4080644.pdf
Available from: https://ash.confex.com/ash/2012/webprogram/Paper47060.html [Last updated on Dec 2012; Last accessed on Oct 2013].,OADS,/arxiv_data1/oa_pdf/39/44/IJMPO-35-10.PMC4080644.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/e2/72/IJMPO-35-17.PMC4080656.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/e2/72/IJMPO-35-17.PMC4080656.pdf
Avialable from: http://www.businessandeconomy.org/26052011/storyd.asp?sid=6160andpageno=2 [Last accessed on 2012 December 15].,Non-OADS,/arxiv_data1/oa_pdf/af/0e/IJMPO-35-3.PMC4080659.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/af/0e/IJMPO-35-3.PMC4080659.pdf
Available from: http://emedicine.medscape.,Non-OADS,/arxiv_data1/oa_pdf/ad/92/IJMPO-35-31.PMC4080660.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ad/92/IJMPO-35-31.PMC4080660.pdf
ACKNOWLEDGEMENT The authors would like to acknowledge the sound guidance  and help offered by Mr. Huybert Groenendaal from Epix Analytics ( HYPERLINK “http://www.epixanalytics.com” www.epixanalytics.com) with the Monte Carlo Simulation.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/IJMPO-35-44.PMC4080663.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/68/c4/IJMPO-35-86.PMC4080671.pdf
Chromosomal Translocations  in Sarcomas: New Perspectives ESUN (http://sarcomahelp.org/newsletter/february_2006.html).,Non-OADS,/arxiv_data1/oa_pdf/43/b8/IJMPO-35-89.PMC4080672.pdf
(http://AtlasGeneticsOncology.org/Anomalies/t1222p13q12ID1371.,Non-OADS,/arxiv_data1/oa_pdf/43/b8/IJMPO-35-89.PMC4080672.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2e/c2/srep05515.PMC4080701.pdf
Availability and implementation: R-code freely available for down- load at http://users.ics.aalto.fi/pemartti/gene_metabolome/.,OADS,/arxiv_data1/oa_pdf/37/30/btu140.PMC4080737.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/30/btu140.PMC4080737.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/btu161.PMC4080740.pdf
"R package version 2.1-5. http://CRAN.R-project.org/package=fpc (12 April 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/btu161.PMC4080740.pdf
"R package version 0.75-5. http://CRAN.R-project.org/package=diptest (12 April 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/ee/3a/btu161.PMC4080740.pdf
"The sequences of the selected clones were aligned with the EGFP DNA se- quence using the BioEdit tool ( http://www.mbio.ncsu.edu/ bioedit/bioedit.html ).Theresultswerestatisticallyanalyzed according to previously reported methods ( 37,40) to quan- titativelydetermine theerror-removal efficiency.",OADS,/arxiv_data1/oa_pdf/7e/6a/gku405.PMC4081059.pdf
"Sequence analysis Sequence homologs, as bidirectional best hits from Ba- sic Local Alignment Search Tool (BLAST) for the previ-ously characterized B.subtilis NrnA, from different bacte- rial groups were obtained from NCBI ( http://ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/8a/32/gku425.PMC4081065.pdf
"As negative controls, a randomly generated list of 50 mRNAs (RSA-tools,http://rsat.ulb.ac.be/random-genes form.cgi) and the top 50 mRNAs associated with the AU-rich binding HuR were used ( 43).",OADS,/arxiv_data1/oa_pdf/9d/23/gku430.PMC4081066.pdf
"The software used for this analysis, ‘Canion’, is freely available, along with the latest version of Curves+ and the necessary user guides, at the following site: http://bisi.ibcp.",OADS,/arxiv_data1/oa_pdf/36/21/gku504.PMC4081102.pdf
"available along with Curves+, Canal and other utility soft- ware (http://bisi.ibcp.fr/tools/curves plus/).",Non-OADS,/arxiv_data1/oa_pdf/36/21/gku504.PMC4081102.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/ee/main.PMC4081155.pdf
Superoxide dismutase (SOD) is an antioxidant enzyme that converts superoxide anion radicals into hydrogen http://dx.doi.org/10.1016/j.fob.2014.05.003 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/ee/main.PMC4081155.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: AA, L-ascorbic acid; ApoB, Apolipoprotein B; AST, aspartate aminotransferase; DHA, dehydroascorbic acid; DHE, dihydroethidium; DKO, doubleknockout; EDTA, ethylenediaminetetraacetic acid; FFA, free fatty acid; Grp78,glucose-regulated protein 78 kDa; KO, knockout; MTP, microsomal triglyceridetransfer protein; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholicsteatohepatitis; PL, phospholipid; PPAR a, peroxisome proliferator-activated recep- tor-a; qPCR, quantitative real-time polymerase chain reaction; SDS, sodium dodecyl sulfate; SMP30, senescence marker protein-30; SOD, superoxide dismutase; SREBP, sterol regulatory element binding protein; T-cho, total cholesterol; TBARS, thio- barbituric acid reactive substances; TG, triglyceride; VLDL, very low-densitylipoprotein ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/fb/ee/main.PMC4081155.pdf
Acknowledgments This study was supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/ index.html) KAKENHI Grant Number 23790122 (Y.K.,Non-OADS,/arxiv_data1/oa_pdf/fb/ee/main.PMC4081155.pdf
"Louagie YA , Jamart J , http://www.ncbi.nlm.nih.gov/ pubmed?term=Eucher%20P%5BAuthor%5D&cauthor=true&cauthor_ uid=8215671 Buche M, Schoevaerdts JC.",OADS,/arxiv_data1/oa_pdf/05/0d/abc-101-05-0466.PMC4081171.pdf
Chimera analyses were performed by using de novo and reference-based chimera checks against the pre-built 16S rRNA reference database provided in the Microbiome Utilities (http://microbiomeutil.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/2d/05/bmfh-33-053.PMC4081183.pdf
[Medline]  [CrossRef]  5. http://mica.ibest.uidaho.edu/pat.php.,Non-OADS,/arxiv_data1/oa_pdf/13/e1/bmfh-33-065.PMC4081184.pdf
[Medline]  [CrossRef]  13. http://www.megasoftware.net/ Molecular Evolutionary  Genetics Analysis.,OADS,/arxiv_data1/oa_pdf/13/e1/bmfh-33-065.PMC4081184.pdf
"1 1      http://www.medsci.org  850  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  850-856.  doi: 10.7150/ ijms.8633   Research Paper   Presence of Anti bodies against Self Human Leukocyte  Antigen Class II Molecules in Autoimmune Hepatitis  Satoshi Yamagiwa1, Hiroteru Kamimura1, Masaaki Takamura1, Takuya Genda2, Takafumi Ichida2*,  Minoru Nomoto1, and Yutaka Aoyagi1   1.",Non-OADS,/arxiv_data1/oa_pdf/ee/17/ijmsv11p0850.PMC4081305.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ee/17/ijmsv11p0850.PMC4081305.pdf
"11     http://www.medsci.org  851  mune  reactions against host liver antigens are b e- lieved to be the major pathogenic  mechanism of AIH,  and the disease responds satisfactorily to immuno- suppressive treatment.",Non-OADS,/arxiv_data1/oa_pdf/ee/17/ijmsv11p0850.PMC4081305.pdf
"11     http://www.medsci.org  852  din-biotin -peroxidase complex method with the Ve c- tastain Elite ABC kit (Vector Laboratories Inc.,  Burlingame, CA).",Non-OADS,/arxiv_data1/oa_pdf/ee/17/ijmsv11p0850.PMC4081305.pdf
"11     http://www.medsci.org  853  jured bile ducts, consistent with previous studies [19]  (arrow in Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/ee/17/ijmsv11p0850.PMC4081305.pdf
11     http://www.medsci.org  854    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/ee/17/ijmsv11p0850.PMC4081305.pdf
11     http://www.medsci.org  855  (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/ee/17/ijmsv11p0850.PMC4081305.pdf
11     http://www.medsci.org  856  Competing  Interest   The authors have declared that no competing  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/ee/17/ijmsv11p0850.PMC4081305.pdf
1 1      http://www.medsci.org  857  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  857-862.  doi: 10.7150/ ijms.8874   Research Paper   How Much Colonic Redundancy Could Be Obtained by  Splenic Flexure Mobilization in Laparoscopic Anterior  or Low Anterior Resection ?,Non-OADS,/arxiv_data1/oa_pdf/62/92/ijmsv11p0857.PMC4081306.pdf
This is an open- access article  distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/62/92/ijmsv11p0857.PMC4081306.pdf
11     http://www.medsci.org  858  believe that SFM is necessary to en sure a tension -free  and well -vascularized anastomosis.,Non-OADS,/arxiv_data1/oa_pdf/62/92/ijmsv11p0857.PMC4081306.pdf
11     http://www.medsci.org  859    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/62/92/ijmsv11p0857.PMC4081306.pdf
11     http://www.medsci.org  860  resection margin; 4 ) the length of specimen; 5) total  operati on time; 6 ) the time  required for SFM; and 7 )  the ratio of  the time required for SFM and total ope r- ation time.,Non-OADS,/arxiv_data1/oa_pdf/62/92/ijmsv11p0857.PMC4081306.pdf
11     http://www.medsci.org  861  cording to our institutional protocol (approximately 3  months after creation).,Non-OADS,/arxiv_data1/oa_pdf/62/92/ijmsv11p0857.PMC4081306.pdf
"11     http://www.medsci.org  862  tension from such activities as breathing and coug h- ing or from increased abdominal girth, than  in the  upper abdomen.",Non-OADS,/arxiv_data1/oa_pdf/62/92/ijmsv11p0857.PMC4081306.pdf
"11       http://www.medsci.org  863  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  863-869.  doi: 10.7150/ ijms.8912   Research Paper   Risk Factors for Major Adverse Events of  Video -Assisted Thoracic Surgery Lobectomy for Lung  Cancer   Jie Yang*, Yan Xia*, Yang Yang , Zheng -zheng  Ni, Wen -xin He, Hai -feng Wang , Xia o-xiong Xu, Yu -ling  Yang , Ke Fei, Ge- ning Jiang   Department  of Thoracic Surgery, Shanghai Pulmonary Hospital, Tong ji University School of Medicine, Shanghai, 200433, China    * Dr. Jie Ya ng and Yan Xia contribute equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/13/43/ijmsv11p0863.PMC4081307.pdf
11     http://www.medsci.org  864  complications.,Non-OADS,/arxiv_data1/oa_pdf/13/43/ijmsv11p0863.PMC4081307.pdf
"11     http://www.medsci.org  865  Patient’s general information, findings on auxiliary  examinations, comorbidities, and pathological dia g- nosis were collected.",Non-OADS,/arxiv_data1/oa_pdf/13/43/ijmsv11p0863.PMC4081307.pdf
11     http://www.medsci.org  866  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/13/43/ijmsv11p0863.PMC4081307.pdf
"11     http://www.medsci.org  867  Conversion Patients   43(2.4%) cases were converted to thoracotomy  for the following reasons: uncontrolled bleeding in 7,  severe adhesions in 24, sleeve resection in 5, chest wall invasion in 3, vascular invasion in 4 cases.",Non-OADS,/arxiv_data1/oa_pdf/13/43/ijmsv11p0863.PMC4081307.pdf
"11     http://www.medsci.org  868  togenarians undergoing video assisted major pulm o- nary resection had a higher incidence of atrial fibrill a- tion and admission to the intensive care unit for ca r- diopulmonary support but otherwise were not dif- ferent from younger age groups in the conversion  rate, morbidity or mortality 20.",Non-OADS,/arxiv_data1/oa_pdf/13/43/ijmsv11p0863.PMC4081307.pdf
http://evs.nci.nih.gov/ftp1/CTCAE/About.html.,OADS,/arxiv_data1/oa_pdf/13/43/ijmsv11p0863.PMC4081307.pdf
11     http://www.medsci.org  869  10.,Non-OADS,/arxiv_data1/oa_pdf/13/43/ijmsv11p0863.PMC4081307.pdf
http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#nscl.,Non-OADS,/arxiv_data1/oa_pdf/13/43/ijmsv11p0863.PMC4081307.pdf
"1 1      http://www.medsci.org  870  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  870-879.  doi: 10.7150/ ijms.8758   Research Paper   Suppression of Peritoneal Tumorigenesis by  Placenta -Derived Mesenchymal Stem Cells Expressing  Endostatin on Colorectal Cancer  Dongmei Zhang1†, Lan Zheng2†, Huashan Shi1, Xiancheng Chen1, Yang Wan1, Hailong Zhang1, Meng Li1,  Lian  Lu1, Shuntao Luo1, Tao Yin1, Honggang Lin1, Shasha He1, Yan Luo1, Li Yang1  1.",Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
This is an open- access article distributed  under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
11     http://www.medsci.org  871  process of tumor growth and dissemination has been  well established [7].,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
11     http://www.medsci.org  872  pogenic and chondrogenic induction were performed  in vitro .,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
11     http://www.medsci.org  873  monitored daily for 60 days.,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
1 1      http://www.medsci.org  874  Western blotting analyses were performed to  demonstrate the expression of Ad- Endo in PMSCs .,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
11     http://www.medsci.org  875    Fig.,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
"11     http://www.medsci.org  876  Inhibition of tumor angiogenesis and cell  proliferation in vivo   To determine the effects on tumor- induced a n- giogenesis, frozen tumor sections were stained using  the CD31  antibody  for immunofluorescence.",Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
1 1      http://www.medsci.org  877  Discussion   Angiogenesis plays an important role in the  process of solid tumor growth and metastasis.,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
11     http://www.medsci.org  878  Cancers are sometimes considered ‘wounds that  never heal’  because they can generate mobile MSCs  by secreting chemokines and cytokines.,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
11     http://www.medsci.org  879  conditioned medium from tumor cells or bone marrow cells.,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/ijmsv11p0870.PMC4081308.pdf
"1 1      http://www.medsci.org  880  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  880-885.  doi: 10.7150/ ijms.9165   Research Paper   Chuanhu Anti-Gout Mixture versus Colchicine for  Acute Gouty Arthritis: A Randomized, Double -Blind,  Double -Dummy, Non- Inferiority Trial  YanGang Wang1, Luan Wang1, EnZe Li2, Yang Li1, Zhong Chao Wang1, Xiao Fang Sun1, Xiao Long Yu1, Lin  Ma2, Yun Long Wang3, You Xin Wang4   1.",Non-OADS,/arxiv_data1/oa_pdf/e9/94/ijmsv11p0880.PMC4081309.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e9/94/ijmsv11p0880.PMC4081309.pdf
1 1      http://www.medsci.org  883    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/94/ijmsv11p0880.PMC4081309.pdf
"1 1      http://www.medsci.org  886  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  886-892.  doi: 10.7150/ ijms.9338   Research Paper   Gestational Hypoxia Up -regulates Protein Kinase C and  Inhibits Calcium -Activated Potassium Channels in Ovine  Uterine Arteries  Daliao Xiao , Ronghui Zhu, and Lubo Zhang   Center for Perinatal Biology, Division of Pharmacology, Department of Basic Sciences, Loma Linda University School of Medicine, Loma  Linda, CA , USA     Corresponding author : Lubo Zhang, Ph.D. Center for Perinatal Biology , Department of Basic Sciences , Loma Linda University , School of  Medicine, Loma Linda, CA 92350.",Non-OADS,/arxiv_data1/oa_pdf/4f/62/ijmsv11p0886.PMC4081310.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4f/62/ijmsv11p0886.PMC4081310.pdf
11     http://www.medsci.org  887  tone.,Non-OADS,/arxiv_data1/oa_pdf/4f/62/ijmsv11p0886.PMC4081310.pdf
11     http://www.medsci.org  888  O2 and 5% CO 2.,Non-OADS,/arxiv_data1/oa_pdf/4f/62/ijmsv11p0886.PMC4081310.pdf
11     http://www.medsci.org  889    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/4f/62/ijmsv11p0886.PMC4081310.pdf
1 1      http://www.medsci.org  890      Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/4f/62/ijmsv11p0886.PMC4081310.pdf
"11     http://www.medsci.org  891  the uterine artery circulation of late- gestation sheep  caus ed a significant decrease of basal uterine blood  flow from 50% to 80% in the absence of systemic e f- fects or a change in contralateral uterine blood flow  [16,17].",Non-OADS,/arxiv_data1/oa_pdf/4f/62/ijmsv11p0886.PMC4081310.pdf
11     http://www.medsci.org  892  nant animals has a negative regulatory effect on  PKC -induced contraction and myogenic tone of the  uterine artery.,Non-OADS,/arxiv_data1/oa_pdf/4f/62/ijmsv11p0886.PMC4081310.pdf
"1 1      http://www.medsci.org  893  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  893-896.  doi: 10.7150/ ijms.8948   Research Paper   Comparison  of Iodine -125 Seed Implantation and  Pancreaticoduodenectomy i n the Treatment of  Pancreatic Cance r  Kai Liu*, Bai Ji*, Wei Zhang, Songyang Liu, Yingchao Wang, Yahui Liu   Department of Hepatobiliary  and Pancreatic Surgery, the First Bethune Hospital, Jilin University, Jilin 130021, China .",Non-OADS,/arxiv_data1/oa_pdf/83/1d/ijmsv11p0893.PMC4081311.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/83/1d/ijmsv11p0893.PMC4081311.pdf
11     http://www.medsci.org  894  Materials and Methods   Patient enrollment and assessment   Sixty patients were retrospectively included in  this study (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/83/1d/ijmsv11p0893.PMC4081311.pdf
"11     http://www.medsci.org  895  ference was not significant statistically in survival rate  , overall respon se rate, local control rate and pain r e- lief rate between two groups.",Non-OADS,/arxiv_data1/oa_pdf/83/1d/ijmsv11p0893.PMC4081311.pdf
11     http://www.medsci.org  896  risk may be prohib itive.,Non-OADS,/arxiv_data1/oa_pdf/83/1d/ijmsv11p0893.PMC4081311.pdf
"1 1      http://www.medsci.org  897  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  897-904.  doi: 10.7150/ ijms.9026   Research Paper   Comparison of the Antialbuminuric  Effects of Benidipine and  Hydrochlorothiazide in Renin -Angiotensin System  (RAS)  Inhibitor -Treated Hypertensive Patients with Albuminuria :  the COSMO -CKD (CO mbination Strategy on Renal Function  of Benidipine or Diuretics  TreatMent with RAS inhibitOrs in a  Chronic Kidney Disease Hypertensive Population) Study  Katsuyuki Ando1, Kosaku Nitta2, Hiromi Rakugi3, Yoshiki Nishizawa4, Hitoshi Yokoyama5, Takeshi  Nakanishi6, Naoki Kashihara7, Kimio Tomita8, Masaomi Nangaku9, Katsutoshi Takahashi9, Masashi  Isshiki9, Tats uo Shimosawa10, and Toshiro Fujita11  1.",Non-OADS,/arxiv_data1/oa_pdf/68/0e/ijmsv11p0897.PMC4081312.pdf
This is an open- access article distributed u nder the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/68/0e/ijmsv11p0897.PMC4081312.pdf
"1 1      http://www.medsci.org  898  Introduction  Considerable clinical evidence suggests that  renin -angiotensin system (RAS) inhibitors (e.g., ra m- ipril and benazepril ) are  beneficial as first -line agents  for the treatment of hypertension in patients with  chronic kidney disease (CKD) [1 -4].",Non-OADS,/arxiv_data1/oa_pdf/68/0e/ijmsv11p0897.PMC4081312.pdf
"11     http://www.medsci.org  899  weeks) administration of nonsteroidal a n- ti-inflammatory drugs (NSAIDs); 4) a past history of  severe adverse reaction to CCBs, thiazide di uretics,  ARBs, or ACE inhibitors; 5) type 1 diabetes or type 2  diabetes requiring hospitalization due to high hem o- globin A1c content ( > 9.0%), extremely high blood  glucose, or diabetic ketoacidosis; 6) cerebrovascular disease occurring within 6 months of enrollment; 7) severe heart failure (New York Heart Association (NYHA) class >  III), severe arrhythmia (frequent  ventricular or atrial extrasystole, prolonged ventric u- lar tachycardia, atrial tachyarrhythmia with severe  tachycardia, atrial fibrillation or flutter with severe  tachycardia, sick sinus syndrome with severe brad y- cardia, or atrio -ventricular block with severe brady- cardia), angina, or myocardial infarction within 6 months of enrollment; 8) aspartate aminotransferase  (AST) or alanine aminotransferase (ALT) levels of  > 5  times the upper limit;  and 9) pregnancy, the possibi l- ity of pregnancy, or a desire to become pregnant .",Non-OADS,/arxiv_data1/oa_pdf/68/0e/ijmsv11p0897.PMC4081312.pdf
"11     http://www.medsci.org  900  Statistical Analysis     All analyses were performed using SAS version  9.1 (SAS Institute, Cary, NC, USA).",OADS,/arxiv_data1/oa_pdf/68/0e/ijmsv11p0897.PMC4081312.pdf
1 1      http://www.medsci.org  901    Figure 2 .,Non-OADS,/arxiv_data1/oa_pdf/68/0e/ijmsv11p0897.PMC4081312.pdf
"11     http://www.medsci.org  902  drochlorothiazide group (1.09 ( 1.05, 1.13) ).",Non-OADS,/arxiv_data1/oa_pdf/68/0e/ijmsv11p0897.PMC4081312.pdf
1 1      http://www.medsci.org  903  Adverse events occurred  in 65 of 176 patients  (36.9%) in the benidipine group and 74 of 170 patients  (43.5%) in the hydrochlorothiazide group.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/ijmsv11p0897.PMC4081312.pdf
11     http://www.medsci.org  904  tients with microalbuminuria .,Non-OADS,/arxiv_data1/oa_pdf/68/0e/ijmsv11p0897.PMC4081312.pdf
"11       http://www.medsci.org  905  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  905-917.  doi: 10.7150/ ijms.8877   Research Paper   The B asic Social M edical Insurance I s Associated w ith  Clinical Outcomes i n the Patients with ST -elevation  Myocardial I nfarction: A Retrospective Study f rom  Shanghai, China   Baoxin Liu1*, Han Yan2*, Rong Guo1, Xueyuan Liu2, Xiankai Li1, Yawei Xu1   1.",Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
"11     http://www.medsci.org  906  occlusion of coronary arteries, which results from the  formation and rupture of vulnerable coronary ather-osclerotic plaques.",Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
11     http://www.medsci.org  907  echocardiographic and coronary angiography (CAG)  findings were collected.,Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
11     http://www.medsci.org  908  Association Guideline for the manag e- ment of heart failure [18].,Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
11     http://www.medsci.org  909  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
11       http://www.medsci.org  910  Angiographic results   All enrolled patients were confirmed by coro- nary angiography (CAG).,Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
11     http://www.medsci.org  911  Table  3.,Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
"11       http://www.medsci.org  912  Analysis of economic factors   In the study, BSMI -related economic factors were  collected: household income  per year , gross medical  cost, out -of-pocket medical cost and commercial  health insurance.",OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
11       http://www.medsci.org  913  The out -of-pocket cost showed significantly di f- ference in the study groups.,Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
11       http://www.medsci.org  914  Table 5.,Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
"11       http://www.medsci.org  915  Discussion   In this retrospective study to assess the influence  of BSMI on the clinical outcomes in STEMI patients,  approximately 11.5% of patients with NCMS died during a median follow -up of 36 months.",Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
"11     http://www.medsci.org  916  ance has been pointed out in several studies [ 30, 31].",Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
11     http://www.medsci.org  917  References   1.,Non-OADS,/arxiv_data1/oa_pdf/9c/ea/ijmsv11p0905.PMC4081313.pdf
11       http://www.medsci.org  918  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  918-924.  doi: 10.7150/ ijms.8850   Research Paper   Renal Transplantation: Relationship between Hospital/   Surgeon Volume and Postoperative Severe Sepsis/Graft -  Failure.,Non-OADS,/arxiv_data1/oa_pdf/37/32/ijmsv11p0918.PMC4081314.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/37/32/ijmsv11p0918.PMC4081314.pdf
"11       http://www.medsci.org  919  Introduction  Studies on surgeons and hospitals with higher  caseloads provide evidence of better outcomes in  major surgery, especially in cancer [1-3]; however, the  association is controversial in different healthcare  systems [4] and some types of surgery.",Non-OADS,/arxiv_data1/oa_pdf/37/32/ijmsv11p0918.PMC4081314.pdf
"11     http://www.medsci.org  920  (first 1/3) and the medium - and high -volume group  (second  1/3 [medium -volume] and third 1/3  [high -volume] ), based on physician volume: ≤ 33  transplantations (low -volume), and > 33 transplant a- tions (medium - and high -volume), and the hospital  sample was divided into two groups: ≤ 95 transplan- tations (low -volume), and > 95 transplantations (me- dium - and high -volu me).",Non-OADS,/arxiv_data1/oa_pdf/37/32/ijmsv11p0918.PMC4081314.pdf
11     http://www.medsci.org  921  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/37/32/ijmsv11p0918.PMC4081314.pdf
"11     http://www.medsci.org  922  To account for the possibility that patients within  the same hospital -volume group may be more similar  to each other than to patients in other hospital -volume  groups because of specific physician and hospital  treatment practices, we used a logistic regress ion  model with the GEE method  to explore the association  of the 1 -year severe sepsis risk with the same risk  factors used for the other analyses.",Non-OADS,/arxiv_data1/oa_pdf/37/32/ijmsv11p0918.PMC4081314.pdf
"11     http://www.medsci.org  923  volume significantly affects  outcomes, national d e- partments of health ma y want to encourage the ce n- tralization of procedures in a few facilities.",Non-OADS,/arxiv_data1/oa_pdf/37/32/ijmsv11p0918.PMC4081314.pdf
11     http://www.medsci.org  924  11.,Non-OADS,/arxiv_data1/oa_pdf/37/32/ijmsv11p0918.PMC4081314.pdf
"11       http://www.medsci.org  925  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  925-935.  doi: 10.7150/ ijms.8951   Review   Alanine  Aminotransferase -Old Biomarker and New   Concept : A Review   Zhengtao Liu1*, Shuping Que2*, Jing Xu1, Tao Peng1  1.",Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
11     http://www.medsci.org  926  lying the abnorm al ALT level when faced with an  individual patient.,Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
11       http://www.medsci.org  927  5.,Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
"11     http://www.medsci.org  928  serendipitously detected by liver biochemistry testing  during routine health check -ups [69, 70] .",Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
"11     http://www.medsci.org  929  muscle injury  [27, 89, 90] .",Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
"11     http://www.medsci.org  930  119, 120, 122, 123]  and indirect comparisons .",OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
"11     http://www.medsci.org  931  Zheng et al , China ,  2012, [118]  4765/8872  35.3(19 -44) Yes Yes Yes Yes Yes No 95th percentile  one sided  35 for men   23 for women   Alhamoudi et al ,  Saudi Arabia,2013,  [119]  41/93 for path o- logical normality    52/11 for Prati  criteria  28.9±7.3 for  all  28.5±7.3 for men   30.0±7.1 for  women  Yes Yes Yes Yes No Yes 95th percentile  one sided  Normal histological liver  donor :   42 for men   31.1 for women   Subjects met the Prati  criteria:   33 for men   22 for women   Kabir et al ,  Iran,2013, [120]  688/621  61.5 ± 7.9 for  men   61.4 ± 7.9 for  women  Yes Yes Yes Yes No No 95th percentile  one sided  21.4 for men   18.8 for women   Park et al , Ko- rea,2013, [121]  1355/1961  36.3(≥20) Yes Yes Yes Yes No No 95th percentile  one sided  42 for men   25 for women   Sohn  et al, Ko- rea,2013, [122]  297 663 /113 577  24.6±6.4 for  men   22.2±5.2 for  women  Yes Yes Yes No No No 95th percentile  one sided  34 for men   24 for women   15–19 yr: 27 for men, 20 for women   20–24 yr: 31 for men, 21 for  women   25–29 yr: 35 for men, 22 for  women   30–34 yr: 36 for men, 23 for  women   35–39 yr: 36 for men, 24 for  women   40–44 yr: 34 for men, 28 for  women   45–49 yr: 37 for men, 24 for  women   ≥50 yr :33 for men, 29 for  women   Tanaka  et al, Japan,  2013, [123]  1462 /2046  50.6±19.8 for  men   48.8±19.4 for  women  Yes No Yes Yes Yes No 95th percentile  one sided  36 for men   27 for women   Abbreviation : ALT: alanine  aminotransferase ; BMI: body mass index; F: female; M: male; SD: standard deviation ; ULN: upper limit of normal ; U/l: unit per liter; yr: year.",Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
"11       http://www.medsci.org  932  Although controversy exists in the definition of  the ALT normal range for the debate on the focus of  risk-benefit or cost -effectiven ess [124] , the metabolic  disorders should be considered when defining the  normal range of the ALT level .",Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
11       http://www.medsci.org  933    Figure  3.,Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
11     http://www.medsci.org  934  aminotransferase levels in patients with nonalcoholic steatohepatitis.,Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
11     http://www.medsci.org  935  94.,Non-OADS,/arxiv_data1/oa_pdf/13/86/ijmsv11p0925.PMC4081315.pdf
"1 1      http://www.medsci.org  955  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(9):  955-961.  doi: 10.7150/ ijms.9316   Research Paper   Cyclic Phosphatidic Acid Inhibits Alkyl -Glyceropho - sphate -Induced Downregulation of Histone Deacetylase  2 Expression and Suppresses the Inflammatory  Response in Human Coronary Artery Endothelial Cells  Tamotsu Tsukahara1, Hisao Haniu2, and Yoshikazu Matsuda3  1.",Non-OADS,/arxiv_data1/oa_pdf/e3/86/ijmsv11p0955.PMC4081316.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e3/86/ijmsv11p0955.PMC4081316.pdf
11     http://www.medsci.org  956  teries of rodents induces arterial wall remodeling in a  peroxisome proliferator -activated receptor gamma  (PPAR γ)-dependent manner [1].,Non-OADS,/arxiv_data1/oa_pdf/e3/86/ijmsv11p0955.PMC4081316.pdf
11     http://www.medsci.org  957  was added to the medium and incubated for 2 h in an  incubator with 5% CO 2.,Non-OADS,/arxiv_data1/oa_pdf/e3/86/ijmsv11p0955.PMC4081316.pdf
11     http://www.medsci.org  958    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/86/ijmsv11p0955.PMC4081316.pdf
11     http://www.medsci.org  959  AGP -treated HCAECs exhibited increased IL -6 and  IL-8 mRNA expression as compared to cells treated  with vehicle or cPA alone.,Non-OADS,/arxiv_data1/oa_pdf/e3/86/ijmsv11p0955.PMC4081316.pdf
11     http://www.medsci.org  960    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/e3/86/ijmsv11p0955.PMC4081316.pdf
11     http://www.medsci.org  961  Acknowledgements   This work was supported by Grants -in-Aid for  Scientific Research (B) 25293274 (to T.T.),Non-OADS,/arxiv_data1/oa_pdf/e3/86/ijmsv11p0955.PMC4081316.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Attenuation of IP-10/CXCL10 production in TAO S-H Lee et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/47/92/emm201426a.PMC4081550.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Gaining high-quality MSCs by genetic engineering S-M Han et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/de/c6/emm201428a.PMC4081551.pdf
"Four CYP19 polymorphisms sites were selected in public databases (http://www.ncbi.nlm.nih.gov/snp/), including rs2236722:T 4C, rs700518:A 4G, rs10046:T 4C and [TTTA]n tetranucleotide repeat polymorphisms.",OADS,/arxiv_data1/oa_pdf/bf/fa/emm201431a.PMC4081552.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/CYP19 SNP and endometriosis-related infertility LW a n g et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/bf/fa/emm201431a.PMC4081552.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Role of CD36 in atherosclerosis YM Park 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/4f/6c/emm201438a.PMC4081553.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Inhibitory GPCRs as obesity and T2D drug targets ME Kimple et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/81/26/emm201440a.PMC4081554.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/29/b5/ijbsv10p0654.PMC4081601.pdf
Nelfinavir is now under more than 20 Phase I/II clinical trials for cancer  (http://clinicaltrials.gov/).,Non-OADS,/arxiv_data1/oa_pdf/29/b5/ijbsv10p0654.PMC4081601.pdf
"Noneth eless, it  is clear  that d igoxin has a b eneficial effect on patients with  certain types of cancer and is currently  unde rgoing  several clinical trials for the treatment of cancer as a  mon otherapy or in combination with other chem o- therapy drugs ( http://clinicaltrials.gov/).",Non-OADS,/arxiv_data1/oa_pdf/29/b5/ijbsv10p0654.PMC4081601.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/14/ijbsv10p0664.PMC4081602.pdf
"Results   URHC expression is up -regulated in HCC cell  lines and tissues   To determine changes of  lncRNAs in malignant  hepatocytes, we performed a hybridi zation -based  microarray analysis for lncRNA expression (The m i- croarray data discussed in this paper have been de-posited in NCBI Gene Expression Omnibus (GEO)  and are accessible through GEO accession number GSE56384, http://www.ncbi.nlm.nih.gov/geo/  query/a cc.cgi?acc=GSE5638 4).",OADS,/arxiv_data1/oa_pdf/23/14/ijbsv10p0664.PMC4081602.pdf
"GO annotation and KEGG pathway analyses  indicated that aberrantly expressed lncRNAs affected  many genes that may be  associated with tumor bi o- logical processes, such as cell proliferation, cell cycle  progression, apoptosis, migration and/or invasion  (http://david.abcc.ncifcrf.gov/,  Additional file 1:  Supplementary Table 2).",OADS,/arxiv_data1/oa_pdf/23/14/ijbsv10p0664.PMC4081602.pdf
"Therefore, we searched the NCBI  database  (http://www.ncbi.nlm.nih.gov/gene)  and found  that ZAK was located near URHC on chromosome 2  (Fig.",OADS,/arxiv_data1/oa_pdf/23/14/ijbsv10p0664.PMC4081602.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.or g/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0c/79/ijbsv10p0677.PMC4081603.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e7/4f/ijbsv10p0689.PMC4081604.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e3/29/ijbsv10p0702.PMC4081605.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b5/a9/ijbsv10p0715.PMC4081606.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fd/84/ijbsv10p0733.PMC4081607.pdf
Thi s is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,OADS,/arxiv_data1/oa_pdf/3e/e1/ijbsv10p0746.PMC4081608.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/aa/srep05575.PMC4081870.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5369 | DOI: 10.1038/srep05369 5",Non-OADS,/arxiv_data1/oa_pdf/d7/d2/srep05369.PMC4081871.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: K.X., M.R.V., and J.T.",Non-OADS,/arxiv_data1/oa_pdf/d3/f9/srep05571.PMC4081873.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5571 | DOI: 10.1038/srep05571 5",Non-OADS,/arxiv_data1/oa_pdf/d3/f9/srep05571.PMC4081873.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9f/4e/srep05568.PMC4081874.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5568 | DOI: 10.1038/srep05568 9",Non-OADS,/arxiv_data1/oa_pdf/9f/4e/srep05568.PMC4081874.pdf
"The latter has advantages against classic QSAR models, such as the OECD QSAR Toolbox (http://www.oecd.org/chemicalsafety/risk-assessment/theoecdqsartoolbox.htm) and admetSAR 18.",Non-OADS,/arxiv_data1/oa_pdf/d7/74/srep05576.PMC4081875.pdf
"Measurement of the network topology .In order to gain a full understanding of the constructed networks, the Cytoscape plugin MCODE27was applied to define the modules in the MDA network, and NetworkX (http://networkx.lanl.gov/, version1.8.1) was used to calculate three classical topological features, connectivity (k), clustering coefficient (C) and betweenness (B), for the EMA, EDA and MDA networks.",OADS,/arxiv_data1/oa_pdf/d7/74/srep05576.PMC4081875.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d7/74/srep05576.PMC4081875.pdf
"2009;138(4):811-9, http://dx.doi.org/10.1016/j.jtcvs.2008.07.072.2.",OADS,/arxiv_data1/oa_pdf/e0/ca/cln-69-07-500.PMC4081877.pdf
"2008;372(9655):2023-30, http://dx.doi.org/10.1016/S0140-6736(08)61598- 6.",Non-OADS,/arxiv_data1/oa_pdf/e0/ca/cln-69-07-500.PMC4081877.pdf
"2004;128(4):638-41, http://dx.doi.org/10.1016/j.jtcvs.2004.02.042.",OADS,/arxiv_data1/oa_pdf/e0/ca/cln-69-07-500.PMC4081877.pdf
"2012; 18(4):313-20, http://dx.doi.org/10.1097/MCP.0b013e3283539673.",Non-OADS,/arxiv_data1/oa_pdf/e0/ca/cln-69-07-500.PMC4081877.pdf
"1998;133(2):194-8, http://dx.doi.org/10.1001/archsurg.133.2.194.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"1997;10(6):1301- 208, http://dx.doi.org/10.1183/09031936.97.10061301.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"1997;111(3):564-72, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2006;144(8):596-608, http://dx.doi.org/10.7326/0003-4819-144-8-200604180- 00011.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"1999;54:458-65, http://dx.doi.org/10.1136/ thx.54.5.458.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"1997;111(6):1536-41, http://dx.doi.org/10.1378/chest.111.6.1536.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2005;26(1):153-61, http://dx.doi.org/10.1183/09031936.05.00034505.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2006;130(6):1887-900, http://dx.doi.org/10.1378/chest.130.6.1887.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2001;120(3):971-8, http://dx.doi.org/10.1378/ chest.120.3.971.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2000;161 (4 Pt 1):1372-5, http://dx.doi.org/10.1164/ajrccm.161.4.9907082.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"1996;110(3):744- 50, http://dx.doi.org/10.1378/chest.110.3.744.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"1999;115(5):58S-63S, http://dx.doi.org/10.1378/chest.115.suppl_2.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2006;32(11):1722-32, http://dx.doi.org/ 10.1007/s00134-006-0349-5.CLINICS 2014;69(7):483-486 Pulmonary volumes after abdominal surgery de Cleva R et al.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2007;33(6):951-62, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2000;4(1):23-9, http://dx.doi.org/10.1186/cc646.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2001;56(4):123-30, http://dx.doi.org/10.1590/S0041-87812001000400006.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"J Trauma 1998;44(3):440-5, http://dx.doi.org/10.1097/00005373-199803000-00002.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"Arch Surg 1995; 130(5):544-8, http://dx.doi.org/10.1001/archsurg.1995.01430050094016.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2007;33(4):397-406, http://dx.doi.org/10.1590/S1806-37132007000400008.26.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2001;119(6):1858-65, http://dx.doi.org/10.1378/chest.119.6.1858.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"1992;36(6):546-53, http://dx.do i.org/10.1111/j.1399-6576.1992.tb03516.x.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2007;101(4):808-13, http://dx.doi.org/10.1016/j.rmed.2006.07.015.",OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2010;3(4):318-25, http://dx.doi.org/10.4103/ 0974-2700.70747.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/cln-69-07-483.PMC4081878.pdf
"2008;4(11):600-9, http://dx.doi.org/10.1038/ncpneuro0924.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2009;30(1):41-7, http://dx.doi.org/10.1016/j.tips.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2013;76(3):272-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2013;26(4): 374-80, http://dx.doi.org/10.1097/WCO.0b013e3283632d08.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2012;27(14):1718-28, http://dx.doi.org/10.1002/mds.25214.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2012;34(5):1049-55, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2012;10:1, http://dx.doi.org/10.1186/ 1741-7015-10-1.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2005;365(9459):595-7, http://dx.doi.org/10.1016/S0140-6736(05) 17909-4.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2007;22(1):41-7, http://dx.doi.org/ 10.1002/mds.21198.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"1988;14(1):61-8, http://dx.doi.org/10.1016/ 0165-0327(88)90072-9.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2003;54(4):507-13, http://dx.doi.org/10.1002/ana.10711.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2008;14(1):43-5, http://dx.doi.org/ 10.1016/j.parkreldis.2007.05.011.",OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2012;139(2):103-12, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2012;27(3):379-86, http://dx.doi.org/10.1002/mds.24041.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2006;66(7):968-75, http://dx.doi.org/10.1212/01.wnl.0000215437.80053.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2003;47(2):152-8, http://dx.doi.org/10.1002/syn.10160.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2002;58(8):1239-46, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2012;135(Pt 11):3206-26, http://dx.doi.org/10.1093/brain/aws023.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2009;8(12):1128-39, http://dx.doi.org/10.1016/S1474-4422(09)70293-5.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2002;59(11):1724-8, http://dx.doi.org/10.1001/archneur.59.11.1724.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2001;58(10):1611-5, http://dx.doi.org/10.1001/archneur.58.10.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2012;18(5):446-52, http://dx.doi.org/10.1016/j.parkreldis.",OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2006;21(12):2150-6, http://dx.doi.org/10.1002/ mds.21153.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2008;7(7):583-90, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2012;27(10):1276-82, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2012;18(10):1053-61, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"Nutr Rev 2011;69(9):520-32, http://dx.doi.org/10.1111/j.1753-4887.2011.00413.x.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2012;33(5):947- 71, http://dx.doi.org/10.1016/j.neuro.2012.05.011.",OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"2013;28(1):8-13, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/9d/cln-69-07-457.PMC4081879.pdf
"1998;19(2):143-53, http://dx.doi.org/ 10.1055/s-0028-1082964.",Non-OADS,/arxiv_data1/oa_pdf/62/ae/cln-69-07-469.PMC4081880.pdf
"2002;33(1):25-8, http://dx.doi.org/10.1016/S0188-4409(01)00342-3.",Non-OADS,/arxiv_data1/oa_pdf/62/ae/cln-69-07-469.PMC4081880.pdf
"1970;92(4):311-24, http://dx.doi.org/10.1001/archotol.1970.04310040005002.",Non-OADS,/arxiv_data1/oa_pdf/62/ae/cln-69-07-469.PMC4081880.pdf
"2004;114(2):327-32, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/ae/cln-69-07-469.PMC4081880.pdf
"2010a;15(2):174-8, http://dx.doi.org/10.1590/S1516-80342010000200005.",Non-OADS,/arxiv_data1/oa_pdf/62/ae/cln-69-07-469.PMC4081880.pdf
"2002;34(3):418-9, http://dx.doi.org/10.1086/324368.",Non-OADS,/arxiv_data1/oa_pdf/62/ae/cln-69-07-469.PMC4081880.pdf
"1997;54(4):407-10, http://dx.doi.org/10.1001/archneur.1997.00550160049015.",Non-OADS,/arxiv_data1/oa_pdf/62/ae/cln-69-07-469.PMC4081880.pdf
"2010b;22(3):269-74, http://dx.doi.org/ 10.1590/S0104-56872010000300019.",Non-OADS,/arxiv_data1/oa_pdf/62/ae/cln-69-07-469.PMC4081880.pdf
"2001;33(12):2100-01, http://dx.doi.org/10.1086/324361.",Non-OADS,/arxiv_data1/oa_pdf/62/ae/cln-69-07-469.PMC4081880.pdf
"2008;42(4):664-71, http://dx.doi.org/10.1590/S0034-89102008005000039.",Non-OADS,/arxiv_data1/oa_pdf/70/60/cln-69-07-497.PMC4081881.pdf
"2006;38(3):305-10, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/60/cln-69-07-497.PMC4081881.pdf
"2010;36(4):181-6, http://dx.doi.org/10.3109/00952990.2010.491877.",Non-OADS,/arxiv_data1/oa_pdf/70/60/cln-69-07-497.PMC4081881.pdf
"2008;24(Suppl 4):s545-57, http://dx.doi.org/ 10.1590/S0102-311X2008001600007.",Non-OADS,/arxiv_data1/oa_pdf/70/60/cln-69-07-497.PMC4081881.pdf
"2012; 34(1):24-33, http://dx.doi.org/10.1590/S1516-44462012000100006.",Non-OADS,/arxiv_data1/oa_pdf/70/60/cln-69-07-497.PMC4081881.pdf
"2001;33(3):241-53, http://dx.doi.org/10.1080/02791072.2001.10400571.",Non-OADS,/arxiv_data1/oa_pdf/70/60/cln-69-07-497.PMC4081881.pdf
"2008;42(4):664-71, http://dx.doi.org/10.1590/S0034-89102008005000039.",Non-OADS,/arxiv_data1/oa_pdf/70/60/cln-69-07-497.PMC4081881.pdf
"1995;151(1):184-93, http://dx.doi.org/10.1164/ajrccm.151.1.7812551.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"1995;151(5):1635-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2004;22:789-815, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"1999;104(8):1021-9, http://dx.doi.org/10.1172/JCI7631.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2006;13(4):205-8, http://dx.doi.org/10.1159/000100405.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2009;14(6):877-84, http://dx.doi.org/10.1111/j.1440-1843.2009.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2006;11(5):572-8, http://dx.doi.org/10.1111/j.1440-1843.2005.00893.x.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"1999;58(6):300-8, http://dx.doi.org/10.1159/000028295.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2001;74(1):83-8, http://dx.doi.org/10.1016/S0378- 8741(00)00314-7.",OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2002;40(8):596-602, http://dx.doi.org/10.1076/phbi.40.8.596.14653.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"Pharmacol Rep. 2010;62(5):910-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2013;147(2):530-5, http://dx.doi.org/10.1016/j.jep.",OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2011;12(3):201-9, http://dx.doi.org/10.1631/jzus.B1000163.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"1999;5(4):285-94, http://dx.doi.org/10.1097/00054725-199911000-00009.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2008;122(1):78-85, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2002;166(5):703-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2004;90(1):105-14, http://dx.doi.org/10.1016/j.jep.2003.09.031.",OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2003;8(4):473-8, http://dx.doi.org/10.1046/j.1440-1843.2003.00511.x.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2011;66(5):879-87, http://dx.doi.org/10.1590/S1807-59322011000500027.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2003;55(4):265-70, http://dx.doi.org/10.1078/0940-2993- 00320.",Non-OADS,/arxiv_data1/oa_pdf/a0/8f/cln-69-07-491.PMC4081882.pdf
"2011;32(4):445-55, http://dx.doi.org/10.1002/humu.21462.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2003;58(1):3-11, http://dx.doi.org/10.1179/acb.2003.58.1.001.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2012;5(3):264-73, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2002;17(4):269-71, http://dx.doi.org/10.1177/ 088307380201700406.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"1993;2(7):869-73, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"1993;73(1):159-68, http://dx.doi.org/ 10.1016/0092-8674(93)90168-P. 10.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"1993;5(1):11-6, http://dx.doi.org/10.1038/ng0993- 11.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2002;39(8):554-8, http://dx.doi.org/10.1136/ jmg.39.8.554.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"1988;113(2):318-26, http://dx.doi.org/10.1016/S0022-3476(88)80272-5.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2013;83(2):155-61, http://dx.doi.org/10.1111/j.1399-0004.2012.01862.x.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2011;66(6):959-64, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"1994;19(3):367-71, http://dx.doi.org/10.1097/00007632- 199402000-00021.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2012;119(10):474-8, http://dx.doi.org/10.5177/ntvt.2012.10.12210.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2012;119(11):531-5, http://dx.doi.org/10.5177/ntvt.2012.11.12232.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2010;128(2):69-73, http://dx.doi.org/10.1590/S1516-31802010000200005.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2009;61(1):1-14; quiz 15-6, http://dx.doi.org/10.1016/j.jaad.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2013;39(2):431-55, http://dx.doi.org/10.1016/j.rdc.2013.03.004.",OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2008;93(12):1012-6, http://dx.doi.org/10.1136/adc.2007.123836.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2008;52(5):800-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"1932;7(4):193-208, http://dx.doi.org/10.1136/adc.7.40.193.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"1962;26:1235-40, http://dx.doi.org/10.1161/01.CIR.26.6.1235.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"1998;87(1):48-53, http://dx.doi.org/10.1080/08035259850157868.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"1996;11(1):63-5, http://dx.doi.org/10.1177/088307389601100116.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"1991;21(7):508-10, http://dx.doi.org/10.1007/BF02011725.Scoliosis in Williams-Beuren syndrome patients Damasceno ML et al.CLINICS 2014;69(7):452-456 456",Non-OADS,/arxiv_data1/oa_pdf/59/d4/cln-69-07-452.PMC4081883.pdf
"2009;51(3):371-6, http://dx.doi.org/10.1111/j.1442- 200X.2008.02740.x.",Non-OADS,/arxiv_data1/oa_pdf/72/58/cln-69-07-464.PMC4081884.pdf
"2007;89(1):100-6, http://dx.doi.org/10.1302/0301-620X.89B1.17940.",Non-OADS,/arxiv_data1/oa_pdf/72/58/cln-69-07-464.PMC4081884.pdf
"2005;44(12):1559-63, http://dx.doi.org/10.1093/rheumatology/kei092.",Non-OADS,/arxiv_data1/oa_pdf/72/58/cln-69-07-464.PMC4081884.pdf
"1976;35(3):198-205, http://dx.doi.org/10.1136/ard.35.3.198.16.",Non-OADS,/arxiv_data1/oa_pdf/72/58/cln-69-07-464.PMC4081884.pdf
"2001;121(9):521-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/72/58/cln-69-07-464.PMC4081884.pdf
"2005;53(7):1210-3, http://dx.doi.org/10.1111/j.1532-5415.",Non-OADS,/arxiv_data1/oa_pdf/72/58/cln-69-07-464.PMC4081884.pdf
"2009;51(3):377- 80, http://dx.doi.org/10.1111/j.1442-200X.2008.02791.x.",Non-OADS,/arxiv_data1/oa_pdf/72/58/cln-69-07-464.PMC4081884.pdf
"2008;2(3):229-37, http://dx.doi.org/10.1007/s11832-008- 0094-0.",Non-OADS,/arxiv_data1/oa_pdf/72/58/cln-69-07-464.PMC4081884.pdf
"2013;33(4):464-7, http://dx.doi.org/10.1097/BPO.0b013e318278484f.",Non-OADS,/arxiv_data1/oa_pdf/72/58/cln-69-07-464.PMC4081884.pdf
"1992;11(1):9-13, http://dx.doi.org/10.1097/00006454-199201000- 00004.",Non-OADS,/arxiv_data1/oa_pdf/72/58/cln-69-07-464.PMC4081884.pdf
"2012;67(12):1523-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/16/25/cln-69-07-504.PMC4081885.pdf
"2000;95 (6 Pt 1):899-904, http://dx.doi.org/10.1016/S0029-7844(99)00640-7.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2013;8(8):e70549, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2011;118(5):1095-101, http://dx.doi.org/10.1097/AOG.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2004;104(2):278-85, http://dx.doi.org/ 10.1097/01.AOG.0000134524.58795.bd.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2004;103(5 Pt 1):907-12, http://dx.doi.org/10.1097/01.AOG.0000124568.71597.ce.7.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"1999;354(9180):776, http://dx.doi.org/10.1016/S0140-6736(05)76016-5.",OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2003;188(1):220-7, http://dx.doi.org/10.1067/mob.2003.64.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"1987;156(1):52-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2010;89(7):896-902, http://dx.doi.org/10.3109/00016349.2010.487893.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"1994;73(4):313-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2012;286(6):1363-7, http://dx.doi.org/10.1007/s00404-012-2461-9.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"1997;177(5):1063-6, http://dx.doi.org/10.1016/S0002-9378(97)70015-2.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2001;97(2):169-74, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2005;112(8):1139-44, http://dx.doi.org/10.1111/j.1471-0528.2005.00631.x.",Non-OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2004;190(2):428-34, http://dx.doi.org/10.1016/j.ajog.",OADS,/arxiv_data1/oa_pdf/36/ee/cln-69-07-447.PMC4081886.pdf
"2006 15;26(7):2115-23, http://dx.doi.org/10.1523/JNEUROSCI.4985-05.2006.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"2012;14(61):274-80, http://dx.doi.org/10.4103/1463-1741.104893.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"2005;48(5):1204- 35, http://dx.doi.org/10.1044/1092-4388(2005/084).",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"2011; 13(55):392-401, http://dx.doi.org/10.4103/1463-1741.90293.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"1995;24(2):97-100, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"2001;157(1-2):52-64, http://dx.doi.org/10.1016/S0378-5955(01)00277-5.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"2008;134(6):647-51, http://dx.doi.org/10.1001/archotol.134.6.647.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"1993;71(1-2):106-13, http://dx.doi.org/10.1016/0378-5955(93)90026-W. 13.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"1996;122(2):143- 8, http://dx.doi.org/10.1001/archotol.1996.01890140029007.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"1996;116(4):534-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"2006;(556):20-6, http://dx.doi.org/10.1080/03655230600895309.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
"1996b;35(5):259-70, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2d/3d/cln-69-07-487.PMC4081887.pdf
Retrieved from http://www.ncri.ie/pubs.shtml.,Non-OADS,/arxiv_data1/oa_pdf/95/1c/srep05569.PMC4081888.pdf
"2005;294(7):813-8, http://dx.doi.org/10.1001/jama.294.7.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"1999;56(3):1058-63, http://dx.doi.org/ 10.1046/j.1523-1755.1999.00622.x.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"2008;36(12):3165-70, http://dx.doi.org/10.1097/CCM.0b013e318186ab70.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"2003;19(11-12):909-16, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"2012;7(6):887-94, http://dx.doi.org/ 10.2215/CJN.11131111.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"1987;11(1):8-13, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"1994;271(1):54-8, http://dx.doi.org/10.1001/jama.1994.03510250070038.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"2003;6(2):211-6, http://dx.doi.org/10.1097/00075197- 200303000-00010.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"2011;39(2):405-6, http://dx.doi.org/10.1097/CCM.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"2005;24(5):830-8, http://dx.doi.org/10.1016/j.clnu.2005.05.",OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"Semin Dial 2011;24(2): 169-75, http://dx.doi.org/10.1111/j.1525-139X.2011.00831.x.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
"2008;73(4):391-8, http://dx.doi.org/10.1038/sj.ki.5002585.Nutrition and mortality in AKI Berbel MN et al.CLINICS 2014;69(7):476-482 482",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/cln-69-07-476.PMC4081889.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d6/c4/srep05578.PMC4081890.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/55/4d/srep05303.PMC4081891.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5303 | DOI: 10.1038/srep05303 8",Non-OADS,/arxiv_data1/oa_pdf/55/4d/srep05303.PMC4081891.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/aa/63/srep05566.PMC4081892.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/63/7c/srep05574.PMC4081895.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5574 | DOI: 10.1038/srep05574 7",Non-OADS,/arxiv_data1/oa_pdf/63/7c/srep05574.PMC4081895.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/46/main.PMC4081973.pdf
http://dx.doi.org/10.1016/j.nicl.2014.06.0052213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/35/46/main.PMC4081973.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/46/main.PMC4081973.pdf
Solution point generation and electrode coregistration 1Available at https://sites.google.com/site/cartoolcommunity/ ﬁles.78 G. Birot et al.,OADS,/arxiv_data1/oa_pdf/35/46/main.PMC4081973.pdf
"were performed in Cartool (D. Brunet, Geneva University Hospital and Medical School, Center for Biomedical Imaging (CIBM), Geneva, Switzerland http://sites.google.com/site/fbmlab/cartool ).",OADS,/arxiv_data1/oa_pdf/35/46/main.PMC4081973.pdf
http://dx.doi.org/10.1016/j.nicl.2014.05.015,OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1503/   jpn.090186  , 20964952  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1007/s00429-  005- 0025- 5 , 16208455  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/   j.euroneuro.2011.05.003  , 21723712  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1038/mp.2012.150  , 23128153  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.neuroimage.2007.07.007  , 17761438  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/   j.jpsychires.2009.12.009  , 20096419  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.neulet.2009.10.067  ,  19874870  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.jad.2011.03.049  ,  21511342  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.psyneuen.2005.02.010  , 15961250  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1017/S1461145708008973  ,  18544183  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1007/s00429-  008- 0189- x ,  18704495  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/   S0006- 3223(00)00935-  5 , 11063970  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/   j.neuroimage.2004.12.034  , 15850749  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/   10.1002/jmri.20583  , 16649196  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/S0006-  3223(01)01359-  2 ,  11983184  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1111/j.1600-0447.2008.01225.x  , 18644006  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.expneurol.2008.04.043  , 18599044  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1038/mp.2008.57  , 18504424  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.jpsychires.2005.07.008  ,  16243357  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2531-12.2012  , 23238724  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1176/appi.ajp.161.4.631  ,  15056508  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1017/S0033291703001806  , 15554576  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1038/   mp.2010.120  , 21079608  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.jad.2011.10.038  , 22134041  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1038/87865  , 11329053  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1097/YCT.0b013e3181a95da8  , 20190603  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/0028-3932(71)   90067-4  , 5146491  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"British Medical Bulletin 101, 127– 45. http://dx.doi.org/10.1093/bmb/lds004  , 22334281  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
http://dx.doi.org/10.1016/j.tics.,OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1177/0269881112450779  , 22767373  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.pscychresns.2011.10.004  , 22867951  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
http://dx.doi.org/10.1016/j.paid.,OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.pscychresns.2013.09.004  , 24090511  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1006/nimg.2001.0978  , 11771995  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/   10.1192/bjp.bp.106.032201  , 17766761  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/9a/main.PMC4081977.pdf
"The sinus endoscopy highlighted a foreign body at the bottom of the sinus, which led toContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2014.05.003 2211-7539/ &2014 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.",Non-OADS,/arxiv_data1/oa_pdf/33/9a/main.PMC4081977.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/9a/main.PMC4081977.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/8b/main.PMC4081978.pdf
The mother was healthy and indicated that she did not noticed anything different in her daughter duringContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2014.06.001 2211-7539/ &2014 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/94/8b/main.PMC4081978.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/8b/main.PMC4081978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.nicl.2014.05.0182213-1582/© 2014 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
Structural parcellation Cortical reconstruction and volumetric segmentation were performed using the MPRAGE images with the Freesurfer image analysis suite (http://surfer.nmr.mgh.harvard.edu ).,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"Constrained spherical deconvolution ( Tournier et al., 2007, 2012 ) (http://nitrc.org/projects/mrtrix ) was employed to estimate the ﬁbre orientation distribution for tractography at a maximum harmonicorder of 8.",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"Statistical analysis Statistical analysis of the brain network was performed using the NBS toolbox for Matlab ( https://sites.google.com/site/bctnet/comparison/nbs ; (Zalesky et al., 2010 )).",OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.ridd.,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"13, 68. http://dx.doi.org/10.1186/1471-2377-13-68 .",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"512 (1), 53 –58.http://dx.doi.org/10.1016/j.neulet.2012.",OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1111/dmcn.1245 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.3174/ajnr.A0676 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.09.015 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.cortex.2008.05.002 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2012.06.081 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1111/j.1469-8749.2007.00144.x .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1002/ mrm.21890 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1093/cercor/bhh186 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/ 10.1016/j.bbr.2011.07.010 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1002/mrm.22786 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.05.018 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.01.020 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"http://dx.doi.org/10.1007/s00247-012-2427- .Pannek, K., Raffelt, D., Bell, C., Mathias, J.L., Rose, S.E., 2012b.",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.07.022 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1002/mrm.1030 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1007/s00234-011-0996-2 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1002/mrm.10677 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1089/brain.2011.0034 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1111/j.1469- 8749.2012.04332.x .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.03.032 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1109/42.668698 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"420 (1), 34 –38.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"451 (1), 94 –97.http://dx.doi.org/10.1016/j.neulet.2008.12.033 .",OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1093/brain/ awh600 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2007.02.016 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"22 (1), 53 –66.http://dx.doi.org/10.1002/ ima.22005 .",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1007/s00234-010-0703-8 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1007/s00429-013-0656- .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1002/mrm.2196 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1148/radiol.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2010.06.041 .92 K. Pannek et al.,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/a3/main.PMC4081980.pdf
http://dx.doi.org/10.1016/j.nicl.2014.06.0012213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/a3/main.PMC4081980.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/a3/main.PMC4081980.pdf
"SIENAX, which is part of FMRIB's Software Library (FSL, version 5.0.4; http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/ ) was used to calculate whole brain volume as well as total grey matter volume.",OADS,/arxiv_data1/oa_pdf/dd/a3/main.PMC4081980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
http://dx.doi.org/10.1016/j.nicl.2014.06.0032213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
Motion and eddy current correction was performed by co-registering eachvolume to the ﬁrst b0 volume using an af ﬁne registration algorithm in FSL ( http://www.fmrib.ox.ac.uk/fsl ).,OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
"Diffusion Tensor Images (DTIs) were estimated from the Diffusion-Weighted Images in Slicer v2.8 (http://www.slicer.org ), on the basis of a weighted-least-squares estimation.",OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
"De ﬁnition of the six limbic regions-of-interest using FreeSurfer FreeSurfer (v4.2.0; http://surfer.nmr.mgh.harvard.edu/ ) was used to parcellate each participant's T1-weighted MRI into 34 neocortical regions ( Fischl et al., 2004 ).",OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
"Tractography and extraction of the CB sub-connections Each participant's DTI underwent the following processing protocols in Slicer (v.2.8; http://www.slicer.org/ ): 1.Whole-brain tractography: Deterministic (streamline) tractography was performed from every putatively white matter voxel within each participant's Fractional Anisotropy (FA) image ( Whitford et al., 2011).",OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
"Unfortunately, his disease progressed rapidly despite treatment, resulting in death from disease-related complications seven months after diagnosis.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.04.004 2213-0489/ &2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/17/c4/main.PMC4081982.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/c4/main.PMC4081982.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/0d/main.PMC4081983.pdf
"Chemotherapy for AML was withheld due to the severe pancytopenia, hypocellularity, andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.04.002 2213-0489/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/62/0d/main.PMC4081983.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/0d/main.PMC4081983.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e4/c2/srep05580.PMC4082104.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5580 | DOI: 10.1038/srep05580 9",Non-OADS,/arxiv_data1/oa_pdf/e4/c2/srep05580.PMC4082104.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/78/ddu111.PMC4082364.pdf
"Thesoftware package LIMMA (R-library, bioconductor, http://www.R-project.org) was used for statistical analysis and thesearch for differentially expressed genes.",OADS,/arxiv_data1/oa_pdf/d0/78/ddu111.PMC4082364.pdf
Microarray data analysis Microarray data analysis was performed using the MetaCore software suite (http://thomsonreuters.com/metacore/) to iden-tify biological processes associated with gene expression pro-ﬁles.,OADS,/arxiv_data1/oa_pdf/d0/78/ddu111.PMC4082364.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/de/ddu115.PMC4082365.pdf
"Neither this variant, nor the 5 bp deletionwere present in the Exome Variant Server, NHLBI GO ExomeSequencing Project, Seattle, WA, USA (http://eversusgs.washington.edu/EVS/) (accessed Dec 2013) or in 1000 Genomes(http://browser.1000genomes.org/index.html).",OADS,/arxiv_data1/oa_pdf/65/de/ddu115.PMC4082365.pdf
Homozygosity analysis was performedusing dCHIP (http://biosun1.harvard.edu/complab/dchip; 21) and HomozygosityMapper (http://www.homozygositymapper.,OADS,/arxiv_data1/oa_pdf/65/de/ddu115.PMC4082365.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/c6/ddu118.PMC4082368.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2014, 9: 24899 - http://dx.doi.org/10.3402/ljm.v9.24899 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/bb/8f/LJM-9-24899.PMC4082493.pdf
"Calciﬁed IUCD after removal.Awatuf Elshirif 2 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 24899 - http://dx.doi.org/10.3402/ljm.v9.24899",Non-OADS,/arxiv_data1/oa_pdf/bb/8f/LJM-9-24899.PMC4082493.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/f8/ncomms5102.PMC4082631.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Felis, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/53/f8/ncomms5102.PMC4082631.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5102 ARTICLE NATURE COMMUNICATIONS | 5:4102 | DOI: 10.1038/ncomms5102 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/53/f8/ncomms5102.PMC4082631.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/d5/f4/ncomms5128.PMC4082632.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhu, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/f4/ncomms5128.PMC4082632.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5128 ARTICLE NATURE COMMUNICATIONS | 5:4128 | DOI: 10.1038/ncomms5128 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/d5/f4/ncomms5128.PMC4082632.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5077 8 NATURE COMMUNICATIONS | 5:4077 | DOI: 10.1038/ncomms5077 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/07/a9/ncomms5077.PMC4082636.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Tanentzap, A. J. et al.",Non-OADS,/arxiv_data1/oa_pdf/07/a9/ncomms5077.PMC4082636.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5077 ARTICLE NATURE COMMUNICATIONS | 5:4077 | DOI: 10.1038/ncomms5077 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/07/a9/ncomms5077.PMC4082636.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing interests.,Non-OADS,/arxiv_data1/oa_pdf/fd/91/ncomms5051.PMC4082638.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Li, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/fd/91/ncomms5051.PMC4082638.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Timurdogan, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/48/08/ncomms5008.PMC4082639.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/bb/ab/ncomms5109.PMC4082640.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Melinte, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/bb/ab/ncomms5109.PMC4082640.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5109 8 NATURE COMMUNICATIONS | 5:4109 | DOI: 10.1038/ncomms5109 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/bb/ab/ncomms5109.PMC4082640.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: F.K.,Non-OADS,/arxiv_data1/oa_pdf/18/73/ncomms5101.PMC4082641.pdf
"All other authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Westermeier, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/18/73/ncomms5101.PMC4082641.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/c2/45/ncomms5153.PMC4082642.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Suzuki, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/c2/45/ncomms5153.PMC4082642.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5153 ARTICLE NATURE COMMUNICATIONS | 5:4153 | DOI: 10.1038/ncomms5153 | www.nature.com/naturecommunications 13 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/c2/45/ncomms5153.PMC4082642.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Okaba, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/07/a6/ncomms5096.PMC4082643.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5096 ARTICLE NATURE COMMUNICATIONS | 5:4096 | DOI: 10.1038/ncomms5096 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/07/a6/ncomms5096.PMC4082643.pdf
"21. van Dolder BD, van Geest-Daalderop JJH, van’t Land RP, Levi MM, Piersma-Wichers G. De kunst van het doseren: Richtlijn, leidraad en informatie voor het doseren van vitamine K-antagonisten.Available from http://www.fnt.nl/ .",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/12325_2014_Article_124.PMC4082646.pdf
Available from http://www.nice.org.uk/nicemedia/live/14091/ 66498/66498.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ac/a7/12325_2014_Article_124.PMC4082646.pdf
National Comprehensive Cancer Network Inc (2014) NCCN practice guidelines in oncology: cancer and chemotherapy-induced anemia - v.2.http://www.nccn.org/professionals/physician_gls/f_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/fd/e0/520_2014_Article_2189.PMC4082648.pdf
available at www.sciencedirect.com ScienceDirect www.elsevier.com/locate/molonc http://dx.doi.org/10.1016/j.molonc.2014.03.009 1574-7891/$ esee front matter ª2014 Federation of European Biochemical Societies.,Non-OADS,/arxiv_data1/oa_pdf/5f/fb/MOL2-8-0912.PMC4082767.pdf
"This would be in-line with data from the FANTOM5 ZENBU gLyphsGenome Browser ( http://fantom.gsc.rik en.jp/5/suppl/Kana- mori-Katayama_et_al_2011 ), indicating a number of tran- scription initiation sites at the 5 0end of the GLI1 gene both in the sense and antisense orientation, with somehaving the potential for transcriptional overlap(Supplementary Figure 2 ).",Non-OADS,/arxiv_data1/oa_pdf/5f/fb/MOL2-8-0912.PMC4082767.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2014.03.009 .Figure 7 eSchematic representation of the proposed mechanism for the interplay of the GLI1AS and GLI1 regulatory effects.,OADS,/arxiv_data1/oa_pdf/5f/fb/MOL2-8-0912.PMC4082767.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2013-203759).,Non-OADS,/arxiv_data1/oa_pdf/5a/aa/annrheumdis-2013-203759.PMC4083014.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Manzi S, Selzer F, Sutton-Tyrrell K, et al.",Non-OADS,/arxiv_data1/oa_pdf/5a/aa/annrheumdis-2013-203759.PMC4083014.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:163-170 Interrelationships between the Retinal Neuroglia and  Vasculature in Diabetes Timothy S. Kern1,2 1Department of Medicine, Case Western Reserve University Medicine, Cleveland, OH; 2Department of Medicine, Louis Stokes Cleveland Veterans Administration Medical Center, Cleveland, OH, USA For years, diabetic retinopathy has been defined based on vascular lesions, and neural abnormalities were not regarded as impor - tant.",Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
"Surprisingly, dark adaptation did not increase retinal blood Review Complications http://dx.doi.org/10.4093/dmj.2014.38.3.163 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
164Kern TS Diabetes Metab J 2014;38:163-170 http://e-dmj.orgflow in Sprague-Dawley rats.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
165Neurovascular interactions in diabetic retinopathy Diabetes Metab J 2014;38:163-170 http://e-dmj.orgarteries and veins in insulin-dependent diabetic patients [23]  and in healthy subjects made experimentally hyperglycemic  [24] have shown significant reduction compared to controls.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
166Kern TS Diabetes Metab J 2014;38:163-170 http://e-dmj.orgare altered in diabetic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
167Neurovascular interactions in diabetic retinopathy Diabetes Metab J 2014;38:163-170 http://e-dmj.orgtent with a role of photoreceptors in the development of dia - betic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
"168Kern TS Diabetes Metab J 2014;38:163-170 http://e-dmj.orgCONFLICTS OF INTEREST  This work was funded by PHS grants EY00300 and EY022938,  and by a Merit grant from the Veteran’s Administration.",Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
169Neurovascular interactions in diabetic retinopathy Diabetes Metab J 2014;38:163-170 http://e-dmj.orgcontrolled patients with type 1 diabetes without retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
170Kern TS Diabetes Metab J 2014;38:163-170 http://e-dmj.orgfects the course of early diabetic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:171-180 Ubiquitin Ligases in Cholesterol Metabolism Wei Jiang, Bao-Liang Song Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China To maintain cholesterol homeostasis, the processes of cholesterol metabolism are regulated at multiple levels including transcrip - tion, translation, and enzymatic activity.",Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
"), Review Pathophysiology http://dx.doi.org/10.4093/dmj.2014.38.3.171 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
Diabetes Metab J 2014;38:171-180 http://e-dmj.orga coupling of ubiquitin to endoplasmic reticulum (ER) degra - dation (Cue) domain (456-497 aa.,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
173E3s and cholesterol metabolism Diabetes Metab J 2014;38:171-180 http://e-dmj.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
Diabetes Metab J 2014;38:171-180 http://e-dmj.orgtry [4].,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
"175E3s and cholesterol metabolism Diabetes Metab J 2014;38:171-180 http://e-dmj.org In addition to HMGCR, Insig-1, Insig-2, as well as ApoB- 100, a series of other proteins are identified as substrates of  gp78.",Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
Diabetes Metab J 2014;38:171-180 http://e-dmj.org100 aa.),Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
177E3s and cholesterol metabolism Diabetes Metab J 2014;38:171-180 http://e-dmj.orgtion of LXR can decrease the abundance of LDLR without  changing its mRNA level and subsequently inhibited uptake of  LDL in different cells [52].,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
Diabetes Metab J 2014;38:171-180 http://e-dmj.orgsis: sterol-accelerated ubiquitination and degradation of HMG  CoA reductase.,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
179E3s and cholesterol metabolism Diabetes Metab J 2014;38:171-180 http://e-dmj.org34.,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
Diabetes Metab J 2014;38:171-180 http://e-dmj.orgnists.,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:181-186 The Role of Pyruvate Dehydrogenase Kinase in  Diabetes and Obesity In-Kyu Lee Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea The pyruvate dehydrogenase complex (PDC) is an emerging target for the treatment of metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
"Four PDK isoenzymes (PDK1,  2, 3, and 4) and two PDP isoenzymes (PDP1 and PDP2) are Sulwon Lecture 2013 Pathophysiology http://dx.doi.org/10.4093/dmj.2014.38.3.181 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
"182Lee IK Diabetes Metab J 2014;38:181-186 http://e-dmj.orginvolved in this phosphorylation [6,7].",Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
183The role of PDK in diabetes and obesity Diabetes Metab J 2014;38:181-186 http://e-dmj.orga disruption in the suppression of PDK4 by insulin.,Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
184Lee IK Diabetes Metab J 2014;38:181-186 http://e-dmj.orgpatients with atherosclerosis.,Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
185The role of PDK in diabetes and obesity Diabetes Metab J 2014;38:181-186 http://e-dmj.orggene induction by dexamethasone through inactivation of  FOXO transcription factors.,Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
186Lee IK Diabetes Metab J 2014;38:181-186 http://e-dmj.orgCharcot-Marie-Tooth disease (CMTX6) is caused by muta - tions in the pyruvate dehydrogenase kinase isoenzyme 3  (PDK3) gene.,Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:187-193 Journal Metrics-Based Position of Diabetes &  Metabolism Journal  after the Change of Its Text  Language to English Sun Huh Department of Parasitology and Institute of Medical Education, Hallym University College of Medicine, Chuncheon, Korea After changing its language from Korean or English to English only in 2010, the journal metrics of Diabetes & Metabolism Jour - nal (DMJ) were analyzed to assess whether this change in the journal policy was successful.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
"In  2011, the journal underwent another change in title to Diabe - tes & Metabolism Journal (DMJ) to broaden its scope to these Perspective Perspective   http://dx.doi.org/10.4093/dmj.2014.38.3.187 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
188Huh S Diabetes Metab J 2014;38:187-193 http://e-dmj.orgworldwide problems.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
189Position of Diabetes & Metabolism Journal  based on journal metrics Diabetes Metab J 2014;38:187-193 http://e-dmj.orgnals included in the Web of Science are presented in Figs.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
190Huh S Diabetes Metab J 2014;38:187-193 http://e-dmj.orgreports (36.5%) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
191Position of Diabetes & Metabolism Journal  based on journal metrics Diabetes Metab J 2014;38:187-193 http://e-dmj.orgJCR 2012.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
"192Huh S Diabetes Metab J 2014;38:187-193 http://e-dmj.orgbeen cited by Korean researchers for a long time, its citation by  researchers throughout the world has only recently increased.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
Available  from: http://pubmedcentral.org/ (cited 2014 Apr 23).,OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
Available from:  http://pubmed.org/ (cited 2014 Apr 23).,OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
Available from: http://koreamed.org/ (cited 2014 Apr 23).,OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
Avail - able from: http://komci.org/ (cited 2014 Apr 23).,OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
193Position of Diabetes & Metabolism Journal  based on journal metrics Diabetes Metab J 2014;38:187-193 http://e-dmj.org10.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:194-196 It’s Still Not Too Late to Make a Change:   Current Status of Glycemic Control in Korea Sang Y ong Kim Department of Endocrinology and Metabolism, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Korea Corresponding author: Sang Y ong Kim Department of Endocrinology and Metabolism, Chosun University Hospital,  Chosun University School of Medicine, 365 Pilmun-daero, Dong-gu,  Gwangju 501-717, Korea E-mail: diabetes@chosun.ac.krDiabetes is an important chronic disease causing economic  and social burden around the world.",Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
"There - fore, it is crucial to devise a plan-of-action to alleviate this situ - ation in one way or another.Editorial Epidemiology http://dx.doi.org/10.4093/dmj.2014.38.3.194 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
"195Glycemic control in Korea Diabetes Metab J 2014;38:194-196 http://e-dmj.org In this issue, Jeon et al.",Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
196Kim SY Diabetes Metab J 2014;38:194-196 http://e-dmj.orgongoing and upcoming studies will discover valid ways to re - duce diabetic complications.,Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
Available from:  http://kostat.go.kr (updated 2013 Sep 25).,Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:197-203 Current Status of Glycemic Control of Patients with  Diabetes in Korea: The Fifth Korea National Health and  Nutrition Examination Survey Ja Y oung Jeon1, Dae Jung Kim1, Seung-Hyun Ko2, Hyuk-Sang Kwon2, Soo Lim3, Sung Hee Choi3, Chul Sik Kim4, Jee Hyun An5,  Nan Hee Kim5, Jong Chul Won6, Jae Hyeon Kim7, Bong-Yun Cha2, Kee-Ho Song8 on behalf of the Taskforce Team of Diabetes  Fact Sheet of the Korean Diabetes Association 1Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, 2Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 4Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of   Medicine, Anyang,  5Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul,  6Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul,  7Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 8Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea Background:  The Korea National Health and Nutrition Examination Survey (KNHANES) III (2005) reported that 22.9% of in - dividuals with diabetes have a glycated hemoglobin (HbA1c) <6.5% and that 43.5% have an HbA1c <7%.",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
Diabetes is closely related to Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2014.38.3.197 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"Diabetes Metab J 2014;38:197-203 http://e-dmj.orgvarious cardiovascular diseases, including coronary arterial  disease, stroke, peripheral arterial disease, and cardiomyopa - thy; these comorbidities occur in 70% to 80% of patients with  type 2 diabetes mellitus, ultimately leading to death [3].",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"199Glycemic control in Korea Diabetes Metab J 2014;38:197-203 http://e-dmj.orgRESULTS  We first observed the baseline characteristics of the 1,341 dia - betic patients.",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"Diabetes Metab J 2014;38:197-203 http://e-dmj.orgachieve glycemic control in approximately 50% of patients  reaching their goal of glycemic levels [5,7].",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"201Glycemic control in Korea Diabetes Metab J 2014;38:197-203 http://e-dmj.orgbetes refers to subjects with fasting plasma glucose (FPG) ≥126  mg/dL and/or HbA1c ≥6.5% in the absence of known diabe - tes, the prevalence of newly diagnosed diabetes is 4%.",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
Diabetes Metab J 2014;38:197-203 http://e-dmj.org7.0% from 2003 to 2006 and a success rate of 52.5% from 2007  to 2010 [7].,Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"203Glycemic control in Korea Diabetes Metab J 2014;38:197-203 http://e-dmj.orgthe importance of diet and exercise, trains the patients to con - trol their own insulin usage volume and frequency, etc., are es - sential.",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
Available from:  http://kostat.go.kr (updated 2013 Sep 25).,Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:204-210 Efficacy of the Smartphone-Based Glucose  Management Application Stratified by User Satisfaction Hun-Sung Kim1,2, Wona Choi2, Eun Kyoung Baek2, Yun A Kim2, So Jung Y ang2, In Y oung Choi3, Kun-Ho Y oon1,2,  Jae-Hyoung Cho1,2 1Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul,  2Institute of Catholic Ubiquitous Health Care, The Catholic University of Korea, Seoul,  3Department of Medical Informatics, The Catholic University of Korea College of Medicine, Seoul, Korea Background:  We aimed to assess the efficacy of the smartphone-based health application for glucose control and patient satisfac - tion with the mobile network system used for glucose self-monitoring.",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
"In addition, it Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.3.204 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
205Glucose control by smartphone application Diabetes Metab J 2014;38:204-210 http://e-dmj.orgcan also be used for receiving diabetes-related educational  content.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
Diabetes Metab J 2014;38:204-210 http://e-dmj.orgcommunication.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
"207Glucose control by smartphone application Diabetes Metab J 2014;38:204-210 http://e-dmj.orgAnalysis of the questionnaire survey Of the 35 users, two patients expressed unchanged or increased  satisfaction and expectations when compared to the pre-use  survey.",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
Diabetes Metab J 2014;38:204-210 http://e-dmj.orgimportant tool for blood glucose monitoring.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
209Glucose control by smartphone application Diabetes Metab J 2014;38:204-210 http://e-dmj.orgtion with the medical team.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
Diabetes Metab J 2014;38:204-210 http://e-dmj.orgimprove skilled attendance at delivery in Zanzibar: a cluster- randomised controlled trial.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:211-219 The Effect of DPP-4 Inhibitors on Metabolic Parameters  in Patients with Type 2 Diabetes Eun Y eong Choe1,*, Y ongin Cho1,*, Y ounjeong Choi1, Yujung Yun1, Hye Jin Wang2, Obin Kwon1,3, Byung-Wan Lee1,  Chul Woo Ahn1,4, Bong Soo Cha1,2,4, Hyun Chul Lee1,4, Eun Seok Kang1,2,4 1Division of Endocrinology and Metabolism, Department of Internal Medicine, 2Brain Korea 21 Plus Project for Medical Science, 3Department of  Pharmacology, 4Institute of Endocrine Research, Y onsei University College of Medicine, Seoul, Korea Background:  We evaluated the effects of two dipeptidyl peptidase-4 (DPP-4) inhibitors, sitagliptin and vildagliptin, on metabol - ic parameters in patients with type 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
"Among these drugs, dipepti - dyl peptidase-4 (DPP-4) inhibitors have been proven effective Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.3.211 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
Diabetes Metab J 2014;38:211-219 http://e-dmj.orgfor glucose control without inducing hypoglycemia and are  widely used as the primary therapeutic option.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
213Effect of DPP-4 inhibitors Diabetes Metab J 2014;38:211-219 http://e-dmj.orgstrength of the relationships between the clinical and laborato - ry variables.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
Diabetes Metab J 2014;38:211-219 http://e-dmj.orggroup and 1.5±1.4 mg/L in the vildagliptin group at baseline.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
215Effect of DPP-4 inhibitors Diabetes Metab J 2014;38:211-219 http://e-dmj.orgtient clinics.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
Diabetes Metab J 2014;38:211-219 http://e-dmj.orgused as an index of glycemic control during intensive diabetes  treatment as a more rapid glycation index than HbA1c for glu - cose control and excursion [27-29].,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
217Effect of DPP-4 inhibitors Diabetes Metab J 2014;38:211-219 http://e-dmj.orgCONFLICTS OF INTEREST  No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
"Diabetes Metab J 2014;38:211-219 http://e-dmj.orgsini A, Paolisso G. Decreased carotid atherosclerotic process by  control of daily acute glucose fluctuations in diabetic patients  treated by DPP-IV inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
219Effect of DPP-4 inhibitors Diabetes Metab J 2014;38:211-219 http://e-dmj.orgSupplementary  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:220-229 Factors Associated with Health-Related Quality of Life  among Saudi Patients with Type 2 Diabetes Mellitus:   A Cross-Sectional Survey Ayman A. Al Hayek, Asirvatham A. Robert, Abdulghani Al Saeed, Aus A. Alzaid, Fahad S. Al Sabaan Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia Background:  Diabetes mellitus (DM) is associated with high mortality, morbidity, poor general health, and loss of health-related  quality of life (HRQOL).",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
"The chronic  consumption of high energy, high fat diets, and low levels of Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.3.220 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
221Diabetes and health-related quality of life Diabetes Metab J 2014;38:220-229 http://e-dmj.orgphysical activity lead to changes in energy balance with con - servation of energy stored as fat.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
Diabetes Metab J 2014;38:220-229 http://e-dmj.organd seven for depression (HADS-D).,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
223Diabetes and health-related quality of life Diabetes Metab J 2014;38:220-229 http://e-dmj.orgOne hundred and seventy-eight were males (62.9%) and 105  were females (37.1%).,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
Diabetes Metab J 2014;38:220-229 http://e-dmj.orgcomplication of DM ( P<0.05) compared to ≤5 years duration  of DM and DM patients without any complication respective - ly.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
"225Diabetes and health-related quality of life Diabetes Metab J 2014;38:220-229 http://e-dmj.orgfor longer duration (>15 years) had significantly higher risk of  subscale, physical functioning, role of physical health, role  emotional, general health, and health change.",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
Diabetes Metab J 2014;38:220-229 http://e-dmj.orgglycemic control is reported among more than half of Saudi  populations with T2DM [17].,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
"227Diabetes and health-related quality of life Diabetes Metab J 2014;38:220-229 http://e-dmj.orgmization of cardiovascular risk, avoidance of drugs that can  aggravate glucose or lipid metabolism, and screening for dia - betes complications are essential for the management of pa - tients with T2DM.",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
Diabetes Metab J 2014;38:220-229 http://e-dmj.orgREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
229Diabetes and health-related quality of life Diabetes Metab J 2014;38:220-229 http://e-dmj.orgQuality of life and associated characteristics in a large national  sample of adults with diabetes.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:230-239 Current Status of Prescription in Type 2 Diabetic  Patients from General Hospitals in Busan Ji Hye Suk1, Chang Won Lee2, Sung Pyo Son3, Min Cheol Kim4, Jun Hyeob Ahn5, Kwang Jae Lee6, Ja Y oung Park2,  Sun Hye Shin3, Min Jeong Kwon7, Sang Soo Kim8, Bo Hyun Kim8, Soon Hee Lee7, Jeong Hyun Park7, In Joo Kim8, for the  Relationship between Cardiovascular Disease and Brachial-Ankle Pulse Wave Velocity (baPWV) in Patients with Type 2  Diabetes (REBOUND) Study Group 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Woori Medical Clinic, Busan 2Division of Endocrinology and Metabolism, Department of Internal Medicine, Busan St. Mary’s Hospital, Busan, 3Division of Endocrinology and Metabolism, Department of Internal Medicine, Bong Seng Memorial Hospital, Busan, 4Division of Endocrinology and Metabolism, Department of Internal Medicine, Ilsin Christian Hospital, Busan, 5Division of Endocrinology and Metabolism, Department of Internal Medicine, Moonhwa Hospital, Busan, 6Division of Endocrinology and Metabolism, Department of Internal Medicine, Daedong Hospital, Busan, 7Division of Endocrinology and Metabolism, Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine,    Busan, 8Division of Endocrinology and Metabolism, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of   Medicine, Busan, Korea Background:  Data regarding the prescription status of individuals with diabetes are limited.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
Despite  taking into account the regional difference or the change of Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.3.230 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"231Prescription status in type 2 diabetic patients Diabetes Metab J 2014;38:230-239 http://e-dmj.orgstandard diagnostic criteria of diabetes, the prevalence in - creased by ~5-fold during the previous 30 years.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
Diabetes Metab J 2014;38:230-239 http://e-dmj.org‘missing value’ [7].,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
233Prescription status in type 2 diabetic patients Diabetes Metab J 2014;38:230-239 http://e-dmj.orgRESULTS Clinical and laboratory characteristics of the study  population  Table 1 shows the basal characteristic of the study population.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"Diabetes Metab J 2014;38:230-239 http://e-dmj.orgfrequently (43%), followed by Met+dipeptidyl peptidase 4 in - hibitors (DPP4I), Met+TZD, SU+AGI, and SU+TZD combi - nation, which comprised 24%, 14%, 6%, and 5%, respectively  (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"235Prescription status in type 2 diabetic patients Diabetes Metab J 2014;38:230-239 http://e-dmj.org Regarding antidyslipidemic therapy, most patients (88%)  were treated with single class, 12% with two classes, and 0.1%  with three classes.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"Diabetes Metab J 2014;38:230-239 http://e-dmj.orglowed by cilostazol, clopidogrel, sarpogrelate, beraprost, and  ticlopidine, which were used by 20%, 12%, 15%, 1.2%, and  0.1%, respectively (Table 8).",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
237Prescription status in type 2 diabetic patients Diabetes Metab J 2014;38:230-239 http://e-dmj.orgnation.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
Diabetes Metab J 2014;38:230-239 http://e-dmj.orgalso believe that an organized and standardized national re - search is required.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
Available from: http://www-project.org  (cited 2007 Dec 5).,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
239Prescription status in type 2 diabetic patients Diabetes Metab J 2014;38:230-239 http://e-dmj.orgtes Registry Group; Royal College of Physicians Edinburgh.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/53/dmj-38-240.PMC4083031.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:240-241 Association of Vaspin with Metabolic Syndrome:   The Pivotal Role of Insulin Resistance   (Diabetes Metab J 2014;38:143-9) Sung Hee Choi Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College  of Medicine, Seongnam, Korea Corresponding author: Sung Hee Choi Division of Endocrinology and Metabolism, Department of Internal  Medicine, Seoul National University Bundang Hospital, Seoul National  University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 463-707, KoreaDear Editor,  Vaspin is an interesting adipokine, which was isolated from  visceral white adipose tissue of obese, diabetic rat model [1,2].",Non-OADS,/arxiv_data1/oa_pdf/08/53/dmj-38-240.PMC4083031.pdf
"Of note, despite these differences between two Letter http://dx.doi.org/10.4093/dmj.2014.38.3.240 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/08/53/dmj-38-240.PMC4083031.pdf
"241Vaspin and metabolic syndrome Diabetes Metab J 2014;38:240-241 http://e-dmj.orgethnical groups, hyper-TG and obesity index was a common  metabolic factors, which showed significant correlation with  vaspin levels in both groups.",OADS,/arxiv_data1/oa_pdf/08/53/dmj-38-240.PMC4083031.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/8e/dmj-38-242.PMC4083032.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:242-243 Association of Vaspin with Metabolic Syndrome:   The Pivotal Role of Insulin Resistance   (Diabetes Metab J 2014;38:143-9) Alireza Esteghamati, Sina Noshad, Mostafa Mousavizadeh, Ali Zandieh, Manouchehr Nakhjavani Endocrinology and Metabolism Research Center, Vali-Asr Hospital, Tehran University of Medical Sciences School of Medicine, Tehran, Iran Corresponding author: Alireza Esteghamati Endocrinology and Metabolism Research Center, Vali-Asr Hospital, Tehran  University of Medical Sciences School of Medicine, P .O.",Non-OADS,/arxiv_data1/oa_pdf/f1/8e/dmj-38-242.PMC4083032.pdf
Response http://dx.doi.org/10.4093/dmj.2014.38.3.242 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/dmj-38-242.PMC4083032.pdf
243Vaspin and metabolic syndrome Diabetes Metab J 2014;38:242-243 http://e-dmj.orgCONFLICTS OF INTEREST No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/dmj-38-242.PMC4083032.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/02/dmj-38-244.PMC4083033.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:244Erratum http://dx.doi.org/10.4093/dmj.2014.38.3.244 pISSN 2233-6079 · eISSN 2233-6087 Erratum: Corrected Sentence  The Appropriateness of the Length of Insulin  Needles Based on Determination of Skin and  Subcutaneous Fat Thickness in the Abdomen and  Upper Arm in Patients with Type 2 Diabetes Kang Hee Sim1, Moon Sook Hwang2, Sun Y oung Kim1, Hye Mi Lee1, Ji Y eun Chang3, Moon Kyu Lee4 1Department of Nursing, Samsung Medical Center, Seoul, 2Department of Nursing Science, Woo Suk University, Wanju, 3Department of Internal Medicine, Seoul St. Mary’s Hospital, Seoul, 4Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine,     Seoul, Korea Diabetes Metab J 2014;38:120-133. http://dx.doi.org/10.4093/dmj.2014.38.2.120 An error was found in the following published article: Sim KH, Hwang MS, Kim SY , Lee HM, Chang JY , Lee MK,  ‘The Appropriateness of the Length of Insulin Needles Based on Determination of Skin and Subcutaneous Fat Thick - ness in the Abdomen and Upper Arm in Patients with Type 2 Diabetes.",Non-OADS,/arxiv_data1/oa_pdf/32/02/dmj-38-244.PMC4083033.pdf
"113 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHEditorial Dendritic cells (DCs) are professional antigen presenting cells, which play a pivotal  role in antigen-specific (Ag-specific) T cell immunity.",Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
"As of 2014, 289 clinical studies of DC-based cancer vaccines are registered and un - der investigation (2014, http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:113-116 http://dx.doi.org/10.7774/cevr.2014.3.2.113 pISSN 2287-3651 • eISSN 2287-366X  Md.",Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
Selim Ahmed et al • Dendritic cell-based tumor vaccine 114 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.113of 7.1% [4].,Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
Selim Ahmed et al • Dendritic cell-based tumor vaccine 115 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.113systemic antitumor immune responses in tumor bearing mice.,Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
Selim Ahmed http://orcid.org/0000-0002-9601-8031  Yong-Soo Bae http://orcid.org/0000-0002-2233-9449 References 1.,Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
Selim Ahmed et al • Dendritic cell-based tumor vaccine 116 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.113cells in patients with metastatic renal cell carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
"117 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHSpecial article Introduction Avian influenza is an acute infectious disease that occurs and spreads very fast in poul - try, waterfowls, wild birds, animals, and able to zoonotically be transmitted to humans.",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Avian influenza is listed as one of the most dangerous diseases by World Organisation  for Animal Health (OIE; http://www.oie.int/eng/normes/mmanual/A_summry.htm)  that a special attention is needed for control.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:117-127 http://dx.doi.org/10.7774/cevr.2014.3.2.117 pISSN 2287-3651 • eISSN 2287-366X  Thanh Hoa Le, Nga Thi Bich Nguyen Department of Immunology, Institute of  Biotechnology, Vietnam Academy of Science and  Technology, Hanoi, Vietnam Received: April 18, 2014 Revised: May 2, 2014 Accepted: May 11, 2014 Corresponding author: Thanh Hoa Le, DVM, PhD  Department of Immunology, Institute of Biotech - nology, Vietnam Academy of Science and Technol - ogy, 18 Hoang Quoc Viet Rd., Cau Giay, Hanoi,  Vietnam Tel: +84-4-37567297, Fax: +84-4-38363144 E-mail: imibtvn@gmail.com No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
"Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 118 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117genomes contain a single-stranded negative RNA ([-]ssRNA)  of 8 segments (polymerase basic 2 [PB2], polymerase basic 1  [PB1], polymerase acid [PA], HA, nucleoprotein [NP], NA,  matrix [M], non-structural polypeptides [NS]) [1,2], encoding  for 15 proteins in overall, including PB2, PB1, PA, HA, NP , NA,  M1, M2, NS1, NS2, and supplementary proteins recently iden - tified with little or unknown functions [3], i.e., PB1-F2 [4], PB1- N40 [5], PA-X [6], PA-N155 and PA-N182 [7].",OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
" Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 119 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117tral source, have since then spread over the world causing  numerous epidemics [3,14,31].",OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
"Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 120 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117fication, even within clade 2.3.2.1, there have been novel en - demic, dynamically differentiated variants of a, b, c subgroups,  during 2010-2014 in Vietnam.",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
" Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 121 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117vaccines (clade 2.3.4 origin) imported from China were in use  and a national project of testing NIBRG-14 masterseed (rgA/ Vietnam/1194/2004, clade 1, obtained from National Insti - tute for Biological Standards and Control [NIBSC, UK]), was  launched for vaccine production [61,62].",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
"Due to decline in protection and wide  spread of clade 2.3.2.1c, Re-6 vaccine is planned to import for  use in 2014 [49]; according to the Vietnam authority, Depart - ment of Animal Health, 2014 (http://www.cucthuy.gov.vn/).",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
"Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 122 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117ported in China, South Korea, Japan, Mongolia, Nepal, Laos,  Russia, Bangladesh and Indonesia [3,58,69,70]; and similar to  those of clade 2.3.2 origin, but different from clade 2.3.4 and  clade 1 (and 1.1) (Table 1) [3,42,43].",OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
 Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 123 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117in some provinces of the North of Vietnam.,OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 124 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117ed poulty in the field.,OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
 Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 125 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117ORCID Thanh Hoa Le http://orcid.org/0000-0003-3841-368X References  1.,OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Avail - able from: http://www.cdc.gov/ﬂu/about/viruses/types.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 126 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.11727.,OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Available from: http://www.who.int/in - fluenza/vaccines/virus/201402_h5h7h9h10_vaccineviru - supdate.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Available from:  http://www.rr-asia.oie.int/fileadmin/Regional_Re presen- tation/Programme/H_HPAI/JTF/2012_5th_ExpMeeting/  2-1_Dr_Inui.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
 Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 127 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.11752.,OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
128 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction The direct efficacy and effectiveness of the inactivated influenza vaccination among  healthy is relatively well-known.,Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:128-132 http://dx.doi.org/10.7774/cevr.2014.3.2.128 pISSN 2287-3651 • eISSN 2287-366X  Tae Hyong Kim Division of Infectious Diseases, Department of  Internal Medicine, Soonchunhyang University  College of Medicine, Seoul, Korea Received: December 5, 2013 Revised: January 28, 2014 Accepted: February 5, 2014 Corresponding author: Tae Hyong Kim, MD, PhD Department of Internal Medicine Soonchunhyang  University Hospital, Soonchunhyang University  College of Medicine, 59 Daesagwan-ro, Yongsan- gu, Seoul 140-743, Korea Tel: +82-2-709-9194, Fax: +82-2-709-9083 E-mail: geuncom@schmc.ac.kr  No potential conflict of interest relevant to this  article was reported.The seasonal influenza vaccine programs in many regions aimed to protect most vulnerable  population, but current trivalent influenza vaccine does not provide sufficient effectiveness  among people under high risk for severe outcome of the influenza.",Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
" Tae Hyong Kim • Influenza and vaccine herd effect 129 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.128Failure to Protect Elderly and Chronically Ill  Persons Since the introduction of influenza vaccination after the World  War II, immunization against seasonal influenza was focused  on reducing mortality and morbidity of elderly, chronically ill  persons, pregnant women and young children [5].",Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
Tae Hyong Kim • Influenza and vaccine herd effect 130 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.128nated contacts of vaccine and control cohorts (Table 1).,OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
 Tae Hyong Kim • Influenza and vaccine herd effect 131 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.1282008 [34].,Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
ORCID  Tae Hyong Kim http://orcid.org/0000-0003-2920-9038 References   1.,Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
Available from: http://www.who.int/media - centre/factsheets/fs211/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
Tae Hyong Kim • Influenza and vaccine herd effect 132 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.128Socioeconomic impact of influenza on healthy children  and their families.,Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
"133 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Influenza A viruses (IAVs) are highly contagious viral pathogens that have been isolat - ed from a wide variety of animals such as birds, humans, pigs, horses, dogs, cats, and  marine mammals [1].",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:133-139 http://dx.doi.org/10.7774/cevr.2014.3.2.133 pISSN 2287-3651 • eISSN 2287-366X  Dong-Hun Lee, Jae-Keun Park,  Chang-Seon Song Avian Disease Laboratory, College of Veterinary  Medicine, Konkuk University, Seoul, Korea Received: February 6, 2014 Revised: March 4, 2014 Accepted: March 4, 2014 Corresponding author: Chang-Seon Song, PhD Avian Disease Laboratory, College of Veterinary  Medicine, Konkuk University, 120 Neungdong-ro,  Gwangjin-gu, Seoul 143-701, Korea Tel: +82-2-450-3712, Fax: +82-2-455-3712  E-mail: songcs@konkuk.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
"Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 134 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.133Influenza Virus in Animals The IAV genome consists of 8 segments of single-stranded  RNA, each of which encodes a different polypeptide includ - ing 2 surface glycoproteins (hemagglutinin [HA] and neur - aminidase [NA]), nucleoprotein (NP), 3 polymerase proteins  (polymerase basic 2, polymerase basic 1 and polymerase  acidic), 2 matrix proteins (M1 and M2), and 2 nonstructural  proteins (NS1 and NS2) [9].",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
 Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 135 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.133Table 1.,Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
"Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 136 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.133chickens, as a vaccine that can be produced without a purifi - cation process costs less than the highly purified VLP vaccines  reported in other studies.",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
" Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 137 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.133for the production of influenza VLPs for veterinary use, as in - sect cells can readily co-express multiple proteins and assem - ble them into structurally complex VLPs.",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
ORCID  Dong-Hun Lee http://orcid.org/0000-0002-0820-7378 Jae-Keun Park http://orcid.org/0000-0002-3367-1770 Chang-Seon Song http://orcid.org/0000-0002-4158-6402 References 1.,Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 138 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.13311.,Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
" Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 139 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.133ple baculovirus recombinant coexpressing H5, N3, M1  proteins against a homologous H5N3 low-pathogenicity  avian influenza virus challenge in Muscovy ducks.",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
"140 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Influenza A (flu A) viruses belong to the Orthomyxoviridae  family of RNA viruses and  are the causative agent of influenza, a contagious respiratory viral disease of birds and  humans [1].",Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:140-148 http://dx.doi.org/10.7774/cevr.2014.3.2.140 pISSN 2287-3651 • eISSN 2287-366X  Philippe Noriel Q. Pascua,   Young Ki Choi Department of Microbiology, College of Medicine  and Medical Research Institute, Chungbuk  National University, Cheongju, Korea Received: February 8, 2014 Revised: March 28, 2014 Accepted: April 2, 2014 Corresponding author: Young Ki Choi, DVM, PhD  Department of Microbiology, College of Medicine  and Medical Research Institute, Chungbuk   National University, 776 Naesudong-ro,  Heungdeok-gu, Cheongju 361-711, Korea Tel: +82-43-261-3384, Fax: +82-43-272-1603 E-mail: choiki55@chungbuk.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
" Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 141 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140Generally, flu A viruses are found in migratory waterfowls,  the principal natural reservoirs [5].",Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Sporadic cases of AIV A/H9N2 zoonoses followed  ever since with at least 16 human total infections as shown in  the influenza virus sequence database (http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 142 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140Table 1.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
 Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 143 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140ing one fatality.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
"Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 144 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140developing high fever, cough and shortness of breath, but ful - ly recovered upon early medication.",Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
" Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 145 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140(e.g., H6, H9, and H10).",Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
ORCID Philippe Noriel Q. Pascua http://orcid.org/0000-0001-6777-2994 Young Ki Choi http://orcid.org/0000-0002-1894-9896 References 1.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 146 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140generation in pigs of influenza A viruses with pandemic  potential.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Available from: http://www.cidrap.umn.edu/news- perspective/2014/01/fatal-h5n1-case-canada-north-amer - icas-first.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
 Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 147 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140of serum samples from humans exposed to avian H7 in - fluenza viruses in Italy between 1999 and 2003.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Available from: http://www1.paho.org/English/AD/ DPC/CD/eid-eer-07-may-2004.htm.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Available from: http://www.jx - wst.gov.cn/gzdt/201402/t20140213_308109.htm.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 148 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140and pathology of human-isolated H7N9 influenza virus in  ferrets and pigs.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Available from:  http://apps.who.int/gb/pip/pdf_files/pandemic-influen - za-preparedness-en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
"149 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Vaccination is one of the great medical success stories, utilizing immune system.",Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:149-154 http://dx.doi.org/10.7774/cevr.2014.3.2.149 pISSN 2287-3651 • eISSN 2287-366X  Chae Gyu Park Laboratory of Immunology, Severance Biomedical  Science Institute, Brain 21 PLUS project for  Medical Science, Yonsei University College of  Medicine, Seoul, Korea Received: February 8, 2014 Revised: March 26, 2014 Accepted: March 30, 2014 Corresponding author: Chae Gyu Park, PhD Laboratory of Immunology, Severance Biomedi - cal Science Institute, Brain 21 PLUS project for  Medical Science, Yonsei University College of  Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul  120-752, Korea Tel: +82-2-2228-0795, Fax: +82-2-2227-8129  E-mail: ChaeGyu@yuhs.ac  No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
Chae Gyu Park • Dendritic cell targeted vaccine 150 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.149Dendritic Cells DCs are specialized populations of leukocytes essential for  controlling the immune system to tolerate or react properly  against a vast number of different challenges it encounters.,Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
 Chae Gyu Park • Dendritic cell targeted vaccine 151 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.149in vivo  actively establish T cell tolerance by presenting anti - gens from self and environment during the steady state.,Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
Chae Gyu Park • Dendritic cell targeted vaccine 152 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.149Fig.,Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
" Chae Gyu Park • Dendritic cell targeted vaccine 153 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.149heavily on antibody response, the vaccine protein targeted to  DCIR2, compared to CD205, on DCs in vivo  induced higher  antibody titers and thus achieved better protection [20].",Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
ORCID  Chae Gyu Park http://orcid.org/0000-0003-1906-1308 References 1.,Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
Chae Gyu Park • Dendritic cell targeted vaccine 154 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.149senzweig MC.,Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
155 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Tuberculosis (TB) remains a worldwide public health problem.,Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:155-167 http://dx.doi.org/10.7774/cevr.2014.3.2.155 pISSN 2287-3651 • eISSN 2287-366X  Jae-Min Yuk, Eun-Kyeong Jo Department of Microbiology and Infection  Signaling Network Research Center, Chungnam  National University School of Medicine, Daejeon,  Korea  Received: March 3, 2014 Revised: April 1, 2014 Accepted: April 7, 2014 Corresponding author: Eun-Kyeong Jo, MD, PhD  Department of Microbiology and Infection   Signaling Network Research Center, Chungnam  National University College of Medicine, 266  Munhwa-ro, Jung-gu, Daejeon 301-747, Korea Tel: +82-42-580-8243, Fax: +82-42-585-3686 E-mail: hayoungj@cnu.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
Jae-Min Yuk et al • Host immune responses and TB vaccine development 156 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155tracellular trafficking is a fundamental obstacle in the design  and development of a novel vaccine [9].,Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
" Jae-Min Yuk et al • Host immune responses and TB vaccine development 157 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155actions during TB infection [35,36].",OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
Jae-Min Yuk et al • Host immune responses and TB vaccine development 158 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155pathway in improving the effects of a mucosal vaccine against  TB [59].,Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
" Jae-Min Yuk et al • Host immune responses and TB vaccine development 159 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155Antigen 85 complex  The antigen 85 (Ag85) complex comprises the mature secre - tory proteins of Mtb and BCG, and is encoded by three sepa - rate genes on the mycobacterial genome; it consists of three  related antigens, Ag85A (32 kDa), Ag85B (30 kDa), and Ag85C  (32.5 kDa) [83,84].",OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
"Jae-Min Yuk et al • Host immune responses and TB vaccine development 160 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155fusion-protein incorporating ESAT-6, Ag85B, combined with  Rv2660c, conferred protective immunity, promoted CD4+ T  cell responses, and controlled reactivation when administered  post-exposure in mouse models of latent TB [115].",OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
" Jae-Min Yuk et al • Host immune responses and TB vaccine development 161 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155oxal detoxification pathway, induced DC maturation and en - hanced cytokine generation and polarization of Th1 respons - es [125].",OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
"Jae-Min Yuk et al • Host immune responses and TB vaccine development 162 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155improve vaccine efficacy based on the safety, tolerance, and  immunogenicity.",Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
ORCID  Jae-Min Yuk http://orcid.org/0000-0002-0630-9194  Eun-Kyeong Jo http://orcid.org/0000-0002-9623-9037  References      1.,Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
 Jae-Min Yuk et al • Host immune responses and TB vaccine development 163 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155  27.,OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
Jae-Min Yuk et al • Host immune responses and TB vaccine development 164 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155diated and humoral immune responses.,OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
 Jae-Min Yuk et al • Host immune responses and TB vaccine development 165 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155  78.,OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
Jae-Min Yuk et al • Host immune responses and TB vaccine development 166 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.15552.,OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
 Jae-Min Yuk et al • Host immune responses and TB vaccine development 167 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155sible molecular marker of active pulmonary tuberculo - sis.,OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
"168 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Cervical cancer is the second most prevalent cancer among women, accounting for  500,000 cases per year [1].",Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:168-175 http://dx.doi.org/10.7774/cevr.2014.3.2.168 pISSN 2287-3651 • eISSN 2287-366X  Kwang Sung Kim, Shin Ae Park,  Kyung-Nam Ko, Seokjae Yi,   Yang Je Cho Eyegene Inc., Seoul, Korea Received: April 15, 2014 Revised: May 16, 2014 Accepted: May 20, 2014 Corresponding author: Yang Je Cho, PhD Eyegene Inc., B-910, 401 Yangcheon-ro,   Gangseo-gu, Seoul 157-801, Korea Tel: +82-2-322-1687, Fax: +82-2-324-8059 E-mail: white@eyegene.co.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
" Kwang Sung Kim et al • Human papillomavirus vaccines  169 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.168rivalent HPV (qHPV) vaccine, produced by Merck & Co. Inc.  (Gardasil®, Merck, Rahway, NJ, USA); and bivalent HPV vac - cine, produced by GlaxoSmithKline plc.",Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Kwang Sung Kim et al • Human papillomavirus vaccines  170 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.168and 3) clarification by tangential flow filtration.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
 Kwang Sung Kim et al • Human papillomavirus vaccines  171 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.168APCs [40].,OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
"Kwang Sung Kim et al • Human papillomavirus vaccines  172 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.168frequently occurring AEFIs were fever (115 cases, 18%), local  reaction (105 cases, 16%), exanthema/erythema (47 cases,  7%), menstruation problems (44 cases, 7%), headache (44  cases, 7%), and malaise (38 cases, 6%).",Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
ORCID Kwang Sung Kim  http://orcid.org/0000-0001-9765-3443 Shin Ae Park  http://orcid.org/0000-0001-8195-142X Kyung-Nam Ko  http://orcid.org/0000-0002-0391-7936 Yang Je Cho  http://orcid.org/0000-0002-6914-9343 References 1.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
 Kwang Sung Kim et al • Human papillomavirus vaccines  173 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.168particles.,OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from:  http://patentscope.wipo.int/search/en/WO2012177970.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.fda.gov/ohrms/ dockets/ac/06/briefing/2006-4222B3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.merck.ca/as - sets/en/pdf/products/GARDASIL-PM_E.pdf.,OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.merck.com/investors/finan - cials/annual-reports/home.html.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://patentscope.wipo.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Kwang Sung Kim et al • Human papillomavirus vaccines  174 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.16833.,OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from:  http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/BloodVaccinesandOther - Biologics/VaccinesandRelatedBiologicalProductsAdviso - ryCommittee/UCM181371.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.fda.gov/downloads/ biologicsbloodvaccines/vaccines/approvedproducts/ ucm237976.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.gsk.com/content/  dam/gsk/globals/documents/pdf/GSK-form-20-F-2012.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.fda.gov/BiologicsBloodVac - cines/SafetyAvailability/VaccineSafety/ucm179549.htm.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.path.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
 Kwang Sung Kim et al • Human papillomavirus vaccines  175 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.16856.,OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
"176 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Rabies is one of the most important zoonoses and caused by rabies virus (RABV), which  is mainly transmitted by rabid animal bites, and migrates to the central nerve system  and causes fatal encephalitis.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:176-184 http://dx.doi.org/10.7774/cevr.2014.3.2.176 pISSN 2287-3651 • eISSN 2287-366X  Dong-Kun Yang1*,   Keisuke Nakagawa2*, Naoto Ito2,  Ha-Hyun Kim1, Bang-Hun Hyun1,  Jin-Ju Nah1, Makoto Sugiyama2,  Jae-Young Song1 1Viral Disease Division, Animal and Plant  Quarantine Agency, MAFRA, Anyang, Korea;   2The United Graduated School of Veterinary  Science, Gifu University, Gifu, Japan * These two authors contributed equally to this  work.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
" Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 177 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176to dramatic decrease of rabies in countries such as Thailand,  India and Korea where numerous of dogs are immunized  yearly with rabies vaccines.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 178 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.17624-well tissue culture plate (Fig.,Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
" Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 179 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176the microplates were reacted with specific monoclonal anti - body against rabies for 45 minutes at 37°C, and then stained  with FITC conjugated goat-anti mouse IgG+IgM.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 180 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176Fig.,OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
 Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 181 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176Fig.,OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 182 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176Fig.,OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
 Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 183 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176ulence in animals [4].,Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
ORCID Dong-Kun Yang http://orcid.org/0000-0001-5765-3043   Keisuke Nakagawa http://orcid.org/0000-0002-6342-4738 Naoto Ito http://orcid.org/0000-0003-0296-966X Ha-Hyun Kim http://orcid.org/0000-000106473-0035 Bang-Hun Hyun http://orcid.org/0000-0002-3429-3425 Jin-Ju Nah http://orcid.org/0000-0002-5021-0941 Makoto Sugiyama http://orcid.org/0000-0002-4300-893X Jae-Young Song http://orcid.org/0000-0002-9554-9252 References 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 184 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.1769.,OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
185 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Urinary tract infections (UTIs) are the second most common infectious disease [1].,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:185-193 http://dx.doi.org/10.7774/cevr.2014.3.2.185 pISSN 2287-3651 • eISSN 2287-366X  Abbas Ali Imani Fooladi1,   Ghasem Bagherpour1,   Nima Khoramabadi2,   Jalil Fallah Mehrabadi3,   Mehdi Mahdavi4, Raheleh Halabian1,   Mohsen Amin5, Jalal Izadi Mobarakeh6,  Behzad Einollahi7 1Applied Microbiology Research Center,  Baqiyatallah University of Medical Sciences,  Tehran; 2Bacteriology Faculty of Medical Sciences,  Tarbiat Modares University, Tehran; 3Department  of Genetic Engineering, Faculty of Biosciences  and Biotechnology, Malekashtar University of  Technology, Tehran; 4Department of Virology,  Pasteur Institute of Iran, Tehran; 5Department  of Drug and Food Control, Tehran University  of Medical Sciences, Tehran; 6Department of  Physiology and Pharmacology, Pasteur Institute of  Iran, Tehran; 7Nephrology and Urology Research  Center, Baqiyatallah University of Medical  Sciences, Tehran, Iran  Received: December 12, 2013 Revised: February 4, 2014 Accepted: February 15, 2014 Corresponding author: Abbas Ali Imani Fooladi, PhD Applied Microbiology Research Center, Baqiyatallah  University of Medical Sciences, Molla-Sadra Street,  Tehran, P .O.",Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 186 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185duce apoptosis) [4].,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
 Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 187 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185Iran) and maintained in the animal facility under standard  conditions.,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
All animal experimentations were performed ac - cording to the guidelines of the National Institutes of Health  (http://oacu.od.nih.gov/training/index.htm).,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
"Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 188 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185Histopathology Bladders of mice from the same groups were removed at the  same time, fixed with 1% formalin, and evaluated histopatho - logically.",Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
" Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 189 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.1854,500 4,000 3,500 3,000 2,500 2,000 15,00 1,000 500 0 pV-FimH(mam)+BoostpV-FimH(wt)+BoostProtein pV(control)PBS Mice groupsIFN-γ (pg/mL)*** **** A CMice groups90 80 70 60 50 40 30 20 10 0 pV-FimH(mam)+BoostpV-FimH(wt)+BoostProtein pV(control)PBSIL -12 (pg/mL)***** B D100 90 80 70 60 50 40 30 20 10 0 pV-FimH(mam)+BoostpV-FimH(wt)+BoostProtein pV(control)PBS Mice groupsIL -4 (pg/mL)100 90 80 70 60 50 40 30 20 10 0 pV-FimH(mam)+BoostpV-FimH(wt)+BoostProtein pV(control)PBS Mice groupsIL -17 (pg/mL)*** *** Fig.",Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 190 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185Fig.,OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
 Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 191 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185optimization.,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 192 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185richia coli triggers oxygen-dependent apoptosis in human  neutrophils through the cooperative effect of type 1 fim - briae and lipopolysaccharide.,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
 Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 193 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185expression of human genes in Escherichia coli: A multi- gene study.,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
194 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Influenza viruses have been the cause of morbidity and mortality in both animals and  humans [1-3].,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:194-201 http://dx.doi.org/10.7774/cevr.2014.3.2.194 pISSN 2287-3651 • eISSN 2287-366X  Byeong-Jae Lee1, Hyeok-il Kwon1,  Eun-Ha Kim1, Su-Jin Park1,   Sang-Ho Lee2,Young Ki Choi1,   Sang-Hyun Kim2 1College of Medicine and Medical Research  Institute, Chungbuk National University, Cheongju;  2Viral Infectious Disease Research Center,  Korea Research Institute of Bioscience and  Biotechnology (KRIBB), Daejeon, Korea Received: February 8, 2014 Revised: April 2, 2014 Accepted: April 10, 2014 Corresponding author: Sang-Hyun Kim, DVM, PhD Viral Infectious Disease Research Center, Korea  Research Institute of Bioscience and Biotechnolo - gy (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon  305-806, Korea  Tel: +82-42-879-8270, Fax: +82-42-879-8498 E-mail: skim@kribb.re.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
 Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 195 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194vants that allows cheaper and more effective vaccine produc - tion.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 196 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194and stored at -80°C until use.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
 Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 197 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.19480 60 40 20 0 A/California/04/09 (1st) A/California/04/09 (2nd)HI titerH1N1+mOMV+Alum (0.05) H1N1+mOMV+Alum (0.1) H1N1+mOMV+Alum (0.5) E80 60 40 20 0 A/California/04/09 (1st) A/California/04/09 (2nd)HI titerH1N1 only (0.05) H1N1 only (0.1) H1N1 only (0.5)80 60 40 20 0 A/California/04/09 (1st) A/California/04/09 (2nd)HI titermOMV only H1N1+mOMV (0.05) H1N1+mOMV (0.1) H1N1+mOMV (0.5) A B 80 60 40 20 0 A/California/04/09 (1st) A/California/04/09 (2nd)HI titerAlum only H1N1+Alum (0.05) H1N1+Alum (0.1) H1N1+Alum (0.5)80 60 40 20 0 A/California/04/09 (1st) A/California/04/09 (2nd)HI titerMF59 only H1N1+MF59 (0.05) H1N1+MF59 (0.1) H1N1+MF59 (0.5) C D Fig.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 198 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194110 100 90 80 70 60 50  0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days post-infectionBody weight change (%)H1N1 only (0.1) H1N1 only (0.5) H1N1 only (0.05)A/California/04/09 (maCA04) only 110 100 90 80 70 60 50  0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days post-infectionBody weight change (%)H1N1+mOMV (0.5) H1N1+mOMV (0.1) H1N1+mOMV (0.05) mOMV onlyA/California/04/09 (maCA04)+mOMV 110 100 90 80 70 60 50  0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days post-infectionBody weight change (%)H1N1+Alum (0.1) H1N1+Alum (0.5) H1N1+Alum (0.05) Alum onlyA/California/04/09 (maCA04)+Alum 110 100 90 80 70 60 50  0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days post-infectionBody weight change (%)H1N1+MF59 (0.5) H1N1+MF59 (0.1) H1N1+MF59 (0.05) MF59 onlyA/California/04/09 (maCA04)+MF59 110 100 90 80 70 60 50  0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days post-infectionBody weight change (%)H1N1+mOMV+Alum (0.5) H1N1+mOMV+Alum (0.1) H1N1+mOMV+Alum (0.05)A/California/04/09 (maCA04)+mOMV+Alum Fig.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
 Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 199 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194the antigen only or the adjuvant only groups.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 200 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194Table 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
ORCID Byeong-Jae Lee https://orcid.org/0000-0002-7492-7867 Hyeok-il Kwon http://orcid.org/0000-0003-2477-4492 Eun-Ha Kim http://orcid.org/0000-0003-1443-3416 Su-Jin Park http://orcid.org/0000-0002-8915-4799 Sang-Ho Lee http://orcid.org/0000-0002-0052-7932 Young Ki Choi http://orcid.org/0000-0002-1894-9869 Sang-Hyun Kim http://orcid.org/0000-0003-0432-0573 References 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
 Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 201 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194940-5.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
202 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Human and animal mortality from rabies remains a major burden in many countries  around the world.,Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:202-211 http://dx.doi.org/10.7774/cevr.2014.3.2.202 pISSN 2287-3651 • eISSN 2287-366X  Padinjaremattathil Thankappan  Ullas*, Anita Desai, Shampur  Narayan Madhusudana Department of Neurovirology, National Institute  of Mental Health and Neurosciences, Bangalore,  Karnataka, India Received: March 25, 2014 Revised: April 29, 2014 Accepted: May 1, 2014 Corresponding author:   Shampur Narayan Madhusudana, MD Department of Neurovirology, National Institute  of Mental Health and Neurosciences, Bangalore,  Karnataka 560029, India Tel: +91-80-26995129, Fax: +91-80-26564830 E-mail: mshampur@gmail.com *Present address: School of Chemical and Bio - technology, SASTRA University, Thanjavur, Tamil  Nadu, India No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
" Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 203 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202of susceptible canine population could prevent rabies trans - mission among canines [3], but this faces technical and logis - tic challenges [4].",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
"Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 204 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202tions were made using a commercial kit (EndoFree Plasmid  Purification Giga Kit, Qiagen, Hilden, Germany).",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
 Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 205 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202[8].,Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
"Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 206 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202(Rabipur), sterile normal saline, or the empty pIRES vector.",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
" Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 207 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202restriction sites Xba I and SalI, yielding the construct pIRES- Rgp-Myd.",OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
"Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 208 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202ed for immunization experiments, we used a commercial  large-scale, endotoxin-free plasmid purification kit, as per  manufacturer instructions.",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
" Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 209 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202Discussion Despite successful demonstrations of efficacy of plasmid DNA- based vaccination strategy for rabies in a number of animal  models, the technology is still constrained by poor immuno - genicity observed in larger animals and the delay in onset of  antibody responses.",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
"Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 210 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202might represent efficacious vaccine candidates for generation  of long-lasting protective immunity against rabies and other  infectious diseases, especially for immunization of animals,  and needs to be evaluated further in field conditions.",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
 Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 211 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202TRANCE as genetic adjuvants for a DNA vaccine to rabies  virus.,Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
212 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Global warming can increase the activity of mosquito carrying out infectious virus to  animals and human.,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:212-219 http://dx.doi.org/10.7774/cevr.2014.3.2.212 pISSN 2287-3651 • eISSN 2287-366X  Dong-Kun Yang, Jin-Ju Nah,   Ha-Hyun Kim, Jae-Young Song  Viral Disease Division, Animal and Plant  Quarantine Agency, Ministry of Agriculture, Food  and Rural Affairs (MAFRA), Anyang, Korea Received: April 4, 2014 Revised: April 14, 2014 Accepted: April 20, 2014 Corresponding author: Dong-Kun Yang, PhD, DVM Viral Disease Division, Animal and Plant   Quarantine Agency, MAFRA, 175 Anyang-ro,  Anyang 430-757, Korea Tel: +82-31-467-1783, Fax: +82-31-467-1797 E-mail:yangdk@korea.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
 Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 213 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212disease showing abortion and weak piglets and caused occa - sional fatal outcome in horses [3].,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 214 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212was adjusted to 8.0 with 1 N NaOH.,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
 Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 215 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.21256°C for 30 minutes.,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 216 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212Fig.,OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
 Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 217 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212Fig.,OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 218 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212 Humoral immune response is responsible for protecting  animals from the JEV challenge [25].,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
ORCID Dong-Kun Yang http://orcid.org/0000­0001­5765­3043 Jin-Ju Nah http://orcid.org/0000­0002­5021­0941 Ha-Hyun Kim http://orcid.org/0000­000106473­0035 Jae-Young Song http://orcid.org/0000­0002­9554­9252 References 1.,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
 Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 219 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212encephalitis virus vaccine.,OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
"220 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Although rabies is a reportable disease, the true incidence of the disease is greatly un - derestimated due to a lack of systematic surveillance and reporting by most develop - ing countries [1].",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:220-226 http://dx.doi.org/10.7774/cevr.2014.3.2.220 pISSN 2287-3651 • eISSN 2287-366X  Sami Darkaoui1, Franck Boué2,   Jean Michel Demerson2,   Ouafaa Fassi Fihri3,   Khadija Id Sidi Yahia1,   Florence Cliquet2 1Moroccan Office for Food Safety (ONSSA), Division  of Pharmacy and Veterinary Inputs, Rue Ikhlass,  Cité Yacoub El Mansour, Rabat, Morocco; 2French  Agency for Food, Environmental and Occupational  Health and Safety (ANSES), Nancy Laboratory for  Rabies and Wildlife, WHO Collaborating Centre for  Research and Management in Zoonoses Control,  OIE Reference Laboratory for Rabies, European  Union Reference Laboratory for Rabies, European  Union Reference Laboratory for Rabies Serology,  Technopôle agricole et vétérinaire, Malzéville Cedex,  France; 3Agronomic and Veterinary Institute Hassan  II, Unit of Microbiology, Immunology and Contagious  Diseases, Department of Pathology and Veterinary  Public Health, Rabat-Instituts, Rabat, Morocco Received: April 8, 2014 Revised: May 5, 2014 Accepted: May 11, 2014 Corresponding author: Sami Darkaoui, DVM Department of Veterinary Medicine, Moroccan Office  for Food Safety (ONSSA), Division de la Pharmacie et  des Intrants Vétérinaires, Rue Ikhlass, Cité Yacoub El  Mansour, BP 4509, Akkari, Rabat, Morocco Tel: +212-537690477, Fax: +212-537690133 E-mail: darkaouisami@gmail.com No potential conflict of interest relevant to this article  was reported.",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
 Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 221 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220mains a serious health problem in Morocco and about 22 hu - man deaths are reported every year [5].,Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
"Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 222 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220recommended by World Health Organisation (WHO) to be  used in dogs by the oral route [11,12].",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
 Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 223 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220Table 2.,Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
"Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 224 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220cies, including 5 from the canine family (of which dog), wild  carnivores, rodents and non-human primates, demonstrated   that SAG2 is an avirulent rabies vaccine strain [28].",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
 Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 225 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220cost of vaccination could be reduced by the use of aerial dis - tribution in certain well defined and restricted areas.,Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
"Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 226 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220ing; 1997 Mar 4-6; Nairobi, Kenya; p.163-74.",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
"227 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Protein cages, such as ferritins, small heat shock proteins, and viral capsids are prom - ising nanoplatform candidates for efficient delivery systems because they have uni - form size, structure, high biocompatibility and biodegradability [1-6].",Non-OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:227-234 http://dx.doi.org/10.7774/cevr.2014.3.2.227 pISSN 2287-3651 • eISSN 2287-366X  Jae-Sun Ra*, Hyun-Hee Shin*,  Sebyung Kang, Yoonkyung Do School of Life Sciences, Ulsan National Institute  of Science and Technology, Ulsan, Korea Received: April 10, 2014 Revised: May 1, 2014 Accepted: May 12, 2014 Corresponding author: Yoonkyung Do, PhD School of Life Sciences, Ulsan National Insti - tute of Science and Technology, 50 UNIST-gil,  Eonyang-eup, Ulju-gun, Ulsan 689-798, Korea Tel: +82-52-217-5326, Fax: +82-217-5309 E-mail: doy@unist.ac.kr *These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 228 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227and fabrication of uniform layer-by-layer assemblies using  non-covalent interaction between surface displayed hexa - hisitidine and Ni-NTA of the AaLS [11].,OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
" Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 229 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227with indicated proteins for 3 hours, washed and then co-cul - tured with the CFSE-labeled T cells at a ratio of 1:3 (DC, 1×105:  T cell, 3×105) in a 96-well U-bottom plate at 37°C.",OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 230 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227Results Surface and ribbon diagram representations of lumazine syn - thase (AaLS) were depicted (Fig.,OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
 Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 231 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227 PBS OVA protein wt AaLS   PBS OVA protein wt AaLS   AaLS-OT -1AaLS-OT -1 A B Fig.,OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
"Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 232 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227were used as a positive and a negative control groups, respec - tively.",Non-OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
" Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 233 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227in E. coli , as well as with co-insertion of selective adjuvants  and antigens together.",OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
ORCID Jae-Sun Ra http://orcid.org/0000-0002-4525-7171 Hyun-Hee Shin http://orcid.org/0000-0003-4945-1059 Sebyung Kang http://orcid.org/0000-0001-7394-3550 Yoonkyung Do http://orcid.org/0000-0001-7947-4767 References 1.,Non-OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 234 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227technol 1997;15:26-32.,OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
235 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculo - sis.,Non-OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:235-243 http://dx.doi.org/10.7774/cevr.2014.3.2.235 pISSN 2287-3651 • eISSN 2287-366X  Jino Lee1, Jihye Kim1, Jeewon Lee1,  Sung Jae Shin2, Eui-Cheol Shin1 1Laboratory of Immunology and Infectious  Diseases, Graduate School of Medical Science  and Engineering, KAIST, Daejeon, 2Department  of Microbiology and Institute of Immunology  and Immunological Diseases, Yonsei University  College of Medicine, Seoul, Korea Received: April 14, 2014 Revised: May 12, 2014 Accepted: May 15, 2014 Corresponding author: Eui-Cheol Shin, MD, PhD Laboratory of Immunology and Infectious   Diseases, Graduate School of Medical Science  and Engineering, KAIST, 291 Daehak-ro,   Yuseong-gu, Daejeon 305-701, Korea Tel: +82-42-350-4236, Fax: +82-42-350-4240 E-mail: ecshin@kaist.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
"Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 236 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235ing countries where protection against TB is the most needed  [7,8].",Non-OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
 Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 237 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235and further diluted to 1 mg/mL with phosphate-buffered sa - line (PBS).,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 238 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235 Optical density (450 nm) ControlRpfB DNARpfB proteinBCG4.0 3.0 2.0 1.0 0.0** **** Fig.,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
 Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 239 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235Fig.,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 240 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235Fig.,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
 Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 241 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235 Polyfunctional T cells simultaneously exert multiple func - tions such as cytokine secretion and cytotoxic activity.,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
ORCID Jino Lee http://orcid.org/0000-0003-2132-4963 Jihye Kim http://orcid.org/0000-0001-6297-4562 Jeewon Lee http://orcid.org/0000-0001-7457-2464 Sung Jae Shin http://orcid.org/0000-0003-0854-4582 Eui-Cheol Shin http://orcid.org/0000-0002-6308-9503 References 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 242 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235BR.,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
" Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 243 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235losis vaccine, AERAS-402, induces robust and polyfunc - tional CD4+ and CD8+ T cells in adults.",Non-OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
244 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHGuideline Guidelines for Vaccination of Dogs Guidelines for vaccination of general veterinary practice by World Small Animal   Veterinary Association (WSAVA) and American Animal Hospital Association (AAHA) Table 1 summarizes vaccination schedule base on  WSAVA vaccination guidelines in  2010 [1] and AAHA vaccination guideline in 2011 [2].,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:244-247 http://dx.doi.org/10.7774/cevr.2014.3.2.244 pISSN 2287-3651 • eISSN 2287-366X  Woo-Jin Song1, Hyun-Tae Kim1,  Han-Sang Yoo2, Hwa-Young Youn1 Departments of 1Veterinary Internal Medicine  and 2Infectious Disease, College of Veterinary  Medicine, Seoul National University, Seoul, Korea Received: March 27, 2014 Revised: April 7, 2014 Accepted: April 10, 2014 Corresponding author: Hwa-Young Youn, DVM, PhD Department of Veterinary Internal Medicine,  College of Veterinary Medicine, Seoul National  University, 1 Gwanak-ro, Gwanak-gu,   Seoul 151-742, Korea Tel: +82-2-880-1266, Fax: +82-2-880-1211 E-mail: hyyoun@snu.ac.kr No potential conflict of interest relevant to this  article was reported.This guideline contains the recommended vaccination schedules of dogs and cats from World  Small Animal Veterinary Association (WSAVA) and American Animal Hospital Association  (AAHA).",Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
 Woo-Jin Song et al • Vaccination guidelines of dogs and cats in Korea  245 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.244Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
Woo-Jin Song et al • Vaccination guidelines of dogs and cats in Korea  246 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.244Table 2.,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
 Woo-Jin Song et al • Vaccination guidelines of dogs and cats in Korea  247 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.244Table 4.,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
Continued ORCID Woo-Jin Song http://orcid.org/0000-0001-9563-6615 Hyun-Tae Kim http://orcid.org/0000-0001-5124-7976  Han-Sang Yoo http://orcid.org/0000-0003-0548-0835 Hwa-Young Youn http://orcid.org/0000-0002-0283-1348 References 1.,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
This pattern was also found /C2112014 Ishiuchi and Torres-Padilla This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after thefull-issue publication date (see http://genesdev.cshlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f2/a7/1381.PMC4083083.pdf
"After six months, it is available under a Creative Com- mons License (Attribution-NonCommercial 4.0 International), as de- scribed at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/f2/a7/1381.PMC4083083.pdf
[Keywords : DNA methylation; evolution; KAP1; LINE1; piRNA; transposon] 1Corresponding author E-mail metp@igbmc.fr Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.246462.114.,OADS,/arxiv_data1/oa_pdf/f2/a7/1381.PMC4083083.pdf
[Keywords : R loops; gene expression; genome integrity] 1Corresponding author E-mail nicholas.proudfoot@path.ox.ac.uk Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.242990.114.,Non-OADS,/arxiv_data1/oa_pdf/ce/cf/1384.PMC4083084.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.241661.114.,Non-OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
LV production protocols are detailed at http://tronolab.epfl.ch.,Non-OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
2011) were obtained from the ENCODEdatabase (https://genome.ucsc.edu/ENCODE).,OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
"Correlation analysis between ChIP-seq peaks, MeDIP-seq tags, and L1 elements was done using the ChIP-cor analysis module (http://ccg.vital-it.ch/chipseq/chip_cor.php).",OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
MeDIP-seq data sets (Hs1376 and Hs1303) were downloaded from http://www.genboree.org/epigenomeatlas.,OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/c6/d2/1410.PMC4083086.pdf
Article and publication date are online at http://www.genesdev.or g/cgi/doi/10.1101/gad.240895.114.,Non-OADS,/arxiv_data1/oa_pdf/c6/d2/1410.PMC4083086.pdf
We considered regions annotated by RepeatMasker(http://www.repeatmasker.org) in the UCSC genome browser forthe mm10 genome (Meyer et al.,OADS,/arxiv_data1/oa_pdf/c6/d2/1410.PMC4083086.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/25/ad/1429.PMC4083087.pdf
org/licenses/by-nc/4.0/.13Corresponding authors E-mail qing_zhang@med.unc.edu E-mail william_kaelin@dfci.harvard.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.242131.114.,Non-OADS,/arxiv_data1/oa_pdf/25/ad/1429.PMC4083087.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b9/84/1445.PMC4083088.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.7Corresponding authors E-mail mkuroda@genetics.med.harvard.edu E-mail peter.kharchenko@post.harvard.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.241950.114.",Non-OADS,/arxiv_data1/oa_pdf/b9/84/1445.PMC4083088.pdf
Please see http://pklab.med.harvard.edu/mass.spec/viewms.html for the counts in other life stages.,Non-OADS,/arxiv_data1/oa_pdf/b9/84/1445.PMC4083088.pdf
"The total number of detected peptides is shown in each cell, with the number of unique peptidesshown in parentheses (for full data set, including peptide counts, see http://pklab.med.harvard.edu/mass.spec/viewms.html).",OADS,/arxiv_data1/oa_pdf/b9/84/1445.PMC4083088.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/85/e1/1461.PMC4083089.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.243832.114.,Non-OADS,/arxiv_data1/oa_pdf/85/e1/1461.PMC4083089.pdf
2013; Chung et al2014; http://daudin.icmb.utexas.edu) with RNA-STAR.,OADS,/arxiv_data1/oa_pdf/85/e1/1461.PMC4083089.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/49/33/1472.PMC4083090.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.4Corresponding author E-mail zou.lee@mgh.harvard.edu Article is online at http://www.genesdev.",Non-OADS,/arxiv_data1/oa_pdf/49/33/1472.PMC4083090.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/47/31/1485.PMC4083091.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.Present addresses:4Department of Molecular Biology, Max-Planck-Institute for Biophysical Chemistry, 37077 Go ¨ttingen, Germany;5The James H Clark Center, Stanford School of Medicine, Stanford, California 94305 USA; 6Department of Early Discovery Bioc hemistry, Genentech, South San Francisco, CA 94080 USA;7Department of Molecular Biology, Presidency University, Kolkata, India;8Department of Biophysics and Biophysical Chemistry, Johns Hopkins Universit y School of Medicine, Baltimore, MD 21205, USA 9Corresponding author E-mail jmberger@jhmi.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.241984.",Non-OADS,/arxiv_data1/oa_pdf/47/31/1485.PMC4083091.pdf
"Except where noted, this panel and all other structural panelswere rendered with PyMOL (http://www.pymol.org).Inhibition of E. coli gyrase by YacG GENES &DEVELOPMENT 1487",Non-OADS,/arxiv_data1/oa_pdf/47/31/1485.PMC4083091.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/69/65/1498.PMC4083092.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.4Corresponding authors E-mail allain@mol.biol.ethz.ch E-mail raul.mendez@irbbarcelona.org Article is online at http://www.genes dev.org/cgi/doi/ 10.1101/gad.241133.114.",Non-OADS,/arxiv_data1/oa_pdf/69/65/1498.PMC4083092.pdf
"Data processing was performed withTopSpin2.1/TopSpin3.0 (Bruker), and analysis was performed with Sparky (http://www.cgl.ucsf.edu/home/sparky).",OADS,/arxiv_data1/oa_pdf/69/65/1498.PMC4083092.pdf
1996) or PYMOL (http://www.pymol.org).,Non-OADS,/arxiv_data1/oa_pdf/69/65/1498.PMC4083092.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"Scale bars: (A, F, G), 200 mm, (B, H), 50 mm, (C, D, E), 10 mm.Intracellular localization of Treponema denticola chymotrypsin Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"MicrobesInfect 2006; 8: 1758 /C163.Intracellular localization of Treponema denticola chymotrypsin Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"[cited: 10th Jan, 2014]; Available from: http://www.alz.",Non-OADS,/arxiv_data1/oa_pdf/38/2c/TONURSJ-8-17.PMC4083186.pdf
"[cited: 10th Jan, 2014]; Available from: http://www.pref.okinawa.jp/site/fukushi/korei/.../ninteityousa.pdf   Received: January 9, 2014 Revised: April 29, 2014 Accepted: May 2, 2014  © Mitoku and Shimanouchi; Licensee Bentham Open.",OADS,/arxiv_data1/oa_pdf/38/2c/TONURSJ-8-17.PMC4083186.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/2c/TONURSJ-8-17.PMC4083186.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/23/main.PMC4083229.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7c/23/main.PMC4083229.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: S.-H.C., S.K., C.O.K.",Non-OADS,/arxiv_data1/oa_pdf/7d/e2/srep05603.PMC4083259.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5603 | DOI: 10.1038/srep05603 6",Non-OADS,/arxiv_data1/oa_pdf/7d/e2/srep05603.PMC4083259.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c4/b8/srep05596.PMC4083260.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5590 | DOI: 10.1038/srep05590 5",Non-OADS,/arxiv_data1/oa_pdf/d9/c5/srep05590.PMC4083261.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/srep05588.PMC4083262.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5588 | DOI: 10.1038/srep05588 5",Non-OADS,/arxiv_data1/oa_pdf/c1/0e/srep05588.PMC4083262.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/76/25/srep05602.PMC4083263.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5602 | DOI: 10.1038/srep05602 12",Non-OADS,/arxiv_data1/oa_pdf/76/25/srep05602.PMC4083263.pdf
"Unpublished thesis, University of Iceland.http://hdl.handle.net/1946/ 11191 (2012).",Non-OADS,/arxiv_data1/oa_pdf/a7/4d/srep05589.PMC4083264.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a7/4d/srep05589.PMC4083264.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5589 | DOI: 10.1038/srep05589 10",Non-OADS,/arxiv_data1/oa_pdf/a7/4d/srep05589.PMC4083264.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b7/a7/srep05587.PMC4083265.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5587 | DOI: 10.1038/srep05587 12",Non-OADS,/arxiv_data1/oa_pdf/b7/a7/srep05587.PMC4083265.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/39/b4/srep05593.PMC4083277.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c7/9e/srep05548.PMC4083279.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/ae/srep05598.PMC4083283.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5599 | DOI: 10.1038/srep05599 10",Non-OADS,/arxiv_data1/oa_pdf/f8/a6/srep05599.PMC4083286.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5592 | DOI: 10.1038/srep05592 5",Non-OADS,/arxiv_data1/oa_pdf/ca/1d/srep05592.PMC4083293.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9d/61/srep05564.PMC4083294.pdf
Available from: http://www.unaids.org/en/media/unaids/con tentassets/documents/epidemiology/2012/gr 2012/20121120_UNAIDS_Global_Report_20 12_en.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/90/18/idr-2014-2-5167.PMC4083298.pdf
Available from: http://www.nacoonline.org/NACO/About_NA CO/Policy__Guidelines/Policies__Guidelin es1/ 5.,Non-OADS,/arxiv_data1/oa_pdf/90/18/idr-2014-2-5167.PMC4083298.pdf
Available from: http://www.who.int/hiv/ pub/paediatric/infants2010/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/90/18/idr-2014-2-5167.PMC4083298.pdf
Estimating risk of disease pro- gression in HIV-infected children.Available from: http://www.hppmcs.org/.,Non-OADS,/arxiv_data1/oa_pdf/90/18/idr-2014-2-5167.PMC4083298.pdf
Available from: http://www.who.int/cancer/palliative/painladder/en/ 5. International Narcotics Control Board (INCB).,Non-OADS,/arxiv_data1/oa_pdf/6f/d9/or-2014-2-5309.PMC4083307.pdf
Available from: http://www.incb.org/docu-ments/Publications/AnnualReports/AR2010/SupplementAR10_availability_English.p df 6 .,Non-OADS,/arxiv_data1/oa_pdf/6f/d9/or-2014-2-5309.PMC4083307.pdf
Available from: http://www.incb.org/documents/Narcotic-Drugs/Technical- P ublications/2012/NDR_2012_Part4_Table s_EFS.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/6f/d9/or-2014-2-5309.PMC4083307.pdf
Available from: http://www.parlamento.it/parlam/leggi/100 38l.htm 10.,Non-OADS,/arxiv_data1/oa_pdf/6f/d9/or-2014-2-5309.PMC4083307.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http:// www.nature.com/jcbfm)Local blood ﬂow versus capacity to raise blood ﬂow D Feuerstein et al 1127 &2014 ISCBFM Journal of Cerebral Blood Flow & Metabolism (2014), 1117 – 1127",Non-OADS,/arxiv_data1/oa_pdf/92/94/jcbfm201453a.PMC4083373.pdf
The microarrayswere analyzed using R 3.0.1 (open source: http://www.r-project.org) andBioconductor 2.12 (open source: http://www.bioconductor.org).,OADS,/arxiv_data1/oa_pdf/4f/81/jcbfm201472a.PMC4083386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http:// www.nature.com/jcbfm)Maternal fructose and offspring brain mitochondria OH Mortensen et al 1211 &2014 ISCBFM Journal of Cerebral Blood Flow & Metabolism (2014), 1205 – 1211",Non-OADS,/arxiv_data1/oa_pdf/4f/81/jcbfm201472a.PMC4083386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http:// www.nature.com/jcbfm)Meta-analysis: serotonin transporter in depression G Gryglewski et al 1103 &2014 ISCBFM Journal of Cerebral Blood Flow & Metabolism (2014), 1096 – 1103",Non-OADS,/arxiv_data1/oa_pdf/92/1d/jcbfm201482a.PMC4083395.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Epple, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/0d/ncomms5132.PMC4083415.pdf
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif.Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/06/ncomms5245.PMC4083417.pdf
"Reprints and permission information is available online at http://www.nature.com/ reprintsandpermissions/ How to cite this article: Asakawa, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/79/06/ncomms5245.PMC4083417.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5245 ARTICLE NATURE COMMUNICATIONS | 5:4245 | DOI: 10.1038/ncomms5245 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/79/06/ncomms5245.PMC4083417.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f4/6a/ncomms5150.PMC4083419.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Steinkellner, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/6a/ncomms5150.PMC4083419.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5150 ARTICLE NATURE COMMUNICATIONS | 5:4150 | DOI: 10.1038/ncomms5150 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f4/6a/ncomms5150.PMC4083419.pdf
"Genome sequences and annotations were downloaded from http://www.amborella.org/ ( A. trichopoda assembly V1.0), http://congenie.org/ ( P. abies assembly V1.0) and the phytozome v9.1 database42 (containing the following annotation versions: A. thaliana TAIR release 10 ,G .m a x Glyma1.1 , M. truncatula Mt3.5v4 , P. trichocarpa JGI annotation v3.0, R. communis TIGR release 0.1 , V. vinifera March 2010 12X assembly and annotation from Genoscope , S. lycopersicum ITAG2.3, O. sativa MSU release 7.0 , S. bicolor Sbi1.4 models from MIPS/PASA, P. patens COSMOSS annotation v1.6 and S.moellendorfﬁi JGI annotation v1.0 ).",OADS,/arxiv_data1/oa_pdf/d7/a4/ncomms5268.PMC4083422.pdf
"Plant material and culture conditions .The Gransden, Honnef and Uppsala-K1 wild-type strains of P. patens (http://www.moss-stock-center.org/), wt4 wild-type strain of Ceratodon purpureus56and wild-type strain of Pseudocrossidium replicatum (gift of Dr Villalobos, CIBA-IPN, Tlaxcala, Mexico) were used in this study.",Non-OADS,/arxiv_data1/oa_pdf/d7/a4/ncomms5268.PMC4083422.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Maumus, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/d7/a4/ncomms5268.PMC4083422.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/3d/29/ncomms5154.PMC4083423.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Hatke, A. T. et al.",Non-OADS,/arxiv_data1/oa_pdf/3d/29/ncomms5154.PMC4083423.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5154 ARTICLE NATURE COMMUNICATIONS | 5:4154 | DOI: 10.1038/ncomms5154 | www.nature.com/naturecommunications 5 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/3d/29/ncomms5154.PMC4083423.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/71/d5/ncomms5170.PMC4083425.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhang, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/ncomms5170.PMC4083425.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5170 ARTICLE NATURE COMMUNICATIONS | 5:4170 | DOI: 10.1038/ncomms5170 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/ncomms5170.PMC4083425.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Klo¨ckner, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/99/ncomms5201.PMC4083426.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Yamaguchi, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/c3/b3/ncomms5256.PMC4083427.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5595 | DOI: 10.1038/srep05595 4",Non-OADS,/arxiv_data1/oa_pdf/5a/1a/srep05595.PMC4083430.pdf
"Array hybridization of RNA isolated from mutant and control cerebella identiﬁed 110 genes differentially expressed at P0 that increased to 2,916 transcripts at P10 ( Po0.01, n¼3 per genotype, statistics was carried out using WEBARRAY online tool (http://www.webarraydb.org/webarray/index.html), which utilizes linear model statistical analysis (modiﬁed t-test)).",OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
Statistics was carried out using WEBARRAY online tool (http://www.webarraydb.org/webarray/index.html) that utilizes linear model statistical analysis (modi ﬁed t-test).NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5181 ARTICLE NATURE COMMUNICATIONS | 5:4181 | DOI: 10.1038/ncomms5181 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.,OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
"On the resulting raw background subtracted signals intra-array normalization (correcting for Cy5/Cy3 bias) was performed with global loess, inter-array normalization with the quantile method and statistical analysis via the WEBARRAY online tool (http://www.we-barraydb.org/webarray/index.html).",OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Alvarez-Saavedra, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5181 18 NATURE COMMUNICATIONS | 5:4181 | DOI: 10.1038/ncomms5181 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: HJD is an employee of Boehringer Ingelheim Pharma GmbH & Co KG.,Non-OADS,/arxiv_data1/oa_pdf/a5/ee/ncomms4897.PMC4083433.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ortner, N. J. et al.",Non-OADS,/arxiv_data1/oa_pdf/a5/ee/ncomms4897.PMC4083433.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4897 10 NATURE COMMUNICATIONS | 5:3897 | DOI: 10.1038/ncomms4897 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/a5/ee/ncomms4897.PMC4083433.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Cirloganu, C. M. et al.",Non-OADS,/arxiv_data1/oa_pdf/4e/7f/ncomms5148.PMC4083434.pdf
"Dosch, M. P. The anesthesia gas machine http://www.udmercy.edu/crna/agm (2006).",OADS,/arxiv_data1/oa_pdf/6a/8e/ncomms5228.PMC4083436.pdf
"Dosch, M. P. The anesthesia gas machine http://www.udmercy.edu/crna/agm/ 07.htm (2012).",Non-OADS,/arxiv_data1/oa_pdf/6a/8e/ncomms5228.PMC4083436.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/8e/ncomms5228.PMC4083436.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Shekhah, O. et al.",Non-OADS,/arxiv_data1/oa_pdf/6a/8e/ncomms5228.PMC4083436.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5228 ARTICLE NATURE COMMUNICATIONS | 5:4228 | DOI: 10.1038/ncomms5228 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/6a/8e/ncomms5228.PMC4083436.pdf
"Acknowledgements This work was supported by the European Union through the projects FP7-ICT-2011-9- 600838 (QWAD—Quantum Waveguides Application and Development—www.qwad-project.eu) and CHISTERA-QUASAR (http://www.chistera.eu/projects/quasar), and bythe ERC (European Research Council) Starting Grant 3D-QUEST (3D-Quantum Inte- grated Optical Simulation; grant agreement number 307783—www.3dquest.eu).",Non-OADS,/arxiv_data1/oa_pdf/f1/08/ncomms5249.PMC4083439.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: G.C., A.C., R.O.",Non-OADS,/arxiv_data1/oa_pdf/f1/08/ncomms5249.PMC4083439.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Corrielli, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/f1/08/ncomms5249.PMC4083439.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5249 6 NATURE COMMUNICATIONS | 5:4249 | DOI: 10.1038/ncomms5249 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f1/08/ncomms5249.PMC4083439.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wientjes, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/82/5d/ncomms5236.PMC4083440.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/75/fd/ncomms5273.PMC4083441.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article: Li, Y.-F. et al.",Non-OADS,/arxiv_data1/oa_pdf/75/fd/ncomms5273.PMC4083441.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5273 14 NATURE COMMUNICATIONS | 5:4273 | DOI: 10.1038/ncomms5273 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/75/fd/ncomms5273.PMC4083441.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/60/63/ncomms5081.PMC4083442.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Fumeaux, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/60/63/ncomms5081.PMC4083442.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5081 14 NATURE COMMUNICATIONS | 5:4081 | DOI: 10.1038/ncomms5081 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/60/63/ncomms5081.PMC4083442.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interest.,Non-OADS,/arxiv_data1/oa_pdf/eb/07/ncomms5133.PMC4083443.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Murakami, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/eb/07/ncomms5133.PMC4083443.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5133 8 NATURE COMMUNICATIONS | 5:4133 | DOI: 10.1038/ncomms5133 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/eb/07/ncomms5133.PMC4083443.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/42/ca/ncomms5244.PMC4083444.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liu, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/42/ca/ncomms5244.PMC4083444.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5244 10 NATURE COMMUNICATIONS | 5:4244 | DOI: 10.1038/ncomms5244 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/42/ca/ncomms5244.PMC4083444.pdf
Cells and ghosts were quantiﬁed using ImageJ software(http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/0a/be/ncomms5200.PMC4083446.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/0a/be/ncomms5200.PMC4083446.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Frandi, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/be/ncomms5200.PMC4083446.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5200 ARTICLE NATURE COMMUNICATIONS | 5:4200 | DOI: 10.1038/ncomms5200 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/0a/be/ncomms5200.PMC4083446.pdf
Available from: http://www.fsi.org.in/cover_2011/uttarakhand.pdf [Last accessed 2013 Nov 10].,Non-OADS,/arxiv_data1/oa_pdf/97/d6/NAJMS-6-274.PMC4083529.pdf
"(Accessed April 24, 2014, at  http://www.health.govt.nz/publication/new-zealand-cardiovascular-risk-charts).",Non-OADS,/arxiv_data1/oa_pdf/c0/e2/NAJMS-6-284.PMC4083531.pdf
"Available from: (Accessed February 19, 2014, at http://www.bupa.com.au/health-and-wellness/tools-and-apps/tools-and-calculators/quick-health-age-check).",Non-OADS,/arxiv_data1/oa_pdf/c0/e2/NAJMS-6-284.PMC4083531.pdf
Available from: http://www.fdagov/downloads/Drugs/GuidanceComplianceRegulatory/ Information/Guidances/ucm070578.pdf.,Non-OADS,/arxiv_data1/oa_pdf/45/e1/IJPI-4-51.PMC4083534.pdf
"American Pharmaceutical review 2011, Available from: http://www.americanpharmaceuticalreview.com/Featured- Articles/37183-Understanding-Infrared-and-Raman-Spectra-of- Pharmaceutical-Polymorphs/.",Non-OADS,/arxiv_data1/oa_pdf/45/e1/IJPI-4-51.PMC4083534.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/58/e7/IJPI-4-77.PMC4083537.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/b5/34/IJPI-4-88.PMC4083538.pdf
Available from: http://www.ich.org/LOB/media/MEDIA4986.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/13/IJPI-4-93.PMC4083539.pdf
Available from: http://www.ich.org/LOB/media/MEDIA1957.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/13/IJPI-4-93.PMC4083539.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199-210    199Lessons in biostatistics ©Copyright by Croatian Society of Medical Biochemistry and Laboratory Medicine.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Observational and interventional study design types; an overview Matthew S. Thiese Rocky Mountain Center for Occupational and Environmental Health, University of Utah, Salt Lake City, Utah, USA *Corresponding author: Matt.thiese@hsc.utah.edu Introduction Study design plays an important role in the quali - ty, execution, and interpretation of biomedical and  public health research (1-12).",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  200Thiese MS. Study design types: an overview logical or interventional, lack one or more of these  elements and have limited application.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199–210    201Thiese MS. Study design types: an overview Study design Measures of disease Measures of risk Temporality Ecological Prevalence (rough estimate) Prevalence ratio Retrospective Proportional mortalityProportional mortality Standardized mortalityProportional mortality ratio Standardized mortality ratioRetrospective Case-crossover None Odds ratio Retrospective Cross-sectionalPoint prevalence Period prevalenceOdds ratio Prevalence odds ratio Prevalence ratio Prevalence differenceRetrospective Case-control None Odds ratio Retrospective Retrospective and  prospective cohortPoint prevalence Period prevalence IncidenceOdds ratio Prevalence odds ratio Prevalence ratio Prevalence difference Attributable risk Incidence rate ratio Relative risk Risk ratio Hazard ratioRetrospective only Both retrospective and  prospective Prospective only Study design Strengths Weaknesses EcologicalVery inexpensive Fast Easy to assign exposure levelsInaccuracy of data Inability to control for confounders Difficulty identifying or quantifying denominator No demonstrated temporality Proportional mortalityVery inexpensive Fast Outcome (death) well capturedUtilize deaths only Inaccuracy of data (death certificates) Inability to control for confounders Case-crossoverReduces some types of bias Good for acute health outcomes with a  defined exposure Cases act as their own controlSelection of comparison time point difficult Challenging to execute Prone to recall bias No demonstrated temporality Cross-sectionalInexpensive Timely Individualized data Ability to control for multiple  confounders Can assess multiple outcomesNo temporality Not good for rare diseases Poor for diseases of short duration No demonstrated temporality Case-controlInexpensive Timely Individualized data Ability to control for multiple  confounders Good for rare diseases Can assess multiple exposuresCannot calculate prevalence Can only assess one outcome Poor selection of controls can introduce bias May be difficult to identify enough cases Prone to recall bias No demonstrated temporality Retrospective and  prospective cohortTemporality demonstrated Individualized data Ability to control for multiple  confounders Can assess multiple exposures Can assess multiple outcomesExpensive Time intensive Not good for rare diseasesTa b l e  1.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  202Thiese MS. Study design types: an overview Observational studies Ecological study design The most basic observational study is an ecologi - cal study.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199–210    203Thiese MS. Study design types: an overview outcome are assessed at the same time, temporal - ity cannot be demonstrated, i.e.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  204Thiese MS. Study design types: an overview relationships that are assessed using case-crosso - ver designs should have health outcomes that do  not have a subclinical or undiagnosed period prior to becoming a “case” in the study (12).,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199–210    205Thiese MS. Study design types: an overview diagnostic procedure, including accuracy, sensitiv - ity, specificity, positive predictive value, negative  predictive value, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio can be calculated.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  206Thiese MS. Study design types: an overview measuring compliance, controlling for co-inter - ventions, measuring dropout, analysing results by  intention to treat, and assessing each treatment arm at the same time point in the same manner.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199–210    207Thiese MS. Study design types: an overview there may be a therapeutic difference between  the two treatment arms.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  208Thiese MS. Study design types: an overview Standard name Acronym Website Consolidated Standards Of Reporting Trials CONSORT www.consort-statement.org Strengthening the Reporting of Observational studies in Epidemiology STROBE www.strobe-statement.org Standards for Reporting Studies of Diagnostic Accuracy STARD www.stard-statement.org Quality assessment of diagnostic accuracy studies QUADAS www.bris.ac.uk/quadas Preferred Reporting Items for Systematic Reviews and Meta-Analyses PRISMA www.prisma-statement.org Consolidated criteria for reporting qualitative research COREQ Statistical Analyses and Methods in the Published Literature SAMPL Consensus-based Clinical Case Reporting Guideline Development CARE www.care-statement.org/ Standards for Quality Improvement Reporting Excellence SQUIRE www.squire-statement.org Consolidated Health Economic Evaluation Reporting Standards CHEERSwww.ispor.org/taskforces/ EconomicPubGuidelines.asp Enhancing transparency in reporting the synthesis of qualitative research ENTREQTa b l e  3.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199–210    209Thiese MS. Study design types: an overview Conclusion The appropriate selection of a study design is only  one element in successful research.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Research methods in occupational epidemiology: Oxford University Press; 2004. http://dx.doi.org/10.1093/acprof:oso/9780195092424.001.0001.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Handbook of Epi- demiology: Springer; 2005. p. 287-319. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"Meta-analysis, decision analysis, and cost-ef-fectiveness analysis: methods for quantitative synthesis in medicine: Oxford University Press; 1999. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
BMJ 1999;319:670-4. http://dx.doi.org/10.1136/ bmj.319.7211.670.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Biometrika 1999;86:365-79. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
BMC Med Res  Methodol 2001;1:2. http://dx.doi.org/10.1186/1471-2288- 1-2.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
JAMA 2001;285:2000-3. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  210Thiese MS. Study design types: an overview 31.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
1996;17:1-12. http://dx.doi.org/10.1016/0197-2456- (95)00134-4.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
J Clinical Epi-demiol 2004;57:1232-6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
http://dx.doi.org/10.1503/ cmaj.090449.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Qual Saf Health Care 2003;12:18-23. http://dx.doi.org/10.1136/ qhc.12.1.18.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
J Occup Environ Med 2008;50:282-95. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.023 Biochemia Medica 2014;24(2):211–6    211Abstract Despite the fact that there are more than twenty thousand biomedical journals in the world, research into the work of editors and publication pro - cess in biomedical and health care journals is rare.",Non-OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Biochemia Medica 2014;24(2):211–6  http://dx.doi.org/10.11613/BM.2014.023  212Marušić A. et al.,OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
http://dx.doi.org/10.11613/BM.2014.023 Biochemia Medica 2014;24(2):211–6    213Marušić A. et al.,OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Biochemia Medica 2014;24(2):211–6  http://dx.doi.org/10.11613/BM.2014.023  214Marušić A. et al.,OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
http://dx.doi.org/10.11613/BM.2014.023 Biochemia Medica 2014;24(2):211–6    215Marušić A. et al.,OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Available at: http://www.icmje.,Non-OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Biochemia Medica 2014;24(2):211–6  http://dx.doi.org/10.11613/BM.2014.023  216Marušić A. et al.,OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Availa-ble at: http://www.rcuk.ac.uk/research/outputs/.,Non-OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Available at: http://beta.congress.gov/bill/113th-congress/senate-bill/350/text?q=s350.,Non-OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Research integrity corner Abstract This evidence-based opinion piece gives a short overview of the increase in retractions of publications in scientific journals and discusses various  reasons for that increase.",Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
"Key words : accountability; retraction of publication as topic; scientific misconduct Received: March 30, 2014 Accepted: May 19, 2014Retractions of scientific publications: responsibility and accountability Vedran Katavić Department of Anatomy, University of Zagreb School of Medicine, Zagreb, Croatia Corresponding author: vkatavic@mef.hr http://dx.doi.org/10.11613/BM.2014.024 Biochemia Medica 2014;24(2):217–22    217Disclaimer I‘d like to start this opinion piece with a disclaimer  – I am going to do something not entirely com - mon in a scientific journal, and NOT cite those arti - cles I mention in this manuscript!",Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
"Biochemia Medica 2014;24(2):217–22  http://dx.doi.org/10.11613/BM.2014.024  218Katavić V. Retractions of scientific publications: responsibility and accountability editor’s toolbox are, also, expressions of concern  that draw the attention of the public to possible problems in a published article, without, actually, correcting or retracting it (8).",Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.11613/BM.2014.024 Biochemia Medica 2014;24(2):217–22    219Katavić V. Retractions of scientific publications: responsibility and accountability Authors with multiple retractions The surprising thing in the analyses of retracted  publications is the number of researchers with multiple retracted publications and the number of retracted publications (or publications found to be fraudulent that are awaiting retraction) they pub - lished (15).,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
"Biochemia Medica 2014;24(2):217–22  http://dx.doi.org/10.11613/BM.2014.024  220Katavić V. Retractions of scientific publications: responsibility and accountability (Ir)reproducibility of published research Out of all the reasons for retractions (9), irrepro - ducibility of results inhabits its own troubling  niche.",Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
"http://dx.doi.org/10.11613/BM.2014.024 Biochemia Medica 2014;24(2):217–22    221Katavić V. Retractions of scientific publications: responsibility and accountability (at the time of writing this opinion piece, both pa - pers are under investigation for fraud).",Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Curr Med Res Opin 2010;26:843-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Science 2006;312:40-1. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1007/ s11948-014-9532-1.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
J Med Libr  Assoc2012;100:184-9.http://dx.doi.org/10.3163/1536-5050.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
J Med Ethics 2011;37:567-70. http://dx.doi.org/10.1136/ jme.2010.040964.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Biochem Med 2010;20:282-7. http://dx.doi.org/10.11613/ BM.2010.035.,OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Nature 2011;478:26-8. http://dx.doi.org/10.1038/  478026a.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
EMBO Rep 2008;9:2. http://dx.doi.org/10.1038/ sj.embor.7401143.,OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1371/jo - urnal.pmed.1001563.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1371/journal.pone.0068397.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Proc Natl Acad Sci USA 2012;109:17028-33. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Biochemia Medica 2014;24(2):217–22  http://dx.doi.org/10.11613/BM.2014.024  222Katavić V. Retractions of scientific publications: responsibility and accountability 16.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Croat Med J 2014;55:61-72. http://dx.doi.org/10.3325/ cmj.2014.55.61.,OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
EMBO Rep 2007;8:422-3. http://dx.doi.org/10.1038/sj.embor.7400970.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Nature 2005;435:737-8. http://dx.doi.org/10.1038/  435737a.,OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Infect Immun 2011;79:3855-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Scientometri-cs 2014;98:337-45. http://dx.doi.org/10.1007/s11192-013- 1033-5.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Science 2009; 325: 813-4. http://dx.doi.org/10.1126/science.325_813c .25.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Nature 2012;483:531-3. http://dx.doi.org/10.1038/483531a.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1371/jour - nal.pmed.0020124.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Nat Rev Drug Discov 2011;10:712. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Ava-ilable at: http://www.nature.com/nature/focus/reproduci- bility/index.html.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1136/medethics-2013- 101822.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    223Abstract Efficiently managing laboratory test utilization requires both ensuring adequate utilization of needed tests in some patients and discouraging su - perfluous tests in other patients.",Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
"Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  224Baird G. Utilization management panel of tests, perhaps only a blood count and  electrolytes, but possibly also any one of a myriad of large so-called “wellness” panels offered by commercial laboratories that have financial incen - tives to drive frequent, high-cost testing.",Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    225Baird G. Utilization management when it is extremely likely that the diagnosis in  question is present.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
"Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  226Baird G. Utilization management and newborn screening are exceptions to Rule 2 is  that there exists evidence demonstrating a benefit of the testing, when coupled with appropriate downstream therapeutic interventions.",Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    227Baird G. Utilization management A second problem with too-frequent testing de - rives from the statistics of repetitive applications  of a single test.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  228Baird G. Utilization management drive unnecessary and costly downstream activi - ties.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
"http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    229Baird G. Utilization management tions, meaning that large relational healthcare in - formation databases(35), although expensive, will  be very valuable in future utilization studies.",Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  230Baird G. Utilization management Ta b l e  1.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    231Baird G. Utilization management Ta b l e  1.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  232Baird G. Utilization management were paid in “book money” on a scale commensu - rate with the size of their collective percentage re - ductions in laboratory and radiology test ordering.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    233Baird G. Utilization management References  1.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Ann Clin Biochem 2012;49:323-36. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Ann Intern Med 1971;75:157-63. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Science 2013;340:1177-8. http://dx.doi.org/10.1126/scien- ce.1236536.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
JAMA 1989;262:89-90. http://dx.doi.org/10.1001/jama.1989.03430010101039.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Clin Chem Lab Med  2004;42:747-51. http://dx.doi.org/10.1515/CCLM.2004.126.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
J Am Coll Cardiol 2004;44:720-32. http://dx.doi.org/10.1016/j.jacc.2004.07.001.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Value Health 2012;15:613-21. http://dx.doi.org/10.1016/j.jval.2012.02.007.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Cost Eff Resour Alloc 2005;3:8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Pediatrics 2003;112:1005-15. http://dx.doi.org/10.1542/peds.112.5.1005.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Ann Intern Med 1979;90:85-91. http://dx.doi.org/10.7326/0003-4819-90-1-85.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Curr Opin Cardi-ol 2008;23:629-33. http://dx.doi.org/10.1097/HCO.0b013e  32830e6b4e .17.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Am J Cardiol 2010;106:994-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Curr Opin Lipidol 2010;21:305-11. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Proceedings of the IRE 1949;37:10-21. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
J Diabetes Sci Technol 2009;3:411-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Neth J Med 1995;47:208-13. http://dx.doi.org/10.1016/0300-2977(95)00100-8.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Inten-sive Care Med 1985;11:304-8. http://dx.doi.org/10.1007/ BF00273541.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Arch In-tern Med 1974;134:1064-7. http://dx.doi.org/10.1001/ archinte.1974.00320240098012.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Int J  Technol Assess Health Care 1997;13:512-20. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
J Clin Pathol 2005;58:457-62. http://dx.doi.org/10.1136/ jcp.2004.021691.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  234Baird G. Utilization management 32.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Clin Chem 2009;55:533-40.  http://dx.doi.org/10.1373/clinchem.2008.116707.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Clin Chem 2003;49:1997-2005. http://dx.doi.org/10.1373/clinchem.2003.021220.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Available at: http://www.acb.org.uk/docs/default-sour - ce/guidelines/acb-mri-recommendations-a4-computer.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Med Care 1982;20:293- 301. http://dx.doi.org/10.1097/00005650-198203000-00006.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Arch In- tern Med 1997;157:2501-8. http://dx.doi.org/10.1001/ archinte.1997.00440420135015.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Postgrad Med J 2006;82:823-9.  http://dx.doi.org/10.1136/pgmj.2006.049551.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Available at: http://www.bcbsks.com/customerser - vice/providers/MedicalPolicies/policies/policies/Testing_VitaminDDeficiency_2011-12-21.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Am J Clin Pathol 2013;139:289-97. http://dx.doi.org/10.1309/AJCP4- G6UAUXCFTQF .,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
JAMA 1998;280:2020-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Am J Clin Pathol 2011;135:108-18. http://dx.doi.org/10.1309/AJCP4GS7KSBDBACF .46.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
BMJ 1990;301:1305-7. http://dx.doi.org/10.1136/ bmj.301.6764.1305.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Arch Pathol Lab Med 2014;138:189-203. http://dx.doi.org/10.5858/arpa.2013-0149-O A.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Am J Clin Pathol 2006;126:200-6. http://dx.doi.org/10.1309/WP59YM73L6CEGX2F .,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Clin Chem 2007;53:1016-22. http://dx.doi.org/10.1373/clinchem.2006.083360.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Arch Pa- thol Lab Med 2014;138:110-3. http://dx.doi.org/10.5858/ arpa.2012-0726-O A.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Arch Intern Med 2002;162:1885-90. http://dx.doi.org/10.1001/ archinte.162.16.1885.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Int J Med Inform 2009;78:639-44. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Blood Coagul Fibrinolysis 2011;22:688-95. http://dx.doi.org/10.1097/MBC.0b013e32834b8246.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Clin Chem 2004;50:321-6. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Am J Clin Pathol 2001;116:879-84. http://dx.doi.org/10.1309/WC83-ERLY-NEDF-471E .,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Abstract Environmental conditions and increased physical activity during scuba diving are followed by increased production of free radicals and disturbed  redox balance.",Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
"Antonija Perovic*1, Adriana Unic2, Jerka Dumic3 1Department of Biochemical and Hematological Laboratory Diagnostics, Dubrovnik General Hospital, Dubrovnik, Croatia 2Clinical Department of Laboratory Diagnostics, Dubrava University Hospital, Zagreb, Croatia 3University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Biochemistry and Molecular Biology, Zagreb, Croatia *Corresponding author: antonija.perovic@email.t-com.hrReview http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    235Introduction In the last few decades, diving with the self con - tained underwater breathing apparatus (scuba)  has become a popular recreational sport activity all around the world.",Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  236Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    237Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  238Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    239Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  240Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    241Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  242Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    243Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  244Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Available at:  http://www.cmas.org/technique/general-documents.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Oxid Med Cell Longev 2012;2012:756132. http://dx.doi.org/10.1155/2012/756132.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Int J Mol Sci 2013;14:3834-59. http://dx.doi.org/10.3390/ ijms14023834.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Free Radic Res 2007;41:274-81. http://dx.doi.org/10.1080/10715760601080371.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Med Sci Sports Exerc 2009;41:1271-6. http://dx.doi.org/10.1249/ MSS.0b013e3181951069.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Int  J Sports Med 2012;33:531-6. http://dx.doi.org/10.1055/s- 0031-1297957.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Clin Physi-ol Funct Imaging 2010;30:432-8. http://dx.doi.org/10.1111/ j.1475-097X.2010.00962.x.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    245Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Eur J Appl Physiol 2009;105: 507-13. http://dx.doi.org/10.1007/ s00421-008-0927-z.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Acta Physiol 2011;202:69-78. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Physiol 2007;578:859-70. http://dx.doi.org/10.1113/ jphysiol.2006.122218.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Aviat Space Envi-ron Med 2007;78:1114-20. http://dx.doi.org/10.3357/ ASEM.2039.2007.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Eur J Appl Physiol 2012;112:2131-7. http://dx.doi.org/10.1007/s00421-011- 2187-6.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Physiol 2005;566:901-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochem Biophys Res Commun 2005;333:404-10. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Physiol 2004;555:637- 42. http://dx.doi.org/10.1113/jphysiol.2003.059360.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Med Sci Sports Exerc 2005;37:1319-23. http://dx.doi.org/10.1113/jphysiol.2003.059360.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Mol Cell Biol 2012;32:704-16. http://dx.doi.org/10.1128/MCB.06448-11.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Cell  Physiol 2013;228:2262-70. http://dx.doi.org/10.1002/ jcp.24399.23.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Cell 2001;107:137-48. http://dx.doi.org/10.1016/ S0092-8674(01)00524-4.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Free Radic Biol Med 2012;52:281- 90. http://dx.doi.org/10.1016/j.freeradbiomed.2011.10.484.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Cell Signal 2013;25:1939-48. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochim Bi-ophys Acta 2010;1804:1626-34. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Cell Adh Migr 2010;4:163-5. http://dx.doi.org/10.4161/cam.4.2.10972.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Exp Mol Med 2007;39:8-13. http://dx.doi.org/10.1038/ emm.2007.2.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Mol Cell 2007;28:91-106. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochem Biophys Res Commun 2009;380:644-9. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Cell Biol 2009;185:203-11. http://dx.doi.org/10.1083/ jcb.200809167.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Annu Rev Pathol 2010;5:253-95. http://dx.doi.org/10.1146/annurev.pathol.4.110807.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  246Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Nat Med 2011;18:159-65. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Mol Cell Biol 2009;29:1989-98. http://dx.doi.org/10.1128/ MCB.00552-08.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Handb Exp Pharmacol 2011;206:163-88. http://dx.doi.org/10.1128/MCB.00552-08.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
EMBO Rep 2011;12:534-41. http://dx.doi.org/10.1038/embor.2011.65.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Mol Biol 2008;382:790-801. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Biol Chem 2005;280:13560-7. http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochem J  2012;444:1-10. http://dx.doi.org/10.1042/BJ20120030.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Tren- ds Cell Biol 2012;22:546-54. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Cell Mol Life Sci 2010;67:3073-87. http://dx.doi.org/10.1007/s00018-010-0402-y .,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
At-herosclerosis 2011;218:530-5. http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Metabolism 2008;57:986-98.  http://dx.doi.org/10.1016/j.metabol.2008.02.017.50.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Eur J Appl Physiol 2010;109:731-43. http://dx.doi.org/10.1007/s00421-010-1413-y .,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Eur J Appl Physiol 2009;107:419-27. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Free Radic Res 2012;46:799-808. http://dx.doi.org/10.3109/10715762.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Sports Sci 2009;27:49-58. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Circ Res 2007;100:1512-21. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Mol Cell Biol 2008;28:6384-401. http://dx.doi.org/10.1128/MCB.00426-08.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Am J Physiol Heart Circ Physiol 2011;301:H1255- 65. http://dx.doi.org/10.1152/ajpheart.01279.2010.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Aging Cell 2010;9:304-12. http://dx.doi.org/10.1111/j.1474-9726.2010.00557.x.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Int J Cardiol 2013;168:3160-72. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Genes Dev 2007;21:2644-58. http://dx.doi.org/10.1101/gad.435107.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Eur J Appl Physiol 2013;113:2637-45. http://dx.doi.org/10.1007/ s00421-013-2676-x.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    247Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Aviat Spa-ce Environ Med 2009;80:716-9. http://dx.doi.org/10.3357/ ASEM.2544.2009.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Life Sci 2001;69:1017- 21. http://dx.doi.org/10.1016/S0024-3205(01)01193-6.71.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochem Med 2012;22:237-46. http://dx.doi.org/10.11613/BM.2012.026.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.1016/j.ahj.2006.03.022.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Biochemia Medica 2014;24(2):248–57  http://dx.doi.org/10.11613/BM.2014.027  248Abstract Introduction : This study describes quality indicators for the pre-analytical process, grouping errors according to patient risk as critical or major, and  assesses their evaluation over a five-year period.",Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
http://dx.doi.org/10.11613/BM.2014.027 Biochemia Medica 2014;24(2):248–57    249Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Biochemia Medica 2014;24(2):248–57  http://dx.doi.org/10.11613/BM.2014.027  250Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
http://dx.doi.org/10.11613/BM.2014.027 Biochemia Medica 2014;24(2):248–57    251Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Biochemia Medica 2014;24(2):248–57  http://dx.doi.org/10.11613/BM.2014.027  252Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
http://dx.doi.org/10.11613/BM.2014.027 Biochemia Medica 2014;24(2):248–57    253Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Biochemia Medica 2014;24(2):248–57  http://dx.doi.org/10.11613/BM.2014.027  254Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
http://dx.doi.org/10.11613/BM.2014.027 Biochemia Medica 2014;24(2):248–57    255Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Biochemia Medica 2014;24(2):248–57  http://dx.doi.org/10.11613/BM.2014.027  256Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Ann Saudi Med 2011;31:223-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
"Available at: http://www.aacc.org/publicati- ons/cln/2011/november/Pages/ANewApproachtoQuali- tyControl.asp x. Accessed October 30, 2012.",Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
BMC Clin Pathol 2001;1:5. http://dx.doi.org/10.1186/1472-6890-1-5.,Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem 2007;53:1338-42. http://dx.doi.org/10.1373/clinchem.2007.088344.,Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2009;47:143-53. http://dx.doi.org/10.1515/ CCLM.2009.045.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
http://dx.doi.org/10.11613/BM.2014.027 Biochemia Medica 2014;24(2):248–57    257Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2007;45:708-11. http://dx.doi.org/10.1515/ CCLM.2007.169.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2006;44:150-60. http://dx.doi.org/10.1515/CCLM.2006.028.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Am J Clin Pathol 2009;131:418-31. http://dx.doi.org/10.1309/AJCPJF8JI4ZL - DQUE .,Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2004;42:578- 82. http://dx.doi.org/10.1515/CCLM.2004.100.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2011;49:463-70. http://dx.doi.org/10.1515/ CCLM.2011.067.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem 2012;58:638-42. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2007;45:786-96. http://dx.doi.org/10.1515/CCLM.2007.135.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2011;49:835-44. http://dx.doi.org/10.1515/ CCLM.2011.128.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem 2006;52:1442-3. http://dx.doi.org/10.1373/ clinchem.2006.069534.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2007;45:720-7. http://dx.doi.org/10.1515/CCLM.2007.167.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem  Lab Med 2013;51:187-95. http://dx.doi.org/10.1515/cclm- 2012-0582.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Biochemia Medica 2014;24(2):258–65  http://dx.doi.org/10.11613/BM.2014.028  258Abstract Introduction : We have previously shown that the concentrations of D-dimer are significantly elevated in saliva compared with plasma.",Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
http://dx.doi.org/10.11613/BM.2014.028 Biochemia Medica 2014;24(2):258–65    259Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Biochemia Medica 2014;24(2):258–65  http://dx.doi.org/10.11613/BM.2014.028  260Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
http://dx.doi.org/10.11613/BM.2014.028 Biochemia Medica 2014;24(2):258–65    261Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Biochemia Medica 2014;24(2):258–65  http://dx.doi.org/10.11613/BM.2014.028  262Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
http://dx.doi.org/10.11613/BM.2014.028 Biochemia Medica 2014;24(2):258–65    263Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Biochemia Medica 2014;24(2):258–65  http://dx.doi.org/10.11613/BM.2014.028  264Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
World  Health Organization 2011; Available at: http://www.who.int/mediacentre/factsheets/fs317/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
JAMA 2003;290:898-904. http://dx.doi.org/10.1001/jama.290.7.898.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Circulation 1997;95:2380-6. http://dx.doi.org/10.1161/01.CIR.95.10.2380.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
http://dx.doi.org/10.11613/BM.2014.028 Biochemia Medica 2014;24(2):258–65    265Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Bioanalysis 2013;5:2249-56. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Arterioscler Thromb Vasc Biol 1999;19:493-8. http://dx.doi.org/10.1161/01.ATV.19.3.493.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
J Hypertens 2013;31:2251-8; discussion 8. http://dx.doi.org/10.1097/ HJH.0b013e328363dcc c. 13.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
N Engl J Med 2006;355:2631-9. http://dx.doi.org/10.1056/NEJ- Moa055373.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
J Thromb Haemost 2005;3:1894-904. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Acta Physiol Scand 1992;145:287-93. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Eur J Oral Sci 2006;114:22-6. http://dx.doi.org/10.1111/j.1600-0722 .2006.00264.x.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Lan- cet 1987;2:3-9. http://dx.doi.org/10.1016/S0140-6736- (87)93050-9.18.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Lancet 1993;342:1076-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Stroke 2000;31:26-32.  http://dx.doi.org/10.1161/01.STR.31.1.26.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
N Engl J Med 2000;342:1792-801. http://dx.doi.org/10.1056/NEJM200006153422406.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Clin Chem 2011;57:675-87. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Ce - llular oncology (Dordrecht) 2013;36:1-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Transl Oncol 2012;5:321-6. http://dx.doi.org/10.1593/ tlo.12232.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Clin Transl Med 2012;1:19. http://dx.doi.org/10.1186/2001- 1326-1-19.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Clin Chim Acta 2012;413:1066-70. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Ann N Y Acad Sci  1993;694:72-7. http://dx.doi.org/10.1111/j.1749-6632.1993.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Clin Chim Acta  2007;382:15-9. http://dx.doi.org/10.1016/j.cca.2007.03.009 .,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
J Immunol Methods 2012;377:62-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Blood 2011;117:3172-80. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original papers Abstract Introduction : Urinary tract infection (UTI) is one of the most common bacterial infectious diseases in children.",Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
"Key words : oxidative stress; inflammation; acute kidney injury Received: December 12, 2013 Accepted: April 12, 2014Oxidative status parameters in children with urinary tract infection Stanislava Petrovic1, Natasa Bogavac-Stanojevic*1, Jelena Kotur-Stevuljevic1, Amira Peco-Antic2,3, Ivana Ivanisevic2, Jasmina Ivanisevic1,  Dusan Paripovic3, Zorana Jelic-Ivanovic1 1Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia 2School of Medicine, University of Belgrade, Belgrade, Serbia 3Department of Nephrology, University Children’s Hospital, Belgrade, Serbia *Corresponding author: naca@pharmacy.bg.ac.rs Biochemia Medica 2014;24(2):266–72  http://dx.doi.org/10.11613/BM.2014.029  266Introduction Oxidative stress as a state of imbalance between  oxidant and antioxidant processes of the human body may be both the cause and the consequence of many diseases.",Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
http://dx.doi.org/10.11613/BM.2014.029 Biochemia Medica 2014;24(2):266–72    267Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Biochemia Medica 2014;24(2):266–72  http://dx.doi.org/10.11613/BM.2014.029  268Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
http://dx.doi.org/10.11613/BM.2014.029 Biochemia Medica 2014;24(2):266–72    269Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Biochemia Medica 2014;24(2):266–72  http://dx.doi.org/10.11613/BM.2014.029  270Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
http://dx.doi.org/10.11613/BM.2014.029 Biochemia Medica 2014;24(2):266–72    271Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Biochemia Medica 2014;24(2):266–72  http://dx.doi.org/10.11613/BM.2014.029  272Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Int J Nep - hrol 2012;2012:465897. http://dx.doi.org/10.1155/2012/  465897.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Mediators of Inflamma-tion 2005;4:242-4. http://dx.doi.org/10.1155/MI.2005.242.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Pediatr Nephrol 1991;5:733-42. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
J Pineal Res 2006;41:220-7. http://dx.doi.org/10.1111/ j.1600-079X.2006.00357.x.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Kidney Int 1981;20:34-42. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Exp Mol Pat-hol 1981;34:34-42. http://dx.doi.org/10.1016/0014-4800- (81)90033-2.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Pe - diatr Nephrol 1995;9:583-6. http://dx.doi.org/10.1007/ BF00860942.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Pediatr Nephrol 2009;24:1533-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Clin Biochem 2004;37:277-85.  http://dx.doi.org/10.1016/j.clinbiochem.2003.11.015.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Clin Biochem 2005;38:1103-11. http://dx.doi.org/10.1016/j.clinbiochem.2005.08.008.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Circulation 2003;107:499-511. http://dx.doi.org/10.1161/01.CIR.0000052939.59093.45.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Biomed Papers 2001;145:81-3. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
BMC  Nephrology 2012;13:136. http://dx.doi.org/10.1186/1471- 2369-13-136.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
J Urol 1991;161:1681-4.  http://dx.doi.org/10.1016/S0022-5347(05)69004-0.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Comp Im- munol Microbiol Infect Dis 2004;27:225-34. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
J Urol  1999;162:1396-8. http://dx.doi.org/10.1016/S0022-5347- (05)68319- X.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Eur Surg Res 2006;38:451-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Pediatr Nephrol 2009;24:2375– 80. http://dx.doi.org/10.1007/s00467-009-1246-2.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.030 Biochemia Medica 2014;24(2):273–80    273Abstract Introduction : Postmenopausal women have higher risk of cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Biochemia Medica 2014;24(2):273–80  http://dx.doi.org/10.11613/BM.2014.030  274Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.11613/BM.2014.030 Biochemia Medica 2014;24(2):273–80    275Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Biochemia Medica 2014;24(2):273–80  http://dx.doi.org/10.11613/BM.2014.030  276Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.11613/BM.2014.030 Biochemia Medica 2014;24(2):273–80    277Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Biochemia Medica 2014;24(2):273–80  http://dx.doi.org/10.11613/BM.2014.030  278Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.11613/BM.2014.030 Biochemia Medica 2014;24(2):273–80    279Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Pathop - hysiol Haemost Thromb 2002;32:325-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Eur J Endocrinol 2008;159:233-41. http://dx.doi.org/10.1530/EJE-07-0848.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Athe - rosclerosis 2004;177:203-10. http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1007/s00210-003 -0833-1.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1016/j.atherosclero - sis.2004.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1161/01.ATV.19.9.2214.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1038/ ng1196-334.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1074/jbc.275.6.3957 .,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1016/S0006-2952(03)00401-5.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Biochemia Medica 2014;24(2):273–80  http://dx.doi.org/10.11613/BM.2014.030  280Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1042/CS20040187.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Clin Biochem 2010;43:1375-80. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
"Topçuoglu A, Uzun H, Aydin S, Kahraman N, Vehid S, Zeybek G, Topçuoglu D. The effect of hormone replacement thera-py on oxidized low density lipoprotein levels and paraoxo - nase activity in postmenopausal women.Tohoku J Exp Med 2005;205:79-86. http://dx.doi.org/10.1620/tjem.205.79.23.",OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Dis Markers 2013;35:85-96. http://dx.doi.org/10.1155/2013/724706.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Obstet Gyne - col 1995;85:523-8. http://dx.doi.org/10.1016/0029-7844- (94)00452- J.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Biochim Biophys Acta 2009;1790:155– 60. http://dx.doi.org/10.1016/j.bbagen.2008.11.009.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1007/s00109-003-0481-4.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    281Abstract Introduction : The aim of this survey study was to assess the current practices and policies in use related to the various steps in the blood gas te - sting process, across hospital laboratories in Croatia.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  282Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    283Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  284Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    285Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  286Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    287Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  288Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    289Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  290Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    291Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chim Acta 2003;333:141-5. http://dx.doi.org/10.1016/S0009-8981- (03)00178-5.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chim Acta 2003;333:185-9. http://dx.doi.org/10.1016/S0009-8981- (03)00184-0.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Biochem Med 2012;22:145-9. http://dx.doi.org/10.11613/BM.2012.017.,Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Biochem Med 2013;23:242-54. http://dx.doi.org/10.11613/ BM.2013.031.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Ann Lab Med 2012;32:5-16. http://dx.doi.org/10.3343/alm.2012.32.1.5.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  292Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chim Acta 2013;pii:S0009-8981(13)00331-8. http://dx.doi.org/10.1016/j.cca.2013.08.021.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Bi-ochem 2013;46:1170-4. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chim Acta 2013;pii:S0009-8981(13)00336-7.  http://dx.doi.org/10.1016/j.cca.2013.07.033.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Biochem Med 2010;20:64-74. http://dx.doi.org/10.11613/BM.2010.008.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chem Lab Med 2013;51:2099-107. http://dx.doi.org/10.1515/cclm- 2013-0183.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Respir Care 2013;58:1694-1703. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Biochem Med 2012;22:189-201. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Biochem Med 2013;23:19-27. http://dx.doi.org/10.11613/ BM.2013.005.,Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin  Chem Lab Med 2011;49:931-2. http://dx.doi.org/10.1515/ CCLM.2011.136.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chem Lab Med 2013;51:1651-4. http://dx.doi.org/10.1515/cclm- 2012-0802.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Int J Emerg Med 2009;2:117-20. http://dx.doi.org/10.1007/s12245-009- 0091-1.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
BMC Ane - sthesiol 2012;12:17. http://dx.doi.org/10.1186/1471-2253- 12-17.,Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
http://acutecaretesting.org/en/ar - ticles/the-importance-of-quality-control-qc-to-quality-blood-gas-testing.,Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chem Lab Med 2007;45:774-80. http://dx.doi.org/10.1515/CCLM.2007.163.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chem 2011;57:1219-20. http://dx.doi.org/10.1373/clinchem.2011.171538.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.032 Biochemia Medica 2014;24(2):293–8    293Abstract Introduction : Alpha-1-antitrypsin deficiency (AATD), genetic risk factor for premature chronic obstructive pulmonary disease (COPD), often remains  undetected.",Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Biochemia Medica 2014;24(2):293–8  http://dx.doi.org/10.11613/BM.2014.032  294Beletic A. et al.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
http://dx.doi.org/10.11613/BM.2014.032 Biochemia Medica 2014;24(2):293–8    295Beletic A. et al.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Biochemia Medica 2014;24(2):293–8  http://dx.doi.org/10.11613/BM.2014.032  296Beletic A. et al.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
http://dx.doi.org/10.11613/BM.2014.032 Biochemia Medica 2014;24(2):293–8    297Beletic A. et al.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Biochemia Medica 2014;24(2):293–8  http://dx.doi.org/10.11613/BM.2014.032  298Beletic A. et al.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Available at: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Can  Med Assoc J 2012;184:1365-71. http://dx.doi.org/10.1503/ cmaj.111749.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
http://dx.doi.org/10.1111/joim.12239.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Clin Chem  2006;52:2236-42. http://dx.doi.org/10.1373/clinchem.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Am J Clin Pathol 2007;128:482-90. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Eur Respir J 2010;35:960-8. http://dx.doi.org/10.1183/09031936.00069709.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
J Med Biochem 2014;33:88-96. http://dx.doi.org/10.2478/jomb- 2013-0038.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Available at: http://www.goldco - pd.org/uploads/users/files/GOLDReport_April112011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Biochem Med 2013;23:242-54. http://dx.doi.org/10.11613/ BM.2013.031.10.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
COPD 2013;10(S1):26-34. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Am J Clin Pathol 2012;138:398-405. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Resp Med 2007;101:1708-14. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Ther Adv Respir Dis 2012;6:79-85. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
http://dx.doi.org/10.2174/  138920310790848368.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
http://dx.doi.org/10.1373/ clinchem.2007.095125.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Available from: http://www.odermatol.com/odermatology/22013doi/ourd.20132.52.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/b7/db/rt-2014-2-5343.PMC4083668.pdf
A vailable from: http://ispub.com/IJS/10/1/9804.,Non-OADS,/arxiv_data1/oa_pdf/b7/db/rt-2014-2-5343.PMC4083668.pdf
Available from: http://www.cdc.gov /nchs/data/ nvsr/nvsr61/nvsr61_06.pdf.,OADS,/arxiv_data1/oa_pdf/29/a3/rt-2014-2-5389.PMC4083673.pdf
Available from: http://www.ohchr.,Non-OADS,/arxiv_data1/oa_pdf/56/ad/AMHSR-4-61.PMC4083714.pdf
Available  from: http://www.ilo.org/global/topics/forced‑labour/Letter to Editor,Non-OADS,/arxiv_data1/oa_pdf/56/ad/AMHSR-4-61.PMC4083714.pdf
Available from: http://www.state.gov/g/tip/ rls/tiprpt/2007.,OADS,/arxiv_data1/oa_pdf/56/ad/AMHSR-4-61.PMC4083714.pdf
Available from: http://www.who.int/reproductivehealth/topics/ violence/vaw_series/en/.,Non-OADS,/arxiv_data1/oa_pdf/56/ad/AMHSR-4-61.PMC4083714.pdf
Available from: http://www.iadr.confex.com/ iadr/2005Balt/techprogram/abstract_61038.htm.,Non-OADS,/arxiv_data1/oa_pdf/57/b0/AMHSR-4-18.PMC4083724.pdf
"OTUs were picked using a closed-reference OTUpicking protocol against the Greengenes database 12_10release, http://greengenes.secondgenome.com/ (De Santiz et al.",OADS,/arxiv_data1/oa_pdf/5a/44/ele0017-0979.PMC4084827.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/a6/main.PMC4084856.pdf
"Direct link to deposited data Deposited data are available here: https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE34422 .Experimental design, materials and methods Cell line The human neuroblastoma cell line BE(2)-C was obtained from ATCC (CRL-2268, ATCC).",OADS,/arxiv_data1/oa_pdf/ef/a6/main.PMC4084856.pdf
"Speci ﬁcations Organism/cell line/tissueHomo sapiens Strain(s) Human neuroblastoma cell line BE(2)-C (CRL-2268, ATCC) Sequencer or array type Microarray: Affymetrix Human Gene 1.0 ST ChIP-seq: Illumina Genome Analyzer IIX Data format Microarray raw data: CEL ﬁles ChIP-seq raw data: FASTQ ﬁles Experimental factors BE(2)-C cells without or with HOXC9 overexpression Experimental features Micr oarray gene expression pro ﬁling to identify genes that are regulated by HOXC9ChIP-seq to map genomic sites that are bound byHOXC9 Consent N/ASample source location N/A http://dx.doi.org/10.1016/j.gdata.2014.04.0022213-5960/© 2014 The Authors.",OADS,/arxiv_data1/oa_pdf/ef/a6/main.PMC4084856.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/a6/main.PMC4084856.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/ef/a6/main.PMC4084856.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ .",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/nihms590117.PMC4084858.pdf
Reprints and permissions information is available online at http://www.nature.com/reprints/index.html .,Non-OADS,/arxiv_data1/oa_pdf/3b/f3/nihms590117.PMC4084858.pdf
"This year, Sage and DREAM (Dialogue for Reverse Engineering Assessments and Methods) are running four open challenges ( http://www.sagebase.org/challenges-overview/2013-dream- challenges/ ).",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/nihms590117.PMC4084858.pdf
"Then, during the validation phase, each team will submit computer code, which the Sage- DREAM team ( http://www.sagebase.org/ ) will test in Synapse to establish whether it runs as expected to predict if a subject is an anti-TNF therapy responder or nonresponder on the basis of the GWAS data.",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/nihms590117.PMC4084858.pdf
"2013 published online, http://dx.doi.org/10.1371/journal.pgen.",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/nihms590117.PMC4084858.pdf
© 2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ *Correspondence: asood@mdanderson.org (A.K.S.,Non-OADS,/arxiv_data1/oa_pdf/66/ba/nihms582020.PMC4084868.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes six figures and one table and can be found with this article online at http://dx.doi.org/10.1016/ j.celrep.2014.02.014 .,OADS,/arxiv_data1/oa_pdf/66/ba/nihms582020.PMC4084868.pdf
"A General Role for Complement in Cancer Growth To investigate whether complement proteins could be produced by other cancer cells besides ovarian cancer, we analyzed expression of C3 mRNA in different cancer cell lines using the Cancer Cell Line Encyclopedia (CCLE) database ( http://www.broadinstitute.org/ccle/home ) and identified a high level of C3 expression in liver, kidney, lung, endometrium, and ovarian cancer cell lines (Figure S6A).",OADS,/arxiv_data1/oa_pdf/66/ba/nihms582020.PMC4084868.pdf
TCGA data portal ( http://tcga.cancer.gov ) was used to download information on clinically annotated information on patients with high- grade serous ovarian cancer and squamous cell lung cancer.,OADS,/arxiv_data1/oa_pdf/66/ba/nihms582020.PMC4084868.pdf
"To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-sa/3.0 Correspondence and requests for materials should be addressed to N.H.P.",Non-OADS,/arxiv_data1/oa_pdf/4c/e5/nihms587989.PMC4085046.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/cb/20/OpenMed-08-46.PMC4085085.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/3b/9d/OpenMed-08-54.PMC4085086.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/70/b5/OpenMed-08-67.PMC4085087.pdf
"Avail - able from: http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-21.html#docContBox 2 Controlled Drugs and Substances Act, section 5619  ➣The Minister may, on such terms and conditions as the Minister  deems necessary, exempt any person or class of persons or any controlled substance or precursor or any class thereof from the application of all or any of the provisions of this Act or the regulations if, in the opinion of the Minister, the exemption is necessary for a medical or scientifi  c purpose or is otherwise in the public interest.",Non-OADS,/arxiv_data1/oa_pdf/49/67/OpenMed-08-73.PMC4085088.pdf
"For more information, please see  http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/49/67/OpenMed-08-73.PMC4085088.pdf
Available from: http://hiru.mc - master.ca/hiru/HIRU_Hedges_home.aspx  (accessed 2012 Jun 23).,Non-OADS,/arxiv_data1/oa_pdf/af/68/OpenMed-08-01.PMC4085089.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/af/68/OpenMed-08-01.PMC4085089.pdf
Available   from: http://virtualmentor.ama-assn.org/2002/10/jdsc1-0210.html   (accessed 2013 Dec 10).,OADS,/arxiv_data1/oa_pdf/75/73/OpenMed-08-10.PMC4085090.pdf
Available from: http://en.wiki - pedia.org/wiki/Predictable_surprise  (2013 Dec 10).,Non-OADS,/arxiv_data1/oa_pdf/75/73/OpenMed-08-10.PMC4085090.pdf
Available from:  http://online.wsj.com/article/SB100008723963904434933045780388119 45287932.html  (accessed 2013 Dec 10).,Non-OADS,/arxiv_data1/oa_pdf/75/73/OpenMed-08-10.PMC4085090.pdf
Avail - able from: http://assembly.coe.int/asp/apfeaturesmanager/default   ArtView.asp?ID=918  (accessed 2013 Dec 10).,OADS,/arxiv_data1/oa_pdf/75/73/OpenMed-08-10.PMC4085090.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/75/73/OpenMed-08-10.PMC4085090.pdf
"When necessary, notices on  the MedEffect web site were supplemented by search - ing the product name in the Drug Product Database  (http://webprod5.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp ).",OADS,/arxiv_data1/oa_pdf/42/40/OpenMed-08-14.PMC4085091.pdf
Available  from: http://publications.gc.ca/collections/collection_2007/hc-sc/ H16448-2007E.pdf  (accessed 2013 Sep 26).,Non-OADS,/arxiv_data1/oa_pdf/42/40/OpenMed-08-14.PMC4085091.pdf
"For more information, please see   http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/42/40/OpenMed-08-14.PMC4085091.pdf
Available from: http://dsol-smed.phac-aspc.gc.ca/dsol-smed/ndis/list-eng.php  (accessed 2012 May 28).,OADS,/arxiv_data1/oa_pdf/45/96/OpenMed-08-20.PMC4085092.pdf
Available from: http://travel.gc.ca/travelling/health-safety/clinic  (accessed 2014 Feb 3).,Non-OADS,/arxiv_data1/oa_pdf/45/96/OpenMed-08-20.PMC4085092.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/45/96/OpenMed-08-20.PMC4085092.pdf
Available from: http://hdl.handle.net/10402/era.23788  (accessed 2012 Mar 20).,OADS,/arxiv_data1/oa_pdf/09/75/OpenMed-08-33.PMC4085093.pdf
Available from: http://hdl.handle.net/10402/era.23779  (accessed 2012 Mar  20).,OADS,/arxiv_data1/oa_pdf/09/75/OpenMed-08-33.PMC4085093.pdf
Available from: https://secure.cihi.ca/free_products/Hospitalizations%20for%20ADR-ENweb.pdf  (accessed 2013 Apr 21).,Non-OADS,/arxiv_data1/oa_pdf/09/75/OpenMed-08-33.PMC4085093.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/09/75/OpenMed-08-33.PMC4085093.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 205–212Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  205PERSPECTIVESopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S6390 3Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
"Or use: http://dvpr.es/1vOrUO nBeyond information retrieval and electronic  health record use: competencies in clinical  informatics for medical education William R Hersh1 Paul N Gorman1 Frances E Biagioli2 Vishnu Mohan1 Jeffrey A Gold3 George C Mejicano4 1Department of Medical Informatics  and Clinical Epidemiology,   2Department of Family Medicine,   3Department of Medicine,  4School of  Medicine, Oregon Health & Science  University, Portland, OR, USA Correspondence: William R Hersh   Department of Medical Informatics and  Clinical Epidemiology, School of Medicine,  Oregon Health & Science University,   3181 SW Sam Jackson Park Rd, BICC,  Portland, OR, USA   Tel +1 503 494 4563  Email hersh@ohsu.ed uAbstract:  Physicians in the  21st century will increasingly interact in diverse ways with  information systems, requiring competence in many aspects of clinical informatics.",Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
"com) or medical (eg, PubMed, http://www.pubmed.go v)  search engines.",Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
gov) and the Centers for Disease Control and Prevention  travel site ( http://wwwnc.cdc.gov/trave l).,Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 EDITOR’S NOTE – About This Supplement There are increasing cases of occupational diseases in industrial working places in Korea.",Non-OADS,/arxiv_data1/oa_pdf/79/63/jkms-29-S1.PMC4085167.pdf
"Sung-Tae Hong, MD Editor-in-Chief Journal of Korean Medical Science Department of Parasitology and Tropical Medicine, National University College of Medicine, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2014.29.S.S1  • J Korean Med Sci 2014; 29: S1EDITORIAL",Non-OADS,/arxiv_data1/oa_pdf/79/63/jkms-29-S1.PMC4085167.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Compensation for Work-Related Cerebrocardiovascular Diseases The purpose of this study was to discuss the history of, and concerns regarding, the newly  amended criteria of occupational cerebrovascular or cardiovascular diseases (CCVDs).",Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
"Keywords:  Myocardial Infarction; Cardiovascular Diseases; Stroke; Overwork; Workers’  Compensation; KoreaJong-Uk Won1 and Inah Kim2 1Department of Preventive Medicine, College of  Medicine, Yonsei University, Seoul; 2Department of  Occupational and Environmental Health, Yonsei  University Graduate School of Public Health, Seoul,  Korea Received: 26 December 2013 Accepted: 2 May 2014 Address for Correspondence: Inah Kim, MD Department of Occupational and Environmental Health, Yonsei  University Graduate School of Public Health, 50 Yonsei-ro,  Seodaemun-gu, Seoul 120-752, Korea  Tel: +82.32-260-3664, Fax: +82.32-260-3667 E-mail: ptdoctor@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.S.S12  • J Korean Med Sci 2014; 29: S12-17 INTRODUCTION On November 24, 1990, the Kyunghyang Shinmun  newspaper  printed the first report on karoshi  (death from overwork) in Ko - rea.",Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
• Compensation for Cerebro-cardiovascular Diseases http://jkms.org   S13 http://dx.doi.org/10.3346/jkms.2014.29.S.S12Table 1.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
• Compensation for Cerebro-cardiovascular Diseases S14  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S12Table 4.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
• Compensation for Cerebro-cardiovascular Diseases http://jkms.org   S15 http://dx.doi.org/10.3346/jkms.2014.29.S.S12are Japan and Taiwan.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
• Compensation for Cerebro-cardiovascular Diseases S16  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S12currence) for 12 weeks before CCVD occurrence.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
ORCID Jong-Uk Won http://orcid.org/0000-0002-9200-3297  Inah Kim http://orcid.org/0000-0003-3568-4484  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
• Compensation for Cerebro-cardiovascular Diseases http://jkms.org   S17 http://dx.doi.org/10.3346/jkms.2014.29.S.S12rea.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Work-Related Musculoskeletal Diseases and the Workers’  Compensation  The Industrial Accident Compensation Insurance Act (IACIA) regulates the workers’  compensation insurance system and the standards for the recognition of occupational  diseases (ODs).",Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
"Keywords:  Work-Related Musculoskeletal Disease (WMSD); Occupational Disease;  Workers’ Compensation; KoreaTae-Won Jang,1 Jung-Wan Koo,1   Soon-Chan Kwon,2 and Jaechul Song2 1Department of Occupational and Environmental  Medicine, College of Medicine, The Catholic  University of Korea, Seoul; 2Department of  Occupational and Environmental Medicine,  Hanyang University College of Medicine, Seoul,  Korea Received: 18 December 2013 Accepted: 12 May 2014 Address for Correspondence: Jaechul Song, MD Department of Occupational and Environmental Medicine,  Hanyang University College of Medicine, 222 Wangsimni-ro,  Seongdong-gu, Seoul 133-791, Korea Tel: +82.2-2220-0663, Fax: +82.2-2220-4663 E-mail: jsong@hanyang.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.S.S18  • J Korean Med Sci 2014; 29: S18-23 INTRODUCTION In Korea, standards for the recognition of occupational diseases  (ODs) were stipulated in the Established Regulations of the  Ministry of Labor for the first time when the Ministry of Labor  was established in 1981.",Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
"• Work-Related Musculoskeletal Diseases in Korea http://jkms.org   S19 http://dx.doi.org/10.3346/jkms.2014.29.S.S18that a disease is associated with non-occupational factors rath - er than occupational factors, workers may not be approved for  compensation.",Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
• Work-Related Musculoskeletal Diseases in Korea S20  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S18Table 3.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
• Work-Related Musculoskeletal Diseases in Korea http://jkms.org   S21 http://dx.doi.org/10.3346/jkms.2014.29.S.S18degenerative musculoskeletal diseases related with work could  be considered compensable ODs.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
